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Abstract
Systematic review to identify and appraise outcome
measures used to evaluate childhood obesity treatment
interventions (CoOR): evidence of purpose, application,
validity, reliability and sensitivity
Maria Bryant,1* Lee Ashton,1 Julia Brown,1 Susan Jebb,2 Judy Wright,3
Katharine Roberts4 and Jane Nixon1
1Clinical Trials Research Unit, University of Leeds, Leeds, UK
2Medical Research Council (MRC) Human Nutrition Research, Cambridge, UK
3Institute of Health Sciences, University of Leeds, Leeds, UK
4National Obesity Observatory (NOO), Oxford, UK
*Corresponding author
Background: Lack of uniformity in outcome measures used in evaluations of childhood obesity treatment
interventions can impede the ability to assess effectiveness and limits comparisons across trials.
Objective: To identify and appraise outcome measures to produce a framework of recommended
measures for use in evaluations of childhood obesity treatment interventions.
Data sources: Eleven electronic databases were searched between August and December 2011, including
MEDLINE; MEDLINE In-Process and Other Non-Indexed Citations; EMBASE; PsycINFO; Health Management
Information Consortium (HMIC); Allied and Complementary Medicine Database (AMED); Global Health,
Maternity and Infant Care (all Ovid); Cumulative Index to Nursing and Allied Health Literature (CINAHL)
(EBSCOhost); Science Citation Index (SCI) [Web of Science (WoS)]; and The Cochrane Library (Wiley) – from
the date of inception, with no language restrictions. This was supported by review of relevant grey
literature and trial databases.
Review methods: Two searches were conducted to identify (1) outcome measures and corresponding
citations used in published childhood obesity treatment evaluations and (2) manuscripts describing the
development and/or evaluation of the outcome measures used in the childhood intervention obesity
evaluations. Search 1 search strategy (review of trials) was modelled on elements of a review by
Luttikhuis et al. (Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury VA, O’Malley C, Stolk RP, et al.
Interventions for treating obesity in children. Cochrane Database Syst Rev 2009;1:CD001872). Search 2
strategy (methodology papers) was built on Terwee et al.’s search filter (Terwee CB, Jansma EP,
Riphagen II, de Vet HCW. Development of a methodological PubMed search filter for finding studies on
measurement properties of measurement instruments. Qual Life Res 2009;18:1115–23). Eligible papers
were appraised for quality initially by the internal project team. This was followed by an external appraisal
by expert collaborators in order to agree which outcome measures should be recommended for the
Childhood obesity Outcomes Review (CoOR) outcome measures framework.
Results: Three hundred and seventy-nine manuscripts describing 180 outcome measures met eligibility
criteria. Appraisal of these resulted in the recommendation of 36 measures for the CoOR outcome
measures framework. Recommended primary outcome measures were body mass index (BMI) and
dual-energy X-ray absorptiometry (DXA). Experts did not advocate any self-reported measures where
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objective measurement was possible (e.g. physical activity). Physiological outcomes hold potential to be
primary outcomes, as they are indicators of cardiovascular health, but without evidence of what constitutes
a minimally importance difference they have remained as secondary outcomes (although the corresponding
lack of evidence for BMI and DXA is acknowledged). No preference-based quality-of-life measures were
identified that would enable economic evaluation via calculation of quality-adjusted life-years. Few
measures reported evaluating responsiveness.
Limitations: Proposed recommended measures are fit for use as outcome measures within studies that
evaluate childhood obesity treatment evaluations specifically. These may or may not be suitable for other
study designs, and some excluded measures may be more suitable in other study designs.
Conclusions: The CoOR outcome measures framework provides clear guidance of recommended primary
and secondary outcome measures. This will enhance comparability between treatment evaluations and
ensure that appropriate measures are being used. Where possible, future work should focus on
modification and evaluation of existing measures rather than development of tools de nova. In addition,
it is recommended that a similar outcome measures framework is produced to support evaluation of adult
obesity programmes.
Funding: The National Institute for Health Research Health Technology Assessment programme.
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Glossary
Some of the following glossary/definitions may be presented alternatively elsewhere. These, however, were
specifically chosen to support the Childhood obesity Outcomes Review study.
Design
Eligibility criteria The requirements that a subject must fulfil to be allowed to enter a study. These are
usually devised to ensure that the subject has the appropriate disease and that he or she is the type of
subject that the researchers wish to study. Inclusion criteria should not simply be the opposites of the
exclusion criteria.
End point A variable that is one of the primary interests in a study. The variable may relate to efficacy,
effectiveness or safety.
Feasibility study Pieces of research done before a main study in order to answer the question ‘Can this
study be done?’. Feasibility studies for randomised controlled trials may not themselves be randomised.
Crucially, feasibility studies do not evaluate the outcome of interest – that is left to the main study.
Outcome measure Measure used to evaluate the primary or secondary end points of an intervention
evaluation; the standard against which the end result of the intervention is assessed.
Pilot study A version of the main study that is run in miniature to test whether the components of the
main study can all work together. In some cases this will be the first phase of the substantive study, and
data from the pilot phase may contribute to the final analysis – an internal pilot.
Primary end point The principal end point in a study, providing the primary data.
Secondary end point One of (possibly many) less important end points in a study than the primary
end point.
Sample
Age Age categories have been assigned in extraction of data for the Childhood obesity Outcomes Review
study as follows: infants=< 36 months; child= 36 months to 12 years; adolescents= 13–18 years.
Ethnicity Information has been extracted for the Childhood obesity Outcomes Review study on ethnicities
for all ethnic groups that contribute to at least 5% of the sample within each study.
Weight status Weight status of participants was assigned using the predetermined status reported
within each paper. Data extraction pertaining to weight status includes (1) ‘All obese’; (2) ‘All overweight’;
(3) ‘All overweight or obese’; (4) ‘Mixed stratified’ (includes all weight status groups, with results stratified
by weight status); or (5) ‘Mixed non-stratified’ (includes all weight status groups, but results not stratified
by weight status).
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Evaluation
Reliability
Inter-rater Consistency between raters (people taking/reporting measures).
Internal reliability The extent to which the questions or tasks on a test are similar. It is the correlation
between different items on the same test or scale, and measures whether several items that propose to
measure the same general construct produce similar scores; commonly presented as an alpha result
(with values of > 0.7 generally considered to be acceptable).
Test–retest A measure of the ability of a tool to produce the same result for two different test periods.
The distance/duration between tests should be considered so that any variation detected reflects reliability
of the instrument rather than changes in the behaviour/construct being measured.
Validity
Confirmatory factor analysis A multivariate statistical procedure that is used to test how well the
measured variables represent the number of constructs. Researchers can specify the number of factors
required in the data and which measured variable is related to which latent variable, and confirmatory
factor analysis is a tool that is used to confirm or reject the measurement theory.
Construct Ability of a measurement tool to actually measure the concept being studied (e.g. association
between a food environment tool and dietary intake).
Content How items and domains appear to relate to construct being measured. Often done by experts to
help in the selection of items.
Convergent/concurrent Degree to which the tool relates to other similar tools measuring the same or
similar constructs.
Criterion How closely the tool relates to the criterion measure or the actual truth, which is a reflection of
the success of the tool to predict or estimate something. For example, a tool to measure blood pressure
should closely relate to actual blood pressure taken from a gold standard. Gold standard measure within
each outcome domain have been predefined for the Childhood obesity Outcomes Review study
(i.e. they are not based on what is reported by authors).
Face Whether the test ‘looks valid’, i.e. whether a test looks as if it measures what it is supposed to
measure. Face validity is often established with people who are administering the tool and/or with the
participants for whom the tool is developed.
[Content and face validity have been extracted as part of the Childhood obesity Outcomes Review but
were not dependently scored as part of the internal appraisal (although were considered relevant as part
of appraisal of tool developments within ‘participant involvement’).]
Internal: Exploratory factor analysis Test to explore the possible underlying factor structure of a set of
observed variables without imposing a preconceived structure on the outcome to identify the number of
constructs and the underlying factor structure.
Responsiveness A measure of change over time (similar to Sensitivity to Change); which is often
associated with treatment. Responsiveness can also be measured without an intervention if the construct is
expected to change and refers to the ability of a tool to measure clinically important change (and should
also remain stable when no change has occurred).
GLOSSARY
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Statistical analysis
%variance Percentage of total variance among the variables accounted for by each factor
(factor analysis).
Cronbach’s alpha A coefficient of reliability often used to measure internal consistency. Cronbach’s alpha
values reflect how closely related a set of items are as a group. A ‘high’ value of alpha is often used as
evidence that the items measure an underlying (or latent) construct (with a reliability coefficient of ≥ 0.70
or being considered ‘acceptable’ in most social science research situations).
Eigenvalue (within factor analysis) The eigenvalue for a given factor reflects the variance in all of the
variables, which is accounted for by that factor. The first factor will always account for the most variance
(and hence have the highest eigenvalue), and the next factor will account for as much of the left over
variance as it can, and so on. Hence, each successive factor will account for less and less variance. A factor
that has a low eigenvalue is contributing little to the explanation of variances in the variables and may be
excluded (with eigenvalues of ≥ 1 considered for inclusion).
Factor loading Correlation coefficients between the variables (rows) and factors (columns) in factor
analysis. Cut-offs are arbitrary and vary considerably, but values of between ≥ 0.4 and ≥ 0.7 are often used
to confirm that independent variables are represented by a particular factor. The Childhood obesity
Outcomes Review considered values of ≥ 0.4 to demonstrate sufficient loading.
Intraclass correlation coefficient An index of concordance for dimensional measurements ranging
between 0 and 1, where 0.75 is considered excellent reliability. The Childhood obesity Outcomes Review
considered that intraclass correlation coefficients of ≥ 0.4 demonstrated sufficient correlation.
Kappa coefficients Reliability defined for nominal variables. Kappa is analogous to a correlation
coefficient and has the same range of values (–1 to +1).
Limits of agreement Descriptive measure of agreement and the mean difference between the two tests
± 2 standard deviations, in which 95% of the differences between the two tests lie within this interval.
Pearson’s r (Pearson product–moment correlation coefficient) A measure of the linear relationship
between two variables. Results are presented generally as ‘r values’ and range from +1 to –1. A correlation
of +1 means that there is a perfect positive linear relationship between variables.
Receiver operating characteristic curve (area under the curve) A measure of a diagnostic test’s
discriminatory power, with an area under the curve value of 1.0 theoretically representing a perfect test
(i.e. 100% sensitive and 100% specific) and a value of 0.5 indicating no discriminative value (i.e. 50%
sensitive and 50% specific). The latter is represented graphically as a diagonal line extending from the
lower left corner to the upper right. There are several scales for area under the curve value interpretation
but, in general, receiver operating characteristic curves with an area under the curve value of < 0.75 are
not clinically useful, and an area under the curve value of 0.97 has a very high clinical value, correlating
with likelihood ratios of approximately 10 and 0.1.
Regression Assessment of the relationship between several independent or predictor variables and a
dependent or criterion variable.
Spearman’s rho (Spearman’s rank correlation coefficient) Non-parametric equivalent to
Pearson’s correlation.
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Scientific summary
Background
The lack of uniformity in the outcome measures used in the evaluation of childhood obesity treatment
interventions often impedes the ability to truly assess effectiveness and limits comparisons across trials. In
part, this arises because of the lack of consensus on what outcomes are required and the most appropriate
outcome measures to use within outcome domains.
Objective
This study aimed to systematically review the literature in order to produce a database of outcome
measures that have been used (or developed for use) in childhood obesity treatment interventions and to
use expert appraisal to develop a framework of recommended outcome measures for use as a resource
to guide researchers when designing childhood obesity treatment evaluations. Secondary objectives include
(1) a summary of the description and measurement properties of all outcome measures identified and
(2) a methodology to determine the quality of outcome measures and/or aid in the development of new
outcome measures in this area.
Methods
Search strategy
Two searches were performed with the aim to identify (1) outcome measures that had already been used
in existing evaluations by searching trials of childhood obesity treatment interventions and (2) methodology
studies that developed and/or evaluated the outcome measures for childhood obesity research. Both
searches were conducted in 11 databases and were supported with literature obtained from relevant
citations (including reviews of measurement tools), conference proceedings and information from
registered clinical trials in progress.
Search strategies were developed by the Information Specialist (JW), with contributions of search terms
from the project team. Searches were agreed by the project team and conducted from the date of
inception, with no language restrictions, from August to October 2011. Terms and keywords were selected
for search 1 to identify manuscripts detailing randomised controlled trials (or pilot/feasibility studies) aimed
at evaluating childhood obesity treatment interventions. Search 2 included keywords/terms pertaining to
the development and/or evaluation of outcome measures.
Process of study selection
Assessment of titles and abstracts was performed independently by two reviewers (MB, LA). Agreement
between reviewers was tested after review of the first 130 search 1 papers and the first 50 search 2
papers. For search 1, 98% agreement was reached; for search 2, 96% agreement was reached.
Disagreements were discussed to refine eligibility clarification. Papers were retained at title and abstract
review if there was any degree of uncertainty by either reviewer. Full papers were then assessed against
eligibility criteria, and disagreements were resolved by discussion. Measures had to have been developed
specifically for childhood obesity research or evaluated in a paediatric obese population (or present results
stratified by obesity) and included those in the following domains: anthropometry (primary outcome), diet,
eating behaviours, physical activity (PA), sedentary time/behaviour, fitness, physiology, environment,
psychological well-being and quality of life.
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Data extraction
Data were extracted from relevant search 1 papers (i.e. trials), including information concerning all
included outcome measures used and corresponding citations of measurement development/evaluation
papers. These cited papers were then located and added to search 2 (i.e. methodology) papers. Data
pertaining to the sample, design, development, evaluation and feasibility of each outcome measurement
development/evaluation paper from search 2 were then extracted on prespecified extraction forms.
Disagreements were resolved by discussion.
Quality assessment
Search 1 trials were not judged on quality/bias, as the study outcome information (i.e. intervention
efficacy/effectiveness) was not relevant to the aims of this study. Quality assessment for measurement
papers in search 2 was based on internal and external appraisal of the rigour in development and
evaluation of each outcome measure. For internal appraisal, members of the internal project team (MB, LA)
appraised each outcome measure related to evidence of development, reliability testing and validity testing
using international guidelines for the development of patient-reported outcomes (e.g. Food and Drug
Administration) and previous work already conducted by the chief investigator. This resulted in a database
of outcome measures with a detailed description of each measure, in addition to a parallel assessment of
quality (based on a scoring system). The internal project team then considered whether each measure was
(1) fit for purpose (i.e. recommended for inclusion to the outcome measures framework); (2) not fit for
purpose (i.e. not recommended for inclusion); or (3) uncertain (i.e. requires further consideration). This
decision was based on existing evidence gathered and was reached by consensus. External appraisal was
then conducted via an expert appraisal meeting, which was held (in person) with 10 national collaborators
(plus five applicants). Collaborators were invited based on their experience and expertise within evaluation
of childhood obesity interventions and/or measurement. Prior to the meeting they were provided with
(1) a list of all included outcome measure development/evaluation papers alongside access to all papers;
(2) tables describing each paper (summarised from the data extraction forms); and (3) internal appraisal
documents, including scores for quality (e.g. for development, reliability and validity) and degree of
certainty from the internal appraisal for each measure related to whether it should be included in the final
framework. They were asked to review all measures but to focus on the outcome domain that was most
closely aligned to their area of expertise (defined by the project team). The purpose of the meeting was
then to agree on whether or not each measure was suitable for inclusion in the final outcome measures
framework based on the evidence provided and any relevant personal experience/knowledge in using
the measures.
Methods of analysis/synthesis
This report provides a narrative summary of outcome measures, which are grouped according to outcome
domain. Analysis of reliability and validity testing was considered for appraisal, but results were not pooled.
Results
Results of search strategy
A total of 25,486 papers were identified from both searches. Eligible search 1 papers (of existing
evaluations) cited 417 additional papers linked to included outcome measures, of which only 56 were
eligible methodology papers. A further 323 outcome development/evaluation methodology papers from
search 2 met eligibility criteria. Combined, these 379 papers described 180 outcome measures.
Results of quality assessment
Based on the reliability and validity evidence, eligible measures were appraised by the internal team,
resulting in 29 outcomes that were considered to be fit for inclusion in the framework as a recommended
tool (i.e. degree of certainty= 1); 35 outcomes deemed unfit for inclusion (i.e. degree of certainty= 2); and
121 requiring further consideration (i.e. degree of certainty= 3). External appraisal considered these
findings alongside their experience and expertise, and concluded that 52 outcomes were fit for inclusion
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across the 10 outcome domains (remaining 128 tools deemed unfit (degree of certainty= 2). Of these,
two [body mass index (BMI) and dual-energy X-ray absorptiometry DXA] out of the 38 anthropometry
measures were recommended. In secondary outcomes, recommended tools included 6 (out of 22)
diet measures (all food frequency questionnaires); 12 (out of 22) eating behaviour measures; 4 (out of 24)
PA measures (with no self-reported measures); 1 (out of 6) sedentary time measure; 1 (out of 13) fitness
measure; 1 (out of 12) physiological measure; 10 (out of 12) health-related quality of life questionnaires;
10 (out of 17) psychological well-being measures; and 5 (out of 10) environmental measures.
The childhood obesity outcome measures framework
Recommended outcome measures are presented by outcome domain alongside details relating to
feasibility of implementation (e.g. number of items, costs, licensing, etc.). This framework is a tool to guide
researchers but the final decision for inclusion of measures must be based on those that are (1) aligned
with the targets of the intervention and (2) appropriate for use in a given population (e.g. age/ethnicity
specific). This framework is recommended as an initial guide outcome measure selection. In exceptional
cases when no measures meet the needs of a particular study, a detailed description of all measures
meeting the eligibility criteria is provided so that researchers are able to self-select the most appropriate
measure given the information available on its validity.
Conclusions
The key findings of this study are:
1. Only 13% of trials correctly cited outcome measures used.
2. Approximately 20% of eligible primary and secondary outcome measures were recommended
by experts.
3. Primary outcome measures recommended are BMI or DXA.
4. Objective measurement must be applied if available (i.e. use of activity monitors instead of
self-reported PA).
5. Physiological outcomes have the potential to be primary outcomes (as they are measured with high
precision and are related to adverse health outcomes) but, at present, there is insufficient evidence on
what constitutes a clinically meaningful change (although it is recognised that this is also the case in
existing primary outcomes).
6. Evidence of ability of measures to detect change was poor or lacking.
7. While new tools are pending, there remains no published preference-based measures for use in
economic evaluations in this population. Cost-effectiveness should therefore include measures most
pertinent to the targets of the intervention [e.g. costs per reduction in body mass index standard
deviation score (BMI-SDS)].
8. The proposed recommended outcome measures are fit for use specifically within studies that evaluate
childhood obesity treatment evaluations. They may or may not be suitable for other study designs.
Implications for clinical practice
The results of the expert appraisal provide clear guidance to researchers about appropriate outcomes
domains and recommended measures in each of these domains to encourage greater adoption of
well-validated tools. This will make it easier to judge clinical effectiveness and enhance the comparability
between different studies or treatment interventions. The review also provides details of other measures
That may be appropriate for other settings with details of the extent of methodological testing already
conduced to inform decision-making. Researchers wishing to use novel tools are recommended to adopt
these alongside the recommended tools, wherever possible, to encourage evolution and the development
of new knowledge. Details of the validity of each of the recommended outcome tools provide a
knowledge trail to encourage more accurate reporting of these measures in future studies.
DOI: 10.3310/hta18510 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 51
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Bryant et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii
Implications for future research
In the case of economic evaluations, primary research is urgently needed as this review did not identify a
single measure that was able to calculate quality-adjusted life-years (although we are aware that some
work in this area is in progress). In all other domains, a large number of outcome measures have been
proposed, but in many cases robust evidence of validity is scant. There may be opportunities to make rapid
progress with further testing and modifications, where necessary, of existing measures. Many outcome
measures rely on self-report and more objective measures would add value, especially for dietary
outcomes. There are also opportunities to consider the use of new technologies to replace pen-and-paper
retrospective questionnaires to collect information on some outcomes measures. Given that a number of
different types of outcome measures were identified within many outcome domains, findings from this
study suggest that future research should invest in the modification (if appropriate) and evaluation of
existing measures (not the development of new measures when others are available).
Research is needed to determine the ability of measures to detect change. For some (more historical)
measures, such as BMI, evidence demonstrating a level of precision over multiple assessment periods may
be sufficient. However, there is a lack of testing of responsiveness in many of the recommended
questionnaire outcomes. Lastly, the lack of data describing the clinically meaningful change and/or
appropriate cut-offs was noted as part of the expert appraisal, specifically for anthropometry, physiology
and fitness outcomes.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Aims and objectives
This study aimed to perform a systematic review to identify and appraise existing outcome measuresfor use in the evaluation of childhood obesity treatment interventions. This aim was met via the
following objectives:
1. Systematic review of the literature in order to produce a database of outcome measures that have been
used (or developed for use) in childhood obesity treatment interventions.
2. Appraisal of outcome measures to identify and highlight those that have been developed and evaluated
using high-quality, fully rigorous methods.
3. Creation of a childhood obesity outcome measures framework, categorised by (1) anthropometry/
weight status; (2) diet; (3) eating behaviours; (4) physical activity (PA); (5) sedentary time; (6) fitness;
(7) psychological well-being; (8) quality of life; (9) environmental measures; and (10) physiological
outcomes. This framework was intended to guide researchers as to the best tool to use in their
evaluation of childhood obesity treatment interventions and aimed to include:
l outcome measure description (name, purpose, number of items and mode of administration)
l outcome-specific issues (population intended for, theoretical orientation)
l content (any evidence given for an underlying conceptual model; list of domains/scales covered)
l measurement evaluation properties (development method, item reduction, validity, reliability,
feasibility and responsiveness)
l cost and practical considerations (details of licensing fees, duration of administration).
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Chapter 2 Background
Many interventions to treat obesity are aimed at children but there remains a lack of high-qualityevidence on effective childhood obesity interventions in the literature.1 Existing systematic reviews
aimed at comparing effectiveness of intervention programmes (particularly those conducting meta-analysis)
are hampered by a lack of quality in the conduct and reporting of trials in this area. There has been some
attenuation in the rising rates of childhood obesity in recent years, and it is therefore probable that many
attempts to prevent and treat obesity in children have been of some success.2 The problem, therefore, may
lie in the methods used to evaluate and report interventions.
The degree to which weight management leads to improvements in a child’s health is reflected by
measuring change in outcomes in clinical trials. Outcomes either directly measure a definitive clinical
change (i.e. primary outcome of weight loss) or assess proximal/secondary outcomes (e.g. change in diet)
that impact on the primary outcome. In the design phase of a trial, choosing the appropriate outcomes is
essential. Use of inappropriate outcomes will result in data that are inaccurate or biased and that do not
indicate the effectiveness of an intervention. Moreover, collection of data using poorly chosen outcomes is
a waste of resources, both for the researchers and participants involved in the trial.3 Inappropriate selection
of outcomes in childhood obesity research is probably due to the uncertainty about which outcome
domains are most relevant to children and their families.4 Furthermore, there is a lack of knowledge on
which can be most reliably measured.
Guidance tools are available to facilitate the design of high-quality research, including the Medical
Research Council (MRC) guidance for the evaluation of complex interventions and, more specifically, the
National Obesity Observatory Standard Evaluation Framework (NOO SEF) for childhood obesity evaluation
(www.noo.org.uk/core/SEF).5 The latter (commissioned by the Department of Health) was produced via
consensus of prominent obesity researchers to aid clinicians in their evaluation of childhood obesity
programmes. It now stands as a grounded tool to enable consistency with research design. The primary
audience for the NOO SEF is those evaluating public health obesity programmes. However, much of the
advice is of relevance to researchers conducting trial evaluations. For example, recommended outcomes are
listed and described as ‘essential’ or ‘desirable’. This resembles the output of a core outcome set, although
the inclusion of each outcome has not been based on formal consensus methodologies, such as those
described by ‘COMET’ (Core Outcome Measures in Effectiveness Trials). Core outcome sets are a minimum
set of outcomes that should be measured and reported within trials or other forms of research for a
specific condition (www.comet-initiative.org/). The use of core outcome sets permits comparisons between
trials that are agreed on by experts within each disease area. At present, there is not a core outcome set
for obesity research – partly because of the complexity and variability in intervention targets (requiring
potentially different outcomes). The NOO SEF therefore stands as a guide, rather than a minimum set of
outcomes. Importantly, the NOO SEF does not provide advice or details of outcome measures that should
be used within each outcome domain that it recommends. Although there have been reviews published
on some individual measures and their general application (e.g. measurement of television exposure6),
there has not been a review that has focused specifically on outcome measures for used in childhood
obesity treatment intervention evaluations.
The lack of consensus in determining appropriate outcome measures for the reliable and valid assessment
of childhood obesity interventions means that comparisons between interventions are consequently
difficult, partly because of a shortage of validated outcome measures available, but also because the
selected outcome measures differ between studies. Consequently, it is a challenge to identify which
interventions are most effective. Such a lack of consistency and inadequacy impedes the progress of
childhood obesity research.
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Chapter 3 Methods
Protocol and registration
A current review protocol exists and can be accessed via the Health Technology Assessment (HTA) website
or direct correspondence with the chief investigator [(CI): MB]. Registration of this study was not required,
as there is no process for doing this at present for systematic reviews of outcome measures.
Design
Evidence synthesis
A systematic review that will guide the production of a childhood obesity outcome measures framework
that will be crucial in guiding researchers aiming to assess the impact of obesity treatment interventions in
children. Resulting outcome measures that were identified by this review were appraised by a two-stage
process of internal and external appraisal. A summary of the design is shown in Figure 1.
Search strategy
Two searches were performed to identify outcome measures. Search 1 identified randomised controlled
trials (RCTs), pilot and feasibility studies of childhood obesity treatment evaluation studies [with the intent
of identifying outcome measures (and corresponding citations) already used in trials]. Search 2 aimed to
identify manuscripts describing the development and/or evaluation of outcome measures intended for use
in childhood obesity intervention evaluations.
Both searches were conducted from August 2011 to October 2011 in 11 databases, including MEDLINE;
MEDLINE In-Process and Other Non-Indexed Citations; EMBASE; PsycINFO; Health Management
Information Consortium (HMIC); Allied and Complementary Medicine Database (AMED); Global Health,
Maternity and Infant Care (all Ovid); Cumulative Index to Nursing and Allied Health Literature (CINAHL)
(EBSCOhost); Science Citation Index (SCI) [Web of Science (WoS)]; and The Cochrane Library (Wiley) – from
the date of inception, with no language restrictions.
Search 1 terms: identification of childhood obesity treatment
intervention evaluations
Search concepts included obesity terms and child terms and evaluative studies terms. The evaluative
studies search consisted of focused ‘text-word’ and subject heading searches (MeSH: exp clinical trial/, or
evaluation studies/or meta-analysis/or validation studies/, Randomised Controlled Trials as Topic/). Child
obesity terms identified in the Cochrane Review1 were also incorporated where appropriate. In addition to
full RCTs, pilot and feasibility trials were searched. Differences in the configuration of databases in
particular for the subject heading searches, led to slight adaptations of the terms used.
Search 2 terms: identification of studies describing the development or
evaluation of relevant outcome measures
Search concepts included obesity terms and child terms and outcome measure properties terms. The
search terms for ‘obesity’ and ‘child’ searches replicated those in search 1. Studies evaluating outcome
measures are recognised as difficult to identify owing to a lack of appropriate indexing terms and highly
inconsistent indexing (and text) terms used across database records. The ‘outcome measures properties’
search was adapted from the validated sensitive search filter developed by Terwee et al.7 Terwee’s filter7
offers a 97.1% sensitivity of retrieving all relevant documents and a precision of 4.4% (references that
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pass the screening stage). Again slight adaptations were applied for specific search terms to meet
requirements of each database.
MEDLINE search strategies used are provided in Appendix 1 (search 1) and Appendix 2 (search 2) as
examples of typical strategies used.
Grey literature and evidence from clinical trials databases
Additional searching was conducted via citation searches of studies that satisfied the inclusion criteria for
search 1 – in particular, references on outcome measures used and cited in the relevant treatment
interventions from identified childhood obesity treatment evaluations. Relevant reviews picked up in either
Data extraction
Internal appraisal of measures to identify measures with evidence
of fully rigorous development and evaluation (according to
Scientific Advisory Committee of the Medical Outcomes Trust
guidance or FDA criteria for patient reported outcomes 
and/or consensus)
Final childhood obesity outcome measures framework produced and disseminated through NOO
(signposted to via evaluation web pages and in any SEF updates), peer reviewed publications and
conference presentation
Obesity Outcomes Framework developed 
Framework eligibility: 
Eligible: outcome measures with some evidence of rigour in development and/or evaluation
Ineligible: outcome measures with no evidence of rigour in development and/or evaluation
Presentation: draft Obesity Outcomes Framework produced containing details of eligible
outcome measures
Expert appraisal of measures in a face-to-face meeting
Where data are missing, attempts made to find original outcome
measure development/evaluation papers 
Appraisal
Removed for not meeting eligibility criteria
Inclusion: search (1) RCTs, pilot and feasibility studies of childhood obesity
interventions; search (2) outcome measures developed for use in childhood
obesity interventions
Exclusion: details of outcome measures for adults only/childhood outcomes
not reported separately; letters; editorials; case reports; general reviews or
guidelines
Studies identified through database searching
Additional studies identified through citation searches of reference lists/
bibliographies and grey literature search
Duplicates removed
Screened (title and abstract; full-text screening)
FIGURE 1 Summary of study design. FDA, Food and Drug Administration.
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search were examined to identify any other additional relevant articles. Unpublished literature was
obtained by grey literature, which was sought by searching a range of relevant databases including Inside
Conferences, Systems for Information in Grey Literature (SIGLE), Web of Science Conference Proceedings
Citation Index-Science (Thomson) and ClinicalTrials.gov. The same eligibility criteria were applied for each
of these additional sources.
Data management
Search results were combined and stored in an EndNote© library (Thomson Reuters, CA, USA), and
duplicates were identified and removed. Results of the abstracts and full-text screenings were recorded in
the EndNote Library and appropriately filed (i.e. by inclusion/exclusion according to outcome domain).
Eligibility criteria
Childhood obesity treatment evaluation studies
Study design
Primary research of obesity treatment intervention evaluation studies including: RCTs, pilot studies and
feasibility studies (with the intention of carrying out RCT). Although a quality assessment was not made on
search 1 papers, the decision to focus on only these designs was based on the capacity of the study to
deliver the results in a timely fashion. However, identified papers with pre–post study designs were
retained and are available on request.
Sample
Any childhood study population (≤ 18 years at baseline). Studies with special populations (i.e. those with a
cause of obesity such as Prader–Willi syndrome) were included.
Type of interventions used
Any intervention to treat obesity, including drug and surgery interventions. These are defined according to
categories of strategies set by a Cochrane Review of childhood obesity treatment trials:1
l lifestyle (dietary, PA and/or behavioural therapy interventions)
l drug (orlistat, metformin, sibutramine, rimonabant)
l surgical interventions.
Types of outcome measures used
All studies had to have obesity reduction as a primary outcome, as measured by any of the
following methods:
l body mass index (BMI)/(also known as Quetelet index)
l waist circumference (WC)
l waist-to-hip ratio (WHR)
l skinfold thickness (SFT; multiple sites or one site – measured with calipers)
l mid-arm circumference
l dual-energy X-ray absorptiometry (DXA)
l bioelectrical impedance analysis (BIA)
l hydrodensitometry weighing
l near-infrared interactance (NIR)
l BOD POD (air displacement)
l total body electrical conductivity (TOBEC)
l magnetic resonance imaging (MRI)
l computed tomography (CT).
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Included secondary outcomes are shown in Table 1 below. Against each outcome is a list of all potential
types of outcome measures, which was provided as a means to support identification and categorisation
of outcome measures. It was not exclusive, therefore citations from trials describing the use of additional
outcome measures within prespecified domains could have been included provided all other eligibility
criteria were met.
TABLE 1 Included secondary outcomes with examples of outcome measures
Outcome measure domain Example outcome measures
Diet Weighed food diary/record
Estimated food diary/record
FFQ
Semiquantitative FFQ
Multiple-pass dietary recall
24-hour dietary recall
Food intake checklist [i.e. specific food/groups (e.g. F&V intake checklist)]
Diet history
Diet observation (DVD or direct observation)
DLW
Dietary nitrogen
Eating behaviour Eating behaviour checklists
Eating disorders questionnaires/observations
Feeding styles questionnaires
PA Activity monitor/movement sensors
Activity diaries
Retrospective questionnaires
Activity recalls
Screen time questionnaires
Direct observation (recorded or researcher conducted)
Sedentary behaviour/time Television questionnaires
Screen time questionnaires
Activity monitor/movement sensors
Direct observation
METHODS
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TABLE 1 Included secondary outcomes with examples of outcome measures (continued )
Outcome measure domain Example outcome measures
Fitness HR (resting and/or recovery)
Aerobic capacity/agility (step test, shuttle runs, sprints, timed/endurance runs/walk/bike)
DLW
Respiratory exchange ratio
Packed cell volume
Muscular strength
Muscular endurance
Flexibility
Psychological well-being Self-esteem
Self-perception
Depression
Anxiety
Behaviour
Psychiatric dysfunction
Perceived competence
Body image
HRQoL Quality-of-life scales
Environment Geospatial (food/retail outlets)
Built environment (e.g. neighbourhood layout)
Home environment [physical (e.g. food availability) and social (e.g. rules and policies)]
Physiological Blood pressure
Metabolic markers (e.g. lipids, glucose, insulin, leptin, adipocytokines)
Room calorimetry (CO2/VO2, energy expenditure)
Indirect calorimetry (CO2/VO2, energy expenditure)
DLW, double labelled water; F&V, fruit and vegetable; FFQ, food frequency questionnaire; HR, heart rate;
HRQoL, health-related quality of life; VO2, oxygen consumption.
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Childhood obesity treatment evaluation studies: exclusions
1. Studies without a primary outcome of obesity reduction, such as weight loss, BMI or
adiposity reduction.
2. Those with a secondary aim of obesity reduction (e.g. those with a primary aim to control diabetes).
3. Those providing details of outcome measures for adults (or childhood outcomes are not
reported separately).
4. Obesity prevention studies (or designs other than those listed in the inclusion criteria, including letters,
editorials, commentaries, dissertations, books, errata, notes, introductory, conference proceedings,
meeting abstracts* and case reports).
5. General reviews or guidelines [unless specifically about the evaluation of childhood obesity treatment
interventions (e.g. Luttikhuis et al.1)].
6. Papers without sufficient information to determine eligibility (where author cannot provide
missing information).
7. Those not specifically focusing on all obese subjects for intervention. Sample must all be obese and
not just a proportion (e.g. obesity prevention studies with a subsample of obese).
8. Maintenance studies that are retrospective to studies previously carried out.
9. School-based interventions considered only if the sample is obese and/or stratified, i.e. treatment.
10. Phase I testing for drug trials (i.e. safety, tolerance, effect).
[*Conference proceedings and meeting abstracts were considered for specific conferences only as part of
the grey literature search in search 2 (see below).]
Outcome development/evaluation methodology studies
Study design
Methodological studies describing the development (e.g. conceptual framework) and evaluation of
outcome methods, including quantitative measurement, qualitative assessment, feasibility
and psychometrics.
Sample
Participants must be obese or results have been stratified by weight status (presenting results separately in
obese), or measures had to be developed, modified or utilised for children (≤ 18 years at baseline). Studies
with special populations (i.e. those with a cause of obesity such as Prader–Willi syndrome) were included.
Type of outcome measures
In line with study aims, outcome measures were eligible if they had been (1) previously used as outcomes
in a trial (i.e. cited in search 1 trials) or (2) developed for childhood obesity research. The latter was
defined by demonstration of the following: (1) the underlying concept for development was based on
measurement within childhood obesity; (2) the development/evaluation was conducted in overweight or
obese children; or (3) the results were stratified by weight status categories.
The exception was with primary outcome measures, in which manuscripts were not included purely on the
basis that they had been used previously in a childhood obesity treatment trial. Given the wealth of
literature describing these methodologies, Childhood obesity Outcomes Review (CoOR) eligibility for those
identified in search 2 (methodology papers) were applied. As they were unlikely to be developed
specifically for childhood obesity research, manuscripts describing primary outcome measures were eligible
only if they conducted evaluation in an overweight or obese sample (or stratified results by weight
status category).
METHODS
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Outcome development/evaluation methodology studies
1. Not primary research (letters, editorials, case reports, general reviews).
2. Papers with no data relating to children unless there is evidence that they have been modified or
utilised for children.
3. General reviews [unless specific to outcomes in childhood obesity research (e.g. Bryant et al.6).
4. Papers without sufficient information to determine eligibility (where the missing information cannot be
sourced from the manuscript authors).
5. Comparisons of different cut-off points or population equations [e.g. World Health Organization
(WHO), International Obesity Task Force (IOTF) and Must et al.8].
6. Standards of population-based criteria.
Data extraction process
Data from studies fulfilling the systematic review eligibility criteria were extracted on to prepared
standardised data extraction forms. Where data were missing, attempts were made to find the original
outcome measures papers with data pertaining to the development and evaluation.
There were two phases of data extraction:
l Phase I Trial description extraction (search 1)
l Phase II Outcome measure methodology extraction (search 2 and citations from search 1).
Phase I: Trial description extraction
A description of papers fulfilling the eligibility criteria for search 1 was entered on to a trial specific data
extraction form (see Appendix 4). Three versions of paper-based forms were initially piloted until a final
form was created and incorporated into the ‘Bristol Online Survey’ (BOS: www.survey.bris.ac.uk). This
enabled relocation of all data into an Microsoft Excel 2010 database (Microsoft Corporation, Redmond,
WA, USA). Two modes of extraction (electronic and paper based) were conducted for all manuscripts.
Phase II: Outcome measure methodology extraction
This phase of data extraction included papers that were identified through search 2 (methodology papers)
and papers that were located following a citation search of search 1 (intervention studies) (i.e. sourcing
methodology papers that were cited for each of the measures provided by the evaluation studies). Separate
data extraction forms were developed for the extraction of each outcome domain, as the methodology to
develop and evaluate measures differs. For example, whereas it is common to conduct internal consistency
(IC) on questionnaire measures, this is not appropriate for non-survey/questionnaire measures. Similarly,
gold standard comparators are dependent on the type of measure. As an example, Appendix 5 provides the
data extraction form for the diet domain. Extraction forms for other domains are available on request.
Each data extraction form began with gathering detailed information on the characteristics of the
manuscript (authors, year of publication), study (e.g. country of origin) and sample (e.g. age, ethnicity).
Where possible, predefined categorical responses were developed to avoid the need to code open
response data. Extraction forms then went on to gather information related to outcome measurement
development (e.g. conceptual framework, involvement of users), reliability, validity, responsiveness and
feasibility. Again, predefined categorical responses were developed as appropriate. Specific sections within
reliability included internal reliability (e.g. IC), test–retest (TRT) reliability and inter-rater reliability. Validity
sections included internal validity [e.g. factor analysis (FA)], criterion validity (with prespecified ‘permitted’
gold standard/criterion measures), convergent validity [described here as the association with another
measure, aimed at assessing the same or similar construct(s)], and construct validity (i.e. ability of a
measurement tool to measure the concept being studied). Data describing face and content validity
were also extracted but were considered to be part of the outcome measurement development.
DOI: 10.3310/hta18510 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 51
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Bryant et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
11
Sample size was recorded for each type of evaluation. Validity and reliability evidence was extracted for
each questionnaire scale or category where available. Overall means and ranges were also extracted if
provided by authors. Otherwise, these were derived from data provided in manuscripts. Mean (and ranges)
were then entered into domain-specific tables for each study.
The Bristol Online Survey was not used in extraction of methodology because of difficulties in amending
the on-line form once it had gone live. Given the volume of data to collect across 10 domains (resulting in
several rounds of piloting of the forms), the team decided to extract data using paper forms, which were
then entered directly in Excel.
Unlike all other outcome domains, evaluation of anthropometric tools is generally limited to assessment of
‘criterion’ validity. As this domain also had multiple papers describing the evaluation of the same measures,
it was not necessary to repeatedly extract full information on the method itself. Instead, key findings related
to the population and the validation were extracted. Often, this information was available within the article
abstract, although reviewers extracted information from other parts of the manuscripts as appropriate.
Appraisal of quality of outcome measures
Each outcome measure was appraised for quality in order to identify those that demonstrate rigorous
methods in both development and evaluation procedures. Appraisal involved two stages: (1) internal
appraisal and (2) external appraisal.
Internal appraisal
Principles of international guidelines9,10 were drawn on (where appropriate) to appraise rigour
(i.e. development and measurement properties) of outcome measures meeting eligibility criteria. Measures
within outcome domains were specifically appraised according to its construct and/or clinical context, as
strict adherence to any individual guideline is not always appropriate. For example, many anthropometric
and physiological outcomes are derived from standard clinical tests, and it would therefore be unlikely to
find published data on measurement development in relation to childhood obesity; thus anthropometric
outcome measures were not expected to have involved obese children in the development stage.
Specific international guidelines that were used in developing the data extraction and scoring systems
were the Scientific Advisory Committee (SAC) of the Medical Outcomes Trust guidelines11 and Food and
Drug Administration (FDA) guidelines on the development of patient-reported outcomes (PROs).10
The SAC defines key attributes that should form part of the development and evaluation of instruments.
With this, there are clear rules on what the committee considered to be important in the reporting of a
reproducibility or validation study (e.g. a clear description of the methods of data collection and reporting
of specific estimates and standard errors). In addition, standards for evaluation are provided, such as for
assessment of reliability and some criteria for good measurement properties, including cut-off points for
intraclass correlations. These criteria were used as a guide rather than explicitly regulating which measures
were and were not considered as rigorously developed and evaluated. FDA guidance describes the best
practice in the review, and evaluation of existing, modified or newly created PRO instruments. The criteria
helped to guide appraisal procedures related to the conceptual framework (definition of the concepts
being measured with description of relationships between items/domains and scores) and measurement
properties (reliability, validity, ability to detect change) of each measure. Specific characteristics that were
included in the CoOR appraisal method include concepts being measured, number of items, conceptual
framework, intended use, population for intended use, data collection method, administration mode,
response options, recall period, scoring, weighting, format and response burden.
A scoring system was also applied to the development and evaluation of each secondary outcome
measure. Scores were based on quality in the conduct and results of evaluation where appropriate and
ranged from ‘1’ to ‘4’ (with ‘1’ being the lowest). These were developed from criteria set by the
METHODS
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international guidelines,9,10 in addition to previous research conducted by the lead applicant (MB). For
example, in reporting the study sample, a maximum score of ‘4’ was assigned to manuscripts reporting a
minimum of the four characteristics: age, gender, ethnicity and socioeconomic status (SES). Those
describing three of these were assigned a score of ‘3’ and so on. Appendix 5 provides the data extraction
form for the diet outcome domain in which the scoring system is fully detailed. In addition, Table 2
provides criteria that were applied in assigning scores.
TABLE 2 Criteria used to allocate robustness scores for evaluation of quality
Measurement development and reporting
The concept to be measured was clearly stated
(rationale and description)
4= strongly agree (concepts are named and clearly defined)
3= agree (concepts are named and general described)
2= disagree (concepts named only but not defined)
1= strongly disagree (concepts are not clearly named or defined)
Was a theoretical or conceptual framework used
or referenced?
4= strongly agree (theory/framework used as a basis for development)
3= agree (theory/framework named and incorporated)
2= disagree (theory/framework named but not used)
1= strongly disagree (no theory/framework described)
0=N/A= (biochemical/anthropometry, direct measures/observations)
Populations that the measure was intended for
were adequately described
4= strongly agree (describes at least four characteristics, including age,
gender, race/ethnicity and SES)
3= agree (three characteristics reported)
2= disagree (two characteristics reported)
1= strongly disagree (no characteristics reported)
Were the populations for which the measure
was intended involved in measurement
development?
4= strongly agree (at least three methods of involvement, including
part of study team, steering committee, pilot testing, cognitive
interviews/focus groups)
3= agree (involved using at least two methods)
2= disagree (populations minimally involved in one method)
1= strongly disagree (populations not involved)
0=N/A (biochemical/anthropometry)
Measurement evaluation
Sample size Appropriate statisticsa Results/findings
IC Five or more participants
per item
Cronbach’s alpha α= 0.7
KR-20
(Kuder–Richardson
coefficient)
Split half
TRT reliability ≥ 50 Spearman r= 0.4
Pearson
Kappa κ= 0.4
Agreement Agreement (not used to score but
reported for comparisons)
continued
DOI: 10.3310/hta18510 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 51
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Bryant et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
13
TABLE 2 Criteria used to allocate robustness scores for evaluation of quality (continued )
Measurement development and reporting
Inter-rater
reliability
Study specific (depending
on design)
Pearson/ICC/rho= kappa r= 0.4
K=Kripendorff’s alpha κ= 0.40
FA Five or more participants
per item
Eigenvalue Eigenvalue≥ 1
Factor loading Factor loading= high> 0.6, low< 0.4
%variance CFA RNSEA < 0.06, RNI close to 1
Criterion
validity
≥ 50 [less for objective such
as DLW (≥ 20)]
Pearson Pearson’s/Spearman≥ 0.4
Spearman
Regression Regression coefficient= p> 0.5 or r≥ 0.50
Agreement Agreement
t-test (not in isolation) t-test p> 0.05, t-value > 1
ANOVA
Sensitivity/specificity AUC > 0.7
Convergent
validity
≥100 Pearson Pearson/Spearman≥ 0.4
Spearman
Regression Regression coefficient= p> 0.5 or r≥ 0.50
Agreement Agreement
t-test (not in isolation) t-test p> 0.05, t-value > 1
ANOVA
Sensitivity/specificity AUC > 0.7
Construct
validity
≥ 100 Pearson Pearson’s/Spearman≥ 0.4
Spearman
Regression Regression coefficient= p> 0.5 or r≥ 0.50
Agreement Agreement
t-test (not in isolation) t-test p> 0.05, t-value > 1
ANOVA
Sensitivity/specificity AUC > 0.7
Responsiveness ≥ 100 MCID MCID/SRM > 0.5
SRM
ROC AUC ROC AUC > 0.7
ES ES > 0.5
t-test t-test p< 0.05
ANOVA, analysis of variance; AUC, area under the curve; CFA, confirmatory factor analysis; ES, effect size; ICC, intraclass
correlation coefficient; MCID, minimal clinically important difference; N/A, not applicable; RNI, reference nutrient intake;
RNSEA, root-mean-square error of approximation; ROC, receiver operating characteristic; SRM, standardised
response mean.
a The protocol for consideration of statistical tests that were not listed included consideration by the team statistician (JB).
METHODS
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It was not feasible to assign scores to all of the anthropometry (primary) outcome measure studies.
The majority of manuscripts meeting criteria for eligibility evaluated multiple measures, which would
mean that scores would have to be provided for an amount of studies that was beyond the capacity of
this study (estimated to be > 300 studies). This was also deemed inappropriate, as multiple studies
evaluated the same measures (generating multiple scores for the same measures). Instead, CoOR members
grouped all manuscripts evaluating the same measure and reported the overall conclusions (reported
by authors) of each paper as: (1) yes, authors advocate its use; (2) no, authors do not advocate its use;
and (3) conclusions drawn by authors are unclear (?). The form used to record this information is provided
in Appendix 17 for clarity. (Note: This also provides the findings.)
Internal recommendation of measures to include or exclude
(degreeof certainty)
Two members of the CoOR internal team (MB and LA) classified each of the primary and secondary
measures into one of three categories (by discussion and consensus) in relation to their confidence
of whether or not each measure should be recommended for inclusion into the final CoOR outcome
measures framework: (1) ‘certain, good evidence, fit for purpose’ (i.e. confident that the measure is robust
and should be recommended for use); (2) ‘certain, poor evidence, not fit for purpose’; and (3) ‘uncertain,
requiring further consideration’. Assignment of certainty considered the data extracted from each study
alongside the scoring system. For example, a measure that was assigned a score of 3 out of 4 for quality
of reliability testing was further investigated to determine why one point was lost. If lost because of poor
reporting methodology, the team may have been more likely to deem a measure ‘uncertain’ rather than
‘unfit’ than lost points due to poor results or inadequate sample size. This was conducted separately for
each domain in order to facilitate comparisons between measures (i.e. questionnaire-style outcome
measures would be expected to include a measure of IC, which was not applicable in objective measures.
Similarly, historical physiological measures, such as blood pressure, would not be expected to have
included obese children in their development). Tools were placed into Category 1 or 2 only, providing that
mutual agreement had been established. Category 1 was assigned only when the tool was clearly highly
robust in terms of development and evaluation. Similarly, Category 2 was assigned only when the tools
was very poorly developed and evaluated. Any disagreements were placed into Category 3 to be further
discussed at the expert appraisal meeting.
Expert appraisal
Results of the systematic review and corresponding files from the internal appraisal were reviewed by
experts with specific proficiency in each outcome, in addition to methodological experts. Each expert was
asked to review all of the included outcome measures that met eligibility criteria of CoOR, as well as
considering the internal appraisal decisions. Figure 2 shows the process in which external appraisal
was conducted.
In Phase I, experts were provided with all materials (via a web-based file share facility: Dropbox). Provided
documents included:
1. A list of all included manuscripts (with information on the pathway in which each was included).
This included manuscripts that did not fully meet eligibility criteria but which the internal team felt had
potential for inclusion.
2. PDFs of all manuscripts meeting eligibility criteria (with copies of measurement questionnaire
if available).
3. Summary tables providing details of all data that were extracted for each measure according to domain
(see Appendices 6–15).
4. Tables providing internal scoring for development and evaluation of each measure (see
Appendices 18–26).
5. Appraisal decision of certainty for each measure [see Appendix 17 (primary) and Appendix 28
(secondary)].
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Experts were asked to look at material for all 10 domains. As part of Phase II, they were then asked to
more closely examine documents within areas of their expertise (predefined by the CoOR team), so that
they could lead discussion in these domains at a future face-to-face meeting. Experts involved were Susan
Jebb and Carolyn Summerbell (diet and eating behaviours), John Reilly (anthropometry/weight status),
Ashley Cooper and Ulf Ekelund (PA and sedentary time/behaviour), Lucy Griffiths and Andrew Hill
(psychological well-being), Maria Bryant and Steven Cummins (environmental outcomes), Paul Kind
(economics/quality of life), and Julian Hamilton-Shield (physiological outcomes). Two further consultants
with expertise in outcome evaluation and clinical trial methodology reviewed the framework (Claudia
Gorecki and Julia Brown, respectively). In addition, a specialist in public health evaluation from the NOO
(Katharine Roberts) facilitated in consideration of measure applicability for public health interventions.
Experts were provided with instruction asking them to consider factors such as appropriateness of
categorisation (i.e. ensure within correct outcome domain); obvious omissions not identified by search
strategy (including knowledge of modified versions of outcomes); and personal and theoretical experience
of use of outcome measures related to feasibility.
Phase III of the external appraisal involved a face-to-face meeting with all experts. A physical (rather than a
remote) meeting was chosen because it was more likely to create a richer, in-depth discussion of the
inclusion (or exclusion) of all outcomes. Experts were provided with a short presentation by the CI (MB)
describing the study aims and methodology. They were then divided into two groups. Group A included
experts for the domains: diet, eating behaviour, psychological well-being, economics/health-related quality
of life (HRQoL) and environment. Group B included experts from the domains of anthropometry, PA,
sedentary behaviour/time, fitness and physiology. Discussions began by determining expert agreement
on the internal appraisal decisions ‘1’ (certain, fit for purpose) and ‘2’ (certain, unfit for purpose).
Disagreements were resolved by discussion. Outcome measures that had been given an internal appraisal
decision of ‘3’ (uncertain, requiring further consideration) were then more fully discussed. Justifications
for decisions were provided at the meeting and final rulings of the tools were made based on consensus.
This was recorded directly on to a predefined pro forma that permitted the recording of internal and
external decisions (see Appendices 16 and 27), alongside any relevant discussion. In addition, discussions
from both groups were recorded and transcribed.
After each group had made decisions regarding certainty, a final discussion was held by both groups
together to review key decisions. All final decisions contributed towards the development of a provisional
framework, which was then forwarded to each expert to secure their final agreement (Phase IV).
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Note: At the time of the expert appraisal meeting, data from some of manuscripts had not been extracted.
These included those that had to be ordered by The British Library and which had not yet been delivered
to the team. The exact same methodology was later applied to these manuscripts; however, experts
were asked to review them remotely. Outcome measures that were appraised using this approach are
highlighted within Appendix 16. The exception to this was with manuscripts written in languages other
than English. Where possible, data were extracted via translation of methodology papers. However, these
were not appraised for quality.
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Chapter 4 Results
Number and type of studies identified
Combined, searches 1 and 2, conducted in 11 databases, identified 25,486 manuscripts (after removal of
8674 duplicates). A further 25 were identified through hand-searching [grey literature, citations and
references from relevant reviews (including manuscripts cited in 48 reviews)]. Of these, 14,419 were
search 1 trial manuscripts and 11,092 were search 2 methodology manuscripts. Screening for eligibility at
both the title and abstract stage and the full paper review resulted in the inclusion of 200 trial manuscripts
from search 1. After data were extracted from these papers, 417 further manuscripts were identified that
were citations linked to the outcome measures used by the trials. However, only 56 cited methodology
manuscripts met eligibility criteria for inclusion as methodology papers. The majority of other citations
were linked to a previous study using the outcome measure (i.e. not papers describing development or
evaluation) or were completely incorrect citations (28 were duplicates, already found in search 2).
Screening of search 2 methodology papers resulted in the inclusion of 320 manuscripts meeting eligibility
criteria. Combined with search 1, a total of 376 manuscripts were identified that described 180 outcome
measures (Figure 3).
Note, although this study did not exclude manuscripts that were not written in English, there was no
formal protocol for translation or extraction of papers. Eligible manuscripts written in languages other than
English (n= 53) that were identified via search 1 are listed in Appendix 27 but data have not been
extracted from them. Manuscripts written in languages other than English (n= 23) that were identified via
search 2 (i.e. pertaining directly to development/evaluation of outcome measures) were included for data
extraction. These are listed within study findings and the language is indicated in the detailed summary
tables (see Appendices 5–14). However, as the level of extraction was not as detailed as with English
papers, measures described by these papers were not considered in appraisal unless already included
within another study manuscript written in English.
Number and type of studies excluded, with reasons
In search 1 (of trials evaluating obesity treatment interventions), a large number of identified studies
(almost 13,000) were not eligible for inclusion when screened by title and abstract. Description of the
reasons for exclusion for each of these has been noted and is available on request, but is it not feasible
to provide here (non-eligible manuscripts are also listed in supplementary on-line material). Details are
provided for the 1175 manuscripts from search 1 that were excluded at full-text screening. Of these,
200 papers did not have a primary outcome of obesity reduction, 30 had a secondary aim of obesity
reduction and 85 papers focused on the prevention of childhood obesity. The sample in 465 of the papers
was reported in adults or was not reported by children separately. Three hundred and fifteen manuscripts
reported a non-eligible study design and one paper was a Phase I trial for drug testing. In 20 papers a pilot
study was implemented but failed to express any intentions of producing a future RCT. Twenty-eight did
not specifically focus on all obese children for the intervention (i.e. school-based interventions with a
subsample of obese). Twenty-one papers were weight maintenance evaluations, with most investigating
the long-term success of interventions that had already been identified. Eight manuscripts described
studies that had already been published (i.e. several publications coming from the same trial). A further
two papers were without sufficient information to determine eligibility. Two reviewers independently
screened manuscripts for eligibility (MB and LA). To ensure consistency, the first 132 articles were reviewed
by both people, which resulted in an agreement of 98% (two disagreements). Issues related to these
disagreements were discussed and the protocol was amended as appropriate.
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In search 2 (methodology papers), 421 manuscripts failed to meet the inclusion criteria at full-text
screening and were excluded from the review. Of these, 107 papers had an ineligible design (with no
assessment of development and/or evaluation of outcome methods for childhood obesity treatment
intervention evaluations), and seven papers conducted minimal psychometric testing and the development/
evaluation was not the main aim of the paper. One hundred and seventy-one papers did not include an
obese sample or results were not stratified by obese. In 95 papers, outcome measures were developed for
adults and had not been modified for children. Six manuscripts described studies that were not primary
research (i.e. reviews, editorials, case reports, etc.), 19 manuscripts compared cut-off thresholds or
population equations (e.g. WHO vs. IOTF cut-offs) and 11 considered reference standards for population
databases. Two further papers assessed the evaluation tools that were not outcome measures. One study
included psychometric testing but results were also available in another publication, and one study
included an outcome measure within a domain not specified in Table 1. Finally, one paper was without
sufficient information to determine eligibility. Agreement between reviewers for search 2 papers was 96%
(48 out of 50 agreed). Similar to search 1, issues with disagreement were resolved by discussion and the
protocol was amended to clarify these issues.
Study characteristics
Manuscripts describing childhood obesity treatment trials
Data were extracted from 200 manuscripts describing the evaluation of a childhood obesity treatment
intervention (see Appendix 3). The majority (156 manuscripts) described a phase III evaluation of a
childhood obesity treatment. Nine manuscripts described a feasibility study, 30 manuscripts described a
pilot study and nine manuscripts were protocol papers for future RCTs. Publication dates ranged from
1960 to 2012, and included sample sizes ranging from 811 to 2112.12 Most studies evaluated a lifestyle
intervention, but there were also evaluations of cognitive interventions, drug and surgical interventions,
drug/surgical interventions combined with lifestyle change and those that focused on reducing sedentary
behaviours. Figure 4 shows the different types of primary outcome measures used by identified trials. The
most common primary outcome was BMI [including those deriving body mass index standard deviation
score (BMI-SDS) or %BMI]. However, measurement of weight was also popular, with 37 evaluations
assessing absolute weight or percentage weight change as the primary outcome.
Eighty-two (41%) of trials included a measure of diet as a secondary outcome. Sixty-eight (34%) studies
included a measure of PA, with the most popular measures being activity recalls and objective measures
(e.g. accelerometers or pedometers). Seventy (35%) of the trials included an evaluation of psychological
BIA, 1 (1%)
BMI, 38 (19%)
BMI-SDS, 49 
(24%)
BMI-SDS
self-report, 1 (1%)
DXA, 10 (5%)
Skinfold, 2 (1%)
WC, 3 (1%)
Weight , 68
(34%)
Weight
self-report,
3 (1%)
Percentage
BMI, 26
(13%)
FIGURE 4 Frequency (%) of primary outcome measures used in search 1 trials.
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well-being, measuring a variety of concepts, including self-esteem, depression and body image.
Physiological measurement was also popular, with 94 (47%) trials measuring outcomes such as blood
pressure, insulin or blood lipids. Other secondary outcomes were used less frequently (Figure 5).
Four hundred and seventeen citations that were linked to primary and secondary outcome measures within
all of the 200 included manuscripts were located. However, only 56 of these referred to manuscripts that
described the development and/or evaluation of outcome measures. Incorrect citations were linked to the
majority of outcome measures, most commonly linking to a previous study that had used the
same measure.
Manuscripts describing the development/evaluation of outcome measures
A total of 379 manuscripts that describe the development or evaluation of 180 measures met inclusion
criteria to CoOR. Fifty-six of the included manuscripts were derived from searching citations of the trials
(from search 1) and the remaining 323 were identified directly from search 2. Of these, 24 were written in
a language other than English. Efforts were made to translate these (and gain information from English
abstracts), resulting in the inclusion of all except for three studies.13–15 A further paper that was not
translated describes a measure that has already been included within the eating behaviour domain.14 It has
been included in the summary table (see Appendix 8), but no data have been extracted from this paper.
Table 3 provides detail on the number of manuscripts and corresponding measures (excluding the three
written in non-English that could not be translated). Some manuscripts evaluated more than one measure
(hence there is a discrepancy between the number of manuscripts and the number of studies). In addition,
some measures have multiple manuscripts describing their evaluation, thus the number of manuscripts and
number of measures are not equal.
Findings of the systematic review
The following text summarises data extraction of measures pertaining to evaluation of reliability and
validity within outcome domains. Key findings are provided with ’in-text’ citations for some manuscripts.
However, given the volume of included manuscripts, not all are cited within the text. However, full details
of data extracted from every manuscript are provided in the corresponding Appendices 5–14 and within
the reference list.
Anthropometry
Data from a total of 162 papers with 38 tools were extracted (see Appendix 6). Of these 162 manuscripts,
15 were written in a language other than English. Data were extracted only from abstracts (which were
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Eating behaviours,
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PA,
68 (34%)
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time/behaviour,
19 (9.5%)
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46
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Psychological
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70 (35%)
Quality of life,
17 (8.5%)
Environment, 
6 (3%)
Physiology, 94
(47%)
FIGURE 5 Frequency (%) of trials using each type of secondary outcome.
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available in English); however, all non-English papers described further evaluation of outcome measures
that were also described in multiple other papers written in English. Appraisal decisions to ‘recommend’ or
‘not recommend’ tools were therefore not based on non-English papers.
Of the 162 papers, only eight evaluated the validity of primary outcomes against a gold standard measure
of body composition using either the four-compartmental (4C) model16–19 or total body water (TBW) by
deuterium dilution.20–24 Each of the four papers using the 4C model as a gold standard describes the
validation of DXA [with Gately et al.17 also validating air displacement plethysmography (ADP) and total
body water]. Wells et al.16 and Gately et al.17 validated DXA in 174 and 30 overweight and obese
adolescents, respectively. Findings were similar, with Gately et al.17 finding that the total error and mean
difference [± 95% limits of agreement (LOA)] compared with the 4C model were 2.74 kg and 1.9 kg
(± 4.0 kg), respectively, and Wells et al.16 finding similar LOA at ± 4.2 kg, with overestimations of fat mass
by DXA of 0.9 kg. However, interpretation of these results differs by authors, with Wells et al.16 applying
more caution to the validity of DXA. Additionally, Wells et al.16 showed that the bias in fat mass was
significantly related to the magnitude of fat mass (so that greater inaccuracies were seen with increasing
fat mass). Further longitudinal analysis was conducted by Wells et al.16 in a subsample of 66 children.
Although average bias was not found to differ significantly from zero for ‘change’ in both lean mass and
fat mass, the LOA in individuals were described as ‘large’ (± 3 kg) compared with an average weight
change of 1.7 kg (lean mass) or 0.6 kg (fat mass). Combined with problems encountered in actually using
the equipment in very obese children, authors conclude that further work (including investment by
companies manufacturing DXA machines to develop technology capable of measuring obese participants)
may be required to enhance measurement accuracy. Variability in accuracy in DXA according to other
factors was also found by Williams et al.18 in a study that compared groups of obese children, ‘normal’
weight children and children with cystic fibrosis. Bias in measurement was found according to the sex, size,
degree of adiposity and disease state of the subjects, indicating that DXA is unreliable for studies of
persons who undergo significant changes in nutritional status between measurements (comparisons with
obese children were based on 28 children). The final paper identified by CoOR in which DXA was validated
against the 4C model also highlighted limitations of the method, although concluded that it remains of
use in longitudinal population comparisons.19 Comparisons were made in per cent body fat in a sample of
children and adolescents and show a mean difference between DXA and 4C of −3.5% (p= 0.171), with
LOA at +5% to −12%.
TABLE 3 Number of eligible manuscripts with corresponding measures by outcome domain
Outcome domain No. of manuscripts No. of studies No. of measures
Anthropometry 162 (including 15 non-English) 258 38 (none exclusively non-English)
Diet 40 44 22
Eating behaviour 39 (including one non-English) 40 22 (none exclusively non-English)
PA 35 45 24
Sedentary time/behaviour 5 6 6
Fitness 14 14 13
Physiology 28 (including two non-English) 28 12 (none exclusively non-English)
HRQoL 25 (including three non-English) 25 16 (including three non-English)
Psychological well-being 19 20 17
Environment 9 10 10
Total 376 490 180
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Further comparisons by Gately et al.17 were made between the 4C model and other anthropometrie
measures of ADP and TBW, finding strong correlations for all measures (r≥ 0.95, p< 0.001; standard
error≤ 2.14). The anthropometric measurement demonstrating the highest validity in this study was ADP
(total error 2.5, mean difference 1.8 kg, 95% limit of agreement ± 3.5 kg for ADP with Siri equations, and
total error 1.82, mean difference 0.04 kg, ± 3.6 for ADP with Loh equations).
Many studies evaluated BIA, but only two reported comparisons against the gold standard methodology of
TBW by deuterium dilution.21,24 Wabitsch et al.24 was also one of the few studies to measure the ability
of a measure to detect change following an intervention. In comparisons between BIA and TBW,
cross-sectional comparisons showed good agreement between BIA and TBW. However, correlations were
poor (r= 0.21) with change, where BIA was not accurate at predicting small changes in TBW. Rush et al.21
also used the deuterium dilution method to compare BIA and BMI in their study of 172 children and
adolescents, although the focus of the paper was actually to develop predication equations in three ethnic
groups. A further study made comparisons with a three-compartmental (3C) model25 and found that BIA
(using Tanita equations) overestimated fat-free mass by 2.7 kg (p< 0.001), although new equations by the
authors improved correlations.
Fifty-five papers tested the use of BMI as a valid measure of change in body fat by deuterium dilution.22,23
Findings from these suggest that fat mass (from TBW) is well correlated with BMI across ethnic groups
(Caucasians r= 0.81, p< 0.001; Sri Lankans r= 0.92, p< 0.001)22 and genders (girl r= 0.82, p< 0.001;
boy r= 0.87, p< 0.001), but that BMI cut-offs often fail to detect obesity as defined by the gold standard
methods. Use of self-reported BMI, however, often failed to produce correlations that were sufficient to
suggest that they are of use for individual-level assessment, although they may be adequate to study
trends on a population basis. This type of evaluation was common in the CoOR review, with 39 papers
describing comparisons between self-report (or parental report) and measured height and weight.
Evaluation of SFT was also common in manuscripts identified by CoOR, with 24 studies reporting
validating various types of skinfold measurements. Of these, just four studies26–29 present strong validity to
advocate its use. However, none of these four studies validated against gold standards of the 4C model or
TBW. Of the 20 studies evaluating WC reviewed here, 10 reported an adequate level of validity for WC.
However, none of these made comparisons with gold standards of the 4C model or TBW.
Diet
A total of 44 studies (within 40 manuscripts) describing 22 different types of dietary assessment
methodologies were extracted (see Appendix 7). These included 16 different food frequency
questionnaires (FFQs), plus other methodologies described in Figure 6.
Diet method × 22Manuscripts × 44
21
3 
11
6
1
1
1
16 × FFQs 
Diet history 
Food diary
Recall
Mixed methods
Biomarker
Observation
FIGURE 6 Diet methodologies included in appraisal.
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Summary findings are shown in Appendix 7. Sixteen FFQs/checklists were described in 21 manuscripts,30–51
of which 10 assessed TRT reliability, with results varying across studies (r= 0.16–0.74). In general, however,
most were classed as adequate. Convergent validity was tested in 13 studies, comparing FFQ data with
24-hour recalls and food records (weighed and estimated). Correlations ranged from 0.23 to 0.66, and
kappa statistics ranged from 0.08 to 0.67. Criterion validity, comparing against the ‘gold standard’ of
direct observation, measure of habitual energy expenditure by doubly labelled water (DLW) or other
biomarkers was conducted in four FFQs, with correlations ranging from 0.01 to 0.91. Worryingly, large
LOA were often evident in these studies. IC was tested for two FFQs, with both showing strong alpha
coefficients ranging from 0.84 to 0.88.30–33 Construct validity was evaluated in three papers – with
comparisons between the FFQs and (1) screen time,34 (2) BMI,52 and (3) diet quality35,52 – showing variable,
but generally significant, correlations (see Appendix 7).
Diet history methods were described in three identified manuscripts.53–55 Reliability testing was not
reported in any of these papers. Each assessed criterion validity against a gold standard method, but
results indicated an impact of BMI on validity. No other evaluation was reported for diet history methods.
Diet diaries were evaluated in 11 of the identified papers.56–64 Of these, one56 tested inter-rater reliability
using a tape-recorded method, with correlations ranging between 0.68 and 0.96. None of the papers
assessed TRT reliability. Criterion validity was evaluated in 10 diet dairy papers, with many reporting
significant effects of weight, BMI or other measures of adiposity on validity.55,57–63 The only paper that
reported no misreporting by body weight was O’Conner et al.64 in their study of 45 children. This paper64
reports low relative bias [mean difference, energy intake (EI) – total energy expenditure (TEE)= at 118 kJ/day]
but with wide LOA (bias plus or minus two standard deviations of the difference) at 118± 3345 kJ/day.
Bias was associated most strongly with reported fat intake.
Recall methodologies were evaluated in six papers, of which findings for reliability and validity testing were
variable. Two papers reported evaluating TRT reliability.65,66 Edmunds et al.66 compared ‘A Day in the Life’
questionnaire (a 24-hour recall method) collected twice, 2 days apart, and found non-significant
differences overall, indicating good TRT reliability. Baxter et al.65 conducted general-linear-model
repeated-measures analysis in which diet was recorded over three time periods and included comparisons
between different weight status groups. The effect of time period (i.e. repeated measures) was significant,
indicating poor repeatability, with a significant interaction by weight status (with greater inaccuracy in
overweight children). Comparisons of each of these methods was against direct observation of eating
episodes. Two diet recall evaluation papers described different forms of inter-rater reliability,56,66 both
providing strong evidence. Van Horn et al.56 compared child report with parental report and show
correlations of r= 0.75 (range 0.65–0.93). Edmunds et al.66 made comparisons between coder and
reported a kappa range of between 0.82 and 0.92.66 Five of the six recall papers evaluated criterion
validity, four of which made comparisons with direct observations33,65–67 and one with DLW.68 Findings
from comparisons with direct observation are difficult to compare, as each was conducted using different
analytical approaches. In general, however, criterion validity using this type of comparator indicates
moderate agreement (see Appendix 7). Johnson et al.68 compared 3-day dietary recalls to data from
DLW in 24 children and reported a poor correlation between reported EI and that estimated by DLW
(r= 0.25, p= 0.24). LOA were −4612± 3356 kJ/day, with a mean difference of −225.1 kJ/day. Precision,
however, was not correlated to body weight.
Three other dietary assessment methodologies meeting eligibility criteria were included. The first describes
the measurement of biomarkers insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding
protein 1 (IGFBP-1) and insulin-like growth factor binding protein 3 (IGFBP-3),69 and reports that, as an
indicator of construct validity, overweight children had higher serum levels of IGF-1 and IGFBP-3 but lower
levels of IGFBP-1. Consequently, biomarker measurement (especially IGF) is advocated by the authors.
The second paper describes the development and preliminary evaluation of a dietary observation method
for use within child-care settings70 in which trained researchers attend centres to view dietary consumption
by children. This paper reports excellent inter-rater reliability between observers of 100% agreement for
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most food items observed. One further paper71 describes the use of a mixed-method approach, including
24-hour recall, FFQ and nutrition, and PA behaviours. The primary purpose of this paper was to compare
self-reported EI across weight status groups. However, further evaluation is reported within the methods
section (see Chapter 3) specifically for evaluation of the recall component (linked to previous abstracts).
Findings indicate good reliability [TRT agreement of 77% overall (range= 62–87%) and inter-rater
reliability between self-report and dietitian report of r= 0.55–0.70]. However, comparisons with direct
observations (for 24-hour recall data) indicate a systematic under-reporting of dietary intake by gender and
weight status.
Eating behaviour
A total of 40 studies (within 39 manuscripts), describing 22 measures of eating behaviours, met the eligibility
criteria. A description of data that was extracted from all studies is presented in Appendix 8. Of these, one
manuscript was written in Portuguese.14 It was not possible to extract data from this manuscript but the
measure that it describes was evaluated by two other manuscripts.72,73 It is included in Appendix 8 for
reference purposes only.
Broadly speaking, eating behaviour questionnaires included those that targeted feeding styles/behaviours
or those that measured affect/emotions related to eating, although some measures included both. Feeding
questionnaires [e.g. Infant Feeding Questionnaire (IFQ) and Preschool Feeding Questionnaire (PFQ),74 Child
Feeding Questionnaire (CFQ),75 Infant Feeding Style Questionnaire (IFSQ)76] included constructs such as
concern, control, difficulties in feeding, pressure, restriction, etc. Measures of emotional eating [e.g. the
Emotional Eating Scale for Children (EES-C),77 Dutch Eating Behaviour Questionnaire (DEBQ),78,79 Eating in
the Absence of Hunger-Children (EAH-C)80] included constructs of eating in response to emotions,
enjoyment of food, satiety, external eating, etc. However, there was little consistency across measures in
the terms/names provided to describe similar constructs. Eligible studies also included those that described
the development/evaluation of measures that screened for disordered eating, many of which had been
included because they had been previously used in childhood obesity treatment trials. The suitability of
these measures was questioned at the point of review, but decisions were left to the expert collaborators
group (see Chapter 3, Expert appraisal).
Internal consistency assessment was common in eating behaviour questionnaires and was tested in 30 studies
(alpha range= 0.54–0.90). Of these, 21 were considered acceptable (α> 0.70). TRT reliability was performed
in 12 studies,73,77,80–89 also demonstrating high correlations (r= 0.58–0.81). Results from inter-rater reliability
testing, however, were less strong; this was assessed in five studies,81,90–93 three of which compared child
self-report with parent report.90–92 Johnson et al.68 reported a poor agreement of 41% (κ= 0.19) for their
evaluation comparing findings from the Questionnaire of Eating and Weight Patterns (QEWP) reported
by adolescents (QEWP-A) and the QEWP reported by parents (QEWP-P). This was later repeated by
Steinberg et al.,91 again demonstrating discordance between reports, with children reporting more
disordered eating (sensitivity= 24%, specificity= 82% for diagnosis of overeating; sensitivity= 20%,
specificity= 80% for diagnosis of eating disorders). Relatively low correlations were also observed by
Braet et al.92 in comparisons between child-reported DEBQ (DEBQ-C) and parent-reported DEBQ (DEBQ-P),
with a range in correlations of between r= 0.35 and r= 0.45. Agreement between parents may be more
similar and this was found by Haycraft et al.93 in their evaluation of the CFQ (r= 0.66, range= 0.53 to 0.78).
Similarly, better inter-rater reliability was observed in correlations between interviewers, with Decaluwé and
Braet81 reporting highly correlated responses (mean r= 0.96, range= 0.91–0.99). Implications of the poor
agreement between child and parent responses may be irrelevant if using these measures as trial outcomes,
however, provided that the same reporter is used at baseline and follow-up in all trial arms. Authors would
also need to clarify details of reporting to permit cross-trial comparisons.
Internal validity was evaluated in 22 eating behaviour papers, with the total variance ranging from 33% to
67%, and factor loadings ranging from 0.17 to 1.51. Of these, eight papers73,74,77,79,80,85,94 had all factors
classed as acceptable (> 0.40) (see Appendix 8). Where appropriate, findings were used to make
alterations to items and/or scales. Criterion validity was assessed in only one study evaluating the CFQ
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using the ‘gold standard’ of direct observation as a comparator.93 Results indicated that fathers (r= 0.33)
had a greater interpretation of child’s eating behaviour than mothers (r= 0.15); however, these results are
based on a sample size of 46. Convergent validity was more frequently evaluated but was generally
restricted to diagnostic measures of eating disorders. Other measures in which convergent validity was
assessed included the EES-C77 and the Toddler Snack Food Feeding Questionnaire (TSFFQ).82 The EES-C
was compared with data from the QEWP (Spitzer 199295). Authors reported good convergent validity and
show that those with loss of control (LOC) (from QEWP) had higher eating in response to anger, anxiety
and frustration and higher depressive symptoms than people without LOC [although results based test for
difference (analysis of covariance – ANCOVA), p< 0.05]. Convergent validity for the TSFFQ was weak, with
correlations with the CRQ of r= 0.20 (in toddlers) and r= 0.21 (in preschool children) (range= 0.02–0.43).
Implications of these findings when the measures are used to assess change is potentially less important
and will be based on the choice of comparator measure.
Construct validity was evaluated in 18 manuscripts,72,77–80,82–85,90,91,96–101 comparing eating behaviour
measures to weight,72,77,83,84,96–98 weight concerns99,100 and health-related behaviours,77–80,82,85,90,91,101
with correlations ranging from 0.03 to 0.59. Of those making comparisons to weight or weight status,
correlations were weak: r= 0.13 (DEBQ-C83); r= 0.14 (CFQ96); r= 0.28 [Children’s Eating Attitudes Test
(ChEAT)101]; and r= 0.07 (un-named measure of control in parental feeding practices84). Higher correlations
were seen with weight concerns: r= 0.59 for the Youth Eating Disorder Examination-Questionnaire
(YEDE-Q)99 and r= 0.4 for a further study evaluating ChEAT.100
Physical activity
A total of 45 studies (within 35 manuscripts), describing 24 PA measures, were extracted. A summary of all
of these studies is included in Appendix 9. Of these, two did not fully meet eligibility criteria (pathway 4)
but were deemed relevant by experts during the subsequent external appraisal process (see Chapter 4,
Results of expert appraisal)102,103 and have been added retrospectively.
Objective PA measures included pedometers, accelerometers, monitors and direct observations. Objective
methods are considered optimal for quantification of PA and are advantageous over subjective methods
through avoidance of reporting bias.104 Criterion validity was assessed in 12 of the objective studies105–114
(with correlations ranging from r= 0.47 to r= 0.82). Four out of the five studies evaluating accelerometers
measured criterion validity (compared with direct observation105,106); VO2 (oxygen uptake);107 or heart rate
(HR);108 with strong correlations observed for all (range: r= 0.71–0.86). Criterion validity of pedometers
was also common with a range in correlations between r= 0.47 and r= 0.85 in studies comparing steps to
accelerometers112–114 and direct observation.109 One study, assessing per cent error, however, found that
a high degree of error indicated under-reporting.110 Authors commented on the range in validity of
measures relating to the type of equipment used; for example, in the assessment of criterion validity of a
SenseWear band (BodyMedia® SenseWear, Pittsburgh, PA, USA),111 they reported the greatest validity with
one specific model (SWA5.1) when comparing against DLW. Convergent validity was evaluated in three
studies evaluating objective measures with moderate findings: accelerometers compared with Actiwatch
(Actigraph®, Pensacola, FL, USA) data r= 0.36;105 accelerometers compared with activity diaries r= 0.38,108
and SenseWear model SWA5.1 compared with the SWA6.1 model [showing statistically greater estimates
of metabolic equivalents (METs) in boys than girls with the SWA5.1 model than in those with the
SWA6.1 model].111
With regards to external reliability of objective measures, four studies conducted TRT reliability.102,110,112,113
With pedometers, one study112 reported high validity (r= 0.77) but another113 found very poor reliability
(r= 0.08). Another evaluation of pedometer TRT reliability reported a mean difference of 10% between
measures.110 The last of the four objective measures evaluating TRT reliability was the System for Observing
Children’s Activity and Relationships during Play (SOCARP).102 Findings from this study report per cent
agreement ranging from 85% to 93%. Inter-rater reliability analysis was conducted in evaluation of the
two direct observation tools. Both reported high levels of reliability with comparison between observers:
(r= 0.96, κ= 0.8784) (89% agreement102).
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The remaining measures were subjective (questionnaires, recalls, diaries, etc.). Twenty-one of the
manuscripts describing subjective PA measures reported evaluating criterion validity, with a resulting range
in correlation from r= 0.04 for correlations between the Children’s Leisure Activities Study Survey (CLASS)
and accelerometery115 and r= 0.53 for correlations between the Previous Day Physical Activity Recall and
accelerometers.116 Overall, criterion validity was lower than that observed by objective measures,
with 11 of these studies obtaining correlations of less than the adequate standard of 0.4, and some
findings dependent on weight status of the children.117 Convergent validity was assessed in 11 of the
subjective studies118–125 and correlations were slightly higher (r= 0.22–0.88) but most were compared
against other subjective methods and thus the high correlations may not necessarily suggest a robust
instrument (i.e. it could be interpreted as the tools being equally as poor) (see Appendix 7). Construct
validity of self-reported measures was poor118,119,126,127 (correlations ranging from r= 0.07 to r= 0.33). Of
these, two studies failed to report findings for non-significant correlations and thus the lower end of the
range may be less.126 Two construct validity studies made comparisons with body weight/weight
status.126,127 Goran et al.127 report correlations of 0.24 and 0.33 for findings from two substudies
comparing the Physical Activity Questionnaire (PAQ) for Pima Indians with fat mass data from
bioimpedance measurement. Moore et al.126 also report low correlations of r= 0.10 for comparisons
between the Physical Activity Questionnaire for Older Children (PAQ-C) and percentage body fat, which
were also assessed by bioimpedance.
Reliability results of subjective PA measures were generally better than validity findings. Six studies126,128,129
reported IC, with a range of alpha values of between 0.66 and 0.84 (with just one reporting alpha values
of < 0.70126). Results of TRT reliability (conducted in 14 studies) were more variable, with correlations
ranging from r= 0.24 (for child-reported activity in CLASS115 and 0.98 (for the Previous Day Physical
Activity Recall120). One study128 also reported a generalisability coefficient of 0.88. Inter-rater reliability was
evaluated by five studies.102,103,115,120,130 Again, results are highly variable with correlations as high as
r= 0.99 for inter-rater reliability of the Previous Day Physical Activity Recall120 and as low as r= 0.19 for
reliability of CLASS.115 Results for inter-rater reliability evaluation may be dependent on the type of activity
been assessed. For example, Telford et al.115 reported a strong agreement of 87.5% for assessment of
soccer, but just 8% agreement for tennis. This type of evaluation may also be dependent on
obesity status.130
Sedentary behaviour/time
A total of five manuscripts,130–134 describing six measures of sedentary time/behaviour met the eligibility
criteria for CoOR (see Appendix 10).
Of the six measures, three were measures of sedentary time (i.e. time spent being inactive)131,132 using
activity monitors. The remaining three133–135 assessed sedentary behaviours (i.e. frequency or duration spent
doing specific low-energy behaviours such as screen time). Measurement of sedentary time in the included
studies was by objective measurements compared with those assessing sedentary behaviour, which were
all self-reported.
Studies by Reilly et al.131 and Puyau et al.132 (Study 1) both assessed criterion validity of accelerometers for
the measurement of sedentary time using direct observations and room calorimetry, respectively. Both
report high validity. Sample sizes for these were low (52 for Reilly et al.131 and 26 for Puyau et al.132) but
not unusual given the type of measurements used for criterion assessment. Puyau et al.132 also assessed
convergent validity of the accelerometer against another monitor; the Mini-Mitter Actiwatch monitor, with
an average correlation of r= 0.86 (range= 0.82–0.89). A further study (reported in the same paper) by
Puyau et al.132 (Study 2) also evaluated the Mini-Mitter Actiwatch monitor for criterion validity using room
calorimetry and reported a mean correlation between activity and energy expenditure of r= 0.79
(range= 0.82–0.89). Other criterion methods of HR monitoring and microwave activity were also used for
both the accelerometers and Actiwatch, with good overall findings (r= 0.57–0.72 for accelerometers and
r= 0.66–0.83 for the Actiwatch).
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Measures of sedentary behaviour also assessed criterion validity,133–135 although comparison was not made
against direct observation or measured energy expenditure. Ridley et al.133 made comparisons between
the Multimedia Activity Recall for Children and Adolescents and accelerometry, and reported an overall
correlation of r= 0.39 (range= 0.35–0.45). Dunton et al.134 also used a criterion of accelerometry in their
evaluation of the Electronic Momentary Assessment (EMA): a self-report survey on mobile phones – a
method by which behaviours are captured in real time by use of mobile phones. Results indicate that the
number of steps taken was significantly higher for the EMA surveys reporting active play, sports or exercise
than any other type of activity [adjusted Wald test: F= 22.16, degrees of freedom (df)= 8, p< 0.001].
Epstein et al.135 also evaluated criterion validity of a measure of Habit books with index cards against a
criterion of accelerometers and report correlations of r= 0.63 (for average METs) and r= 0.60 [for per cent
time in moderate to vigorous physical activity (MVPA)]. This study was not the primary aim of the
manuscript (which reported trial evaluation results) and was conducted with only 41 participants. TRT
reliability was evaluated in only one study133 finding high correlations (r= 0.92), although it was also
conducted in a small sample of 32 children and adolescents.
Fitness
A total of 14 manuscripts136–149 were identified that described 13 fitness outcome measures. A summary of
the data extracted for these studies is provided in Appendix 11.
The majority (12) of measures described in the included manuscripts assessed aerobic capacity (defined as
the maximal amount of physiological work that an individual can do measured by oxygen use). Two136,137
assessed general fitness, of which one,137 ‘Fitnessgram®’, also includes measurement of aerobic capacity, in
addition to measures of muscular strength; muscular endurance and flexibility; and body composition. This
measure was designed as an educational assessment tool for school populations (i.e. it was not designed
for obesity research). However, it has been used an outcome, which is why it met inclusion criteria here.
Seven included measures136–142 determined TRT reliability, with correlation results ranging from
r= 0.65–0.91, kappa statistics ranging from κ= 0.59–0.81 and per cent agreement ranging from 88% to
91%. Thus, all demonstrated at least moderate TRT results, indicating that they can be reliability assessed
over multiple time periods.
Inter-rater reliability was evaluated in the Fitnessgram study,137 which compared teacher with expert
agreement in recording children’s fitness scores. Results in agreement (84–87%) and kappa statistics
(0.67–0.73) identified adequate robustness of results.
Criterion validity was assessed in 10 studies (r= 0.03–0.81) in which comparisons were made with
measures against a gold standard of measured oxygen consumption [via VO2max (maximum oxygen uptake
to the point in which oxygen demands plateau) or VO2peak (highest value of oxygen uptake from a
particular test which is limited by tolerance level)].138–140,143–149 Of these, four had a sample size of
< 50.144–146,149 In the remaining six studies138–140,143,147,148 that measured criterion validity, two were
evaluations of the 20-m shuttle run;139,140 one assessed basal metabolic mass estimates with fat-free
mass;143 one assessed the 6-minute walk test; 139 one, the adjustable height step test;149 and one,
bioelectrical impedance-derived VO2max148 Correlations for these were mostly moderate but ranged
between r= 0.03147 and 0.81.148 One study140 reported higher validity in obese children (based on stratified
analysis of 126 children). Conversely, Roberts et al.147 assessed bioelectrical impedance-derived VO2max and
reported a weight-dependent correlation with measured VO2max (VO2max ml/kg/minute) of r= 0.03.
Non-weight-dependent correlations (VO2max l/minute) in this sample of 134 obese and overweight
adolescents were considerably higher at r= 0.48. Thus, although the majority of studies report moderate
to high levels of criterion validity, results are varied, with some dependent on weight status and also some
conducting analysis on small samples.
Convergent validity was assessed by two studies.136,141 Of these Loften et al.141 compared different modes
of calculating measured VO2peak from either cycle or treadmill, thus it is a rare study within those identified
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by CoOR that evaluated the actual gold standard measure. Comparisons between the two approaches
reported correlations ranging from r= 0.48 to r= 0.77. Tests for differences were all non-significant
(p> 0.05) but the validation study was conducted in only 21 overweight/obese children/adolescents. This
study also demonstrated strong TRT correlations – again, in a small sample size. Overall findings indicated
that the cycle performed marginally better than the treadmill. However, importantly, children reported
higher acceptability of the cycle than the treadmill. The other study assessing convergent validity was a
comparison between the International Fitness Scale (IFIS)136 and what was described as ‘measured fitness’.
However, the measure of fitness was based on a 20-m shuttle run (i.e. not measured VO2max or VO2peak),
and has therefore been considered as a convergent validity (not criterion) by CoOR. Authors reported
significant positive linear relationships with increased self-report and ‘measured’ fitness. This study also
collected a number of cardiovascular outcomes as a means to test construct validity of the IFIS. Findings
suggest that obesity was negatively associated with levels of fitness in the IFIS, except for measurement of
muscular strength.
Construct validity was assessed in one further paper evaluating aerobic cycling power with insulin and
reported a correlation of r= 0.37.146 Similar to many other evaluations of fitness measurement, assessment
was conducted in only a small sample of 35 obese adolescents.
No fitness measures conducted a formal assessment of the ability to measure change (responsiveness).
Physiology
A total of 28 papers, describing 12 outcome measures, met inclusion criteria for the physiology domain.
A summary of all papers extracted are available in Appendix 12. Two included manuscripts were written
in languages other than English.150,151 Data were partially extracted from each of these, which is included
in Appendix 12 for reference. However, appraisal of these was not conducted (one150 describes evaluation
of ‘indices of insulin sensitivity’, which is evaluated in multiple other included manuscripts).
Of the 28 included manuscripts, the majority described the evaluation of insulin and/or glucose150,152–165 or
energy expenditure or metabolic rate.166–173 Of those assessing criterion validity of measures of insulin or
glucose, six made comparisons with the gold standard of the euglycaemic–hyperinsulinaemic clamp (EHC)
test152,154,156–158,162 reporting correlations ranging from r= 0.4–0.78 for varying indices of insulin sensitivity
in sample sizes ranging from 31156,157 to 323.162 Criterion validity was evaluated in all of the studies
evaluating energy expenditure/metabolic rate, by making comparisons with measures such as direct and
indirect calorimetry, but none used the gold standard of DLW. Moderate to high correlations were
generally reported, but the primary focus of these studies was usually the development or comparisons of
equations used to predict energy expenditure in obese children and adolescents. Except for one study,173
sample sizes were high (with 12 studies154,158,159,162,166–171 including samples of > 100).
Convergent validity was assessed in four studies,152,155,161,174 of which three compared insulin with blood
lipids,152 glucose tolerance155 and fasting insulin,161 and one examined relationships between glycated
haemoglobin (HbA1c) and fasting glucose.174 Findings for convergent validity of indices of insulin sensitivity
were generally high, with correlations ranging between r= 0.60 and r= 0.81 for insulin. Convergent
validity for HbA1c used accuracy testing [receiver operating area under the curve (AUC)], which reported a
range of 0.60–0.81 in AUC in 1156 obese adolescents. However, results were influenced by weight status.
This study also evaluated the relationship between HbA1c and diabetic status, and demonstrated poor
validity with this construct [κ= 0.2 (95% confidence interval 0.14 to 0.26)]. One further study175 evaluated
construct validity in its assessment of ghrelin in 100 obese children. Results suggest that ghrelin is
statistically associated with obesity and cardiovascular outcomes, although correlations are generally weak
(ranging from r= 0.1 to r= 0.5). This study also reported ghrelin pre and post intervention. Tests indicate
that it is able to detect change but that changing values levelled off after a period (advocating testing
immediately post intervention if used). One other study170 that met criteria for inclusion to CoOR reported
measuring the ability of the measure to detect change. This study170 evaluated predicted resting energy
expenditure and reported a mean difference of 7.45% in resting energy expenditure after weight loss.
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Prediction equations for resting energy expenditure in this study170 involved inclusion of fat-free mass.
As weight loss is associated with change in fat-free mass, the authors advocate assessment to be made
only during periods of weight stability.
Only 2176,177 out of the 26 included studies conducted reliability testing. TRT reliability was evaluated by
Libman et al.176 in a study that compared measurement of glucose via fasting and 2-hour samples in
60 overweight/obese adolescents. Results indicated that fasting glucose (r= 0.73) had higher reliability
than 2-hour glucose (r= 0.37) testing. Inter-rater reliability was assessed in one other study177 comparing
radiologists working in three ultrasound units. This study177 reported high correlations between radiologists
(κ≥ 0.8) in ultrasound analysis of liver echogenicity, although the sample size was small (n= 11).
Economic evaluation
The original aim of the CoOR study was to include measures of economic evaluation as one of its outcome
domains. However, review of identified manuscripts failed to find any manuscripts that described the
development or evaluation of measures used that can assess utility and therefore estimate quality-adjusted
life-years (QALYs). The National Institute for Health and Care Excellence (NICE) advocates the conduct of
cost–utility analysis using utility measures (with the QALY as the health-related outcome measure for
economic evaluation). No such measures were found for use in an obese childhood or adolescent
population in this review, although the team are aware of some that are currently under development.
Given that the existing CoOR review strategy did not include terms related to measurement of QALYs, a
separate ‘scoping’ search was conducted. A copy of this search can be found in Appendix 16. This did not
reveal any further appropriate measures of utility. Alternative measures of cost-effectiveness could be
considered (although would not fit within NICE guidance), but assessment of cost (of intervention) per unit
of weight loss is usually preferred (i.e. those described in the anthropometry domain). HRQoL measures are
often used, but CoOR has viewed these as a separate domain, given that they cannot be used to estimate
QALYs. Unless the research is focused on quality of life/psychological well-being, such measures are not
essential. As measures of HRQoL were identified in the CoOR review from those already used as outcome
measures and those that have specifically developed for childhood obesity research, a further domain of
HRQoL has been included. This was possible, as the CoOR search did not include specific search terms
relative to each outcome domain (i.e. it was designed to be sensitive enough to detect any kind of
outcome measure).
Health-related quality of life
A total of 25 papers describing 16 measures were extracted for the HRQoL domain. Of these, four were
written in languages other than English,15,178–180 which describe measures that have not been evaluated by
any other included manuscript. Data have been extracted for three of these.178–180 All have been included
within the summary table in Appendix 13 but were not eligible for appraisal.
Seven HRQoL measures were developed specifically for use in a paediatric obese population: (1) Impact of
Weight on Quality of Life (IWQoL);15,181,182 (2) Sizing Me Up;183 (3) Sizing Them Up (a parent-reported
version of Sizing Me Up);184 and the Youth Quality-of-Life Instrument-Weight Module;185 plus three
German HRQoL measures that were developed specifically for obese children.178–180 Akin to most of the
HRQoL measures, multiple forms of evaluation were conducted on many of these tools. Except for
measures described in non-English papers, all assessed IC, reporting alphas ranging from 0.74184 to
0.92.181,185 All report using FA to develop or refine the questionnaires, and all assess convergent validity by
comparing against other questionnaires aimed at assessing similar constructs. Comparisons with the
Paediatric Quality of Life questionnaire were made with three of the weight specific measures,181,183,184 of
which the highest correlations were reported with the IWQoL questionnaire (r= 0.75).181 Comparisons
between Sizing Them Up and the IWQoL questionnaire reported weaker correlations of r= 0.27.184
Additionally, TRT reliability was conducted on each measure, with each demonstrating at least moderate
to high reliability (ranging from r= 0.67 to r= 0.82), although sample sizes were low for two studies.182,185
Given that these measures were developed specifically for obese children, correlations with BMI
(i.e. construct validity) were surprisingly lower than in other forms of validity, ranging from r= 0.16 for
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Sizing Me Up184 to r= 0.44 for the Youth Quality-of-Life Instrument-Weight Module.181 Finally,
two measures – weight specific – evaluated responsiveness. These were the only studies assessing
responsiveness of all included HRQoL measures in CoOR. In evaluation of 80 children and adolescents,
Kolotkin et al.182 report a standardised response mean (SRM) of 13.43 [effect size (ES) of 0.75]. A smaller,
but significant, SRM of −5.4 was reported in responsiveness testing of Sizing Me Up in 220 obese children
and adolescents,184 both well within acceptable (moderate) levels (described by CoOR as having a SRM of
> 0.5) to support their ability to assess change.
Of the remaining studies assessing generic HRQoL measures, a similar level of evaluation was conducted,
with many reporting findings from multiple types of evaluation. Average IC findings were high in each of
the nine studies186–194 conducting this evaluation, with a range of r= 0.72186 to 0.86187 in those that
presented ‘means’ (and not only ranges). In fact, all of the included measures demonstrated a reasonably
high level of reliability and validity, with some variability in findings of convergent validity (see Appendix 13).
Two measures may be considered redundant, given that newer (or more appropriate) versions are now
available. For example, the Paediatric Cancer Quality of Life measure188,195 would be less appropriate than a
non-cancer version in the evaluation of childhood obesity treatments. Additionally, an older version (V1.0)
of the Paediatric Quality of Life questionnaire191 can be substituted for newer versions.190,191,196
Psychological well-being
A total of 20 papers, describing 17 measures were eligible for data extraction. A summary of all papers
extracted are available in Appendix 14.
Given the nature of these self-reported survey questionnaires, assessment of criterion validity was not
anticipated, where ‘gold standard’ measures are unlikely. Some authors reported conducting criterion
validity, which was defined as ‘construct’ validity by CoOR (e.g. comparisons with body weight). One
study,197 however, did make comparisons between self-report and direct observations in their evaluation of
the Self-Control Rating Scale (SCRS).
Eight of the included psychological well-being studies included evaluation of convergent validity,197–204 each
making comparisons against different psychological measures of differing constructs (often comparing
with more than one other measure). Comparisons of the correlations between these is therefore limited,
however, with a range of between r= 0.06 in the evaluation of convergent validity of the SCRS against
the Delay of Gratification scale197 and r= 0.66 in the evaluation of the Body Esteem Scale against the
Piers–Harris Children’s Self-Concept Scale.204 Three studies evaluating convergent validity reported results
with a correlation of < 0.40 for all of the included comparator measures.197,198,202
Construct validity was assessed in nine studies. Six of these made comparisons to weight or weight
status in children,198,200,204–207 of which findings varied between r= 0.07 (comparing the Body Shape
Questionnaire to WHR206 to r= 0.55 (comparing the Body Esteem Scale to weight204). Stein et al.207 report
significant differences in scores for the Children’s Physical Self-Concept Scale (CPSS) between normal
weight and overweight children (F= 33.91, p< 0.001). Percentage agreement of 90.5% (in obese children)
was also reported by Probst et al.208 for comparisons between the video distortion measure and BMI.
Test–retest reliability was conducted in 12 studies, with correlations ranging from r= 0.52 to
r= 0.91.195,197,199,201,205–211 Thus, all met the criteria (r> 0.4), suggesting that psychological well-being
measures have strong TRT reliability.
Responsiveness testing was not reported in any of the studies evaluating psychometric well-being that
were identified by the CoOR review.
Environment
A total of nine manuscripts,212–219 described 10 measures of the environment, met eligibility criteria
for the environment domain. A summary of all papers extracted are available in Appendix 15.
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Two environmental measures assessed child-care environments212,213 and seven measured home physical
and/or social constructs within the home environment.214–219 A further was a measure capturing
‘perception’ of the built environment.220
Reliability testing in the form of IC was implemented in six studies,215–218,220 all of which demonstrated high
levels of internal reliability (α= 0.75–0.83). Similarly robust results for TRT reliability were evident in one
measure of child-care settings212 and seven measures of the home environment,214,215,217–220 with mean
correlations ranging from r= 0.59 of the home PA equipment scale219 to r= 0.85 of the Family Eating and
Activity Habits Questionnaire215 (FEAHQ) (with mean κ= 0.57–0.66). Results for inter-rater reliability testing
in six studies212,213,215,218,219 were also strong (r= 0.47–0.88). Thus, the outcome domain of environmental
measures demonstrates high levels of multiple indicators of reliability, with no studies performing no form
of reliability.
Internal validity was assessed in two studies,216,220 with total variance ranging from 7% to 47%, and
factor loadings ranging from 0.31 to 0.88, of which one study220 reported all loadings to be above the
acceptable limit of 0.40. However, providing that necessary amendments are made to questionnaires, this
should not preclude the use of measures in which some factor loadings are low. Criterion validity was
evaluated in two studies212,213 in which the gold standard method was direct observations by researchers.
Benjamin et al.212 evaluated criterion validity of their child-care setting measure, the Nutrition and Physical
Activity Self-Assessment for Child Care (NAPSACC), by comparing items to researcher-measured items
reported in the Environment and Policy Assessment and Observation (EPAO)213 also included in the CoOR
review. Results were variable by item, with kappa ranging from 0.11 to 0.79 (mean κ= 0.37). The
comparator gold standard method by Ward et al.213 (EPAO) conducted a study of inter-rater reliability and
reported moderate to high correlations (although also variable by item) (r= 0.63, range= 0.05–1.0). Bryant
et al.214 compared a parent report home environment measure, the ‘Healthy Home Survey’ (HHS) to
researcher-conducted survey completion in the home and also reported variable findings, with a range in
correlations of r= 0.3 to r= 0.88 (mean r= 0.62) and a range in kappa of 0–0.96 (mean κ= 0.55). This
measure appears to be robust, along with strong findings for TRT reliability (r= 0.72, κ= 0.66); however,
authors report concern related to the collection of some open-response items (e.g. food availability in the
home) and are currently working on a new version – ‘HomeSTEAD’.
Convergent validity was assessed in only one study,216 in which the Parenting Strategies for Eating and
Activity Scale (PEAS) was compared with data from the CFQ.62 Findings were low with a mean correlation
of r= 0.22 (range r= 0.02–0.65) in 91 children. Construct validity was evaluated in six studies.216–220 Of
these, four studies216,217,219 assessed correlations with BMI or obesity. Findings are difficult to compare
because of inconsistencies in the analytical approaches used. Larios et al.216 reported very weak
correlations between PEAS and BMI z-score in a sample of 714 children (r= 0.03, range= 0.03–0.21).
McCurdy et al.217 conducted independent samples t-tests to determine whether scores on the Family Food
Behaviour Survey (FFBS) varied by child weight status, and found that overweight was related to increased
maternal control (p= 0.052) and that children were more likely to be of normal weight if there was
increased maternal presence at meal and snack times (p= 0.01). Sample size for this study, was small,
however, with only 28 children included. Both studies by Rosenburg219 to assess two brief scales that
measure PA and sedentary equipment in the home assessed correlations with BMI z-score using linear
regression models. Findings suggest that the electronic equipment scale (specifically, having a television in
the bedroom) was significantly and positively associated with BMI z-score.
Responsiveness was assessed in one study, in which Golan et al.215 reported the ability of the FEAHQ to
detect change following a weight loss intervention. Change in child body weight was found to be
associated to change in scores from the ‘exposure’ and ‘eating style’ scales of the questionnaire in both
intervention and the control, with the change in score explaining 27% variance in weight reduction.
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Results of internal appraisal
Internal appraisal of all outcome measures resulted in 29 outcome measures being classified into
Category 1 (certain, good evidence, fit for purpose). Thirty-five were placed into Category 2 (certain,
poor evidence, not fit for purpose) and 121 were placed into Category 3 (uncertain, requiring further
consideration). Decisions on certainty, alongside any relevant comments were written in two appraisal
forms for (1) anthropometry (primary) outcome measures and (2) all other (secondary) outcome measures
(see Appendices 16 and 27). These forms were also used by experts in external appraisal. Thus, all final
decisions (following internal and external appraisal) are also shown in these appendices. Further details of
the internal appraisal are provided below according to outcome domain.
Scores for development and evaluation of secondary outcome measures were assigned and are shown in
Appendices 17–25.
Anthropometry (1 certainty = ‘1’; 2 certainty = ‘2’; 35 certainty = ‘3’)
Appendix 17 provides the internal appraisal results for all included anthropometry measures. Based on
the evidence, the only anthropometry measure that was assigned a certainty score of ‘1’ (i.e. deemed fit
for inclusion) was ADP. Five17,221–224 out of six17,219–223,225 studies that evaluated this measure generally
advocated its use. The only measures to be assigned a certainty score of ‘2’ (i.e. deemed not fit for
inclusion) following internal appraisal were measures of self-reported height and weight, and
parent-reported height and weight. These methods were commonly evaluated against a criterion of
measured height and weight, with 28 studies evaluating self-report and 14 studies evaluating parent
report. However, only two studies226,227 of self-reported height and weight concluded that the measure
was valid and only one228 did so for parent report. Findings from the remaining studies were consistent in
reporting a poor relationship between measured and self-reported height (for implementation in trials).
All other anthropometry measures were assigned a certainty score of ‘3’ because of inconsistencies
between study findings. This score of uncertainty was also assigned for measures in which little evaluation
had been conducted.
Diet (3 certainty = ‘1’; 9 certainty = ‘2’; 19 certainty = ‘3’)
Scores Two studies evaluating dietary assessment methodologies were assigned a maximum score of four
for demonstrating a high degree of quality in the evaluation of TRT reliability; Lanfer et al.’s evaluation36
of the Children’s Eating Habits Questionnaire food frequency questionnaire (CEHQ-FFQ), and Vance et al.’s
evaluation71 of the Food Beahaviour Questionnaire (FBQ). Vance et al.71 also conducted inter-rater reliability
and received a maximum score of ‘4’ (see Appendix 18).
Maximum scores were also assigned for evaluation of the Short-list Youth/Adolescent Questionnaire
(Short YAQ)34 for both convergent and construct validity. Robust evaluation and findings were additionally
assigned for the convergent validity testing of the YAQ,37 Harvard Service Food Frequency Questionnaire
(HSFFQ)38 and familial influence on food intake – FFQ.39 Maximum scores of ‘4’ were provided to
631,53,54,67,70,40 out of 24 studies that evaluated criterion validity of diet measures.
No measures were assigned the minimum score of ‘1’ for the quality of any form of evaluation. However,
low scores of ‘2’ were assigned to two assessments of TRT reliability,41,42 eight assessments of criterion
validity,30,33,57–59,61–63 five assessments of convergent validity,42–45,52 one assessment of construct validity,52
and two assessments of TRT reliability.41–42
Degree of certainty Of the included diet measures, internal appraisal resulted in assigning a degree of
certainty score of ‘1’ (i.e. fit for inclusion) to three measures: the YAQ,34 the Australian Child and
Adolescent Eating Survey (ACAES)32,46 and the New Zealand FFQ.47 A certainty score of ‘2’ (i.e. not fit
for inclusion) was assigned for nine measures: the Korean FFQ,48 the qualitative dietary fat index;42 fried
food away from home,52 the food intake questionnaire,49 the Crawford 5-day food frequency
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questionnaire (5D FFQ),33 diet history,53–55 the 9-day food diary,57 the 2-week food diary58,69 and the
7-day food diary.61 The remaining measures were all assigned a certainty score of ‘3’ (uncertain)
(see Appendix 28).
[Note: Although there are 22 different types of dietary assessment methods identified, appraisal was
made on individual subtypes of methods. For example, a food diary has been considered to be one
type of dietary assessment methodology, yet appraisal separated these according to the individual
protocols of each (e.g. 3-day food diary appraised separately from 7-day food diary). As such, the total
number of measures appraised (30) is not the same as the total number of included measures.20]
Eating behaviours (5 certainty = ‘1’; 6 certainty = ‘2’; 11 certainty = ‘3’)
Scores Internal scores for evaluation of eating behaviour studies were generally high, with the majority of
studies being assigned a score of ‘3’ or ‘4’ for most types of evaluation. No studies were assigned the
lowest score of ‘1’ for any form of evaluation. Only four studies93,229–231 received a low score of ‘2’,
including one study’s evaluation of IC [Child Eating Disorder Examination Questionnaire (ChEDE-Q)];229
one study’s evaluation criterion validity (CFQ);93 and two studies’ evaluations of convergent validity
[ChEDE-Q,230 Children’s Binge Eating Disorder Scale (C-BEDS)231] (see Appendix 19).
Degree of certainty Of the 22 included outcome measures, five were deemed of high quality (fit for
purpose, certainty= 1), including the EES-C,77 the CFQ,75,93,96,97,113,232 the Child Eating Behaviour
Questionnaire (CEBQ),72,73 the TSFFQ82 and EAH-C80 (see Appendix 28). The internal appraisal judged six
measures to be unfit for purpose, including the QEWP-A,90,91 ChEAT,86,100,101 C-BEDS,233 the McKnight Risk
Factor Survey-III (MRFS-III)87 and an unnamed tool of parental feeding strategies.88 The remaining
11 measures were assigned a certainty score of ‘3’ (uncertain, requiring further consideration).
Physical activity (4 certainty = ‘1’; 9 certainty = ‘2’; 11 certainty = ‘3’)
Scores Nine evaluations of TRT reliability of PA measures were assigned maximum scores of ‘4’, indicating
high-quality reliability evaluation (see Appendix 20). However, a score of ‘4’ was generally not common in
other forms of evaluation, in which internal appraisal assigned ‘4’ in only one evaluation of criterion
validity of the 7-day recall interview,121 and two forms of evaluation of the PAQ-C (internal validity126 and
IC).128 A minimum score of ‘1’ was assigned to only one study119 evaluating the convergent validity of the
Physical Activity Diary. The remaining evaluations were generally assigned quality scores of ‘3’ or ‘4’.
Degree of certainty Of the 24 included PA measures, the internal appraisal team assigned a degree of
certainty score of ‘1’ (i.e. fit for inclusion) to four measures: the accelerometer;105–108,234 the 7-day recall
interview;121 the moderate to vigorous PA screener;235 and the PAQ for Pima Indians127,236 (see Appendix
28). A further nine measures were deemed unfit for purpose (degree of certainty= 2): HR monitoring;237
the Activity Questionnaire for Adults and Adolescents;97 the Activity Rating Scale;121 the Activitygram;113,115
the National Longitudinal Survey of Children and Youth;130 the Outdoor Playtime Checklist;122 the Outdoor
Playtime Recall;122 the Physical Activity Diary;119 and the Youth Risk Behaviour Survey (YRBS).238 The 11
remaining measures were assigned an uncertainty score of ‘3’.
Sedentary behaviour/time (0 certainty = ‘1’; 0 certainty = ‘2’; 6 certainty = ‘3’)
Scores The only study evaluating measures of sedentary time/behaviour that received a maximum score
of ‘4’ (indicating high quality) was for criterion validity evaluation of accelerometry.131 No studies were
assigned the minimum score of ‘1’ but one135 was given a score of ‘2’ for the evaluation of criterion
validity of Habit books with index card. Remaining evaluations were all assigned a quality score of ‘3’
(see Appendix 21).
Degree of certainty All studies evaluating sedentary time/behaviour were assigned a certainty score of ‘3’
(uncertain, requiring further consideration). This was largely due to a lack of identified studies conducting
any form of evaluation of sedentary measures for use as outcome measures in childhood obesity treatment
intervention evaluations (see Appendix 28).
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Fitness (1 certainty = ‘1’; 5 certainty = ‘2’; 7 certainty = ‘3’)
Scores Eight different types of evaluation from 5139,140,148,239,240 out of the 14 included studies were
assigned a maximum score of ‘4’ (see Appendix 22). Of these, the IFIS239 was assigned a maximum score
for all three evaluations of TRT reliability, convergent validity and construct validity. No studies were
assigned the minimum score of ‘1’, but two received a low score of ‘2’, including criterion validity of the
submaximal treadmill test,149 and criterion and construct validity of the aerobic cycling power test.146
Degree of certainty Only one measure of fitness was assigned an internal certainty score of ‘1’ (i.e. fit for
purpose): the IFIS.239 Five were deemed as unfit for purpose including BIA,147 the Fitnessgram,240 basal
metabolic rate (BMR) with fat-free mass,143 estimated maximal oxygen consumption and maximal aerobic
power,118 and aerobic cycling power.146 The remaining fitness measures were assigned an uncertainty score
of ‘3’ (see Appendix 28).
Physiology (2 certainty = ‘1’; 0 certainty = ‘2’; 10 certainty = ‘3’)
Scores Internal appraisal score allocation to studies that evaluated physiological measures were generally
high (see Appendix 23). The majority of studies (22/26) conducted criterion validity and only two of these
scored ‘2’ for quality.164,171 Other studies conducting different forms of evaluation that were assigned a
low-quality score of ‘2’ included two evaluations of construct validity.174,175 A minimum score of ‘1’ was
only assigned to one study that conducted responsiveness testing.170
Degree of certainty Of the 12 different types of measurement, 10 were assigned a certainty score of ‘3’
(uncertain, requiring further consideration) (see Appendix 28). Only two were deemed to be fit for purpose
based on the evidence, including indices of insulin sensitivity152–156,158–162 and DXA lean body mass (LBM)
for resting energy expenditure.172 No measures were considered to be unfit for purpose (degree
of certainty= 2).
Health-related quality of life (4 certainty = ‘1’; 2 certainty = ‘2’;
6 certainty = ‘3’)
Scores HRQoL measures studies often conducted multiple types of evaluation and the overall scores for
these were high, with the majority assigned scores of ‘3’ and ‘4’. No studies were given the maximum of ‘4’
for all of the forms of evaluation but some demonstrated very good quality overall, including an evaluation
of the IWQoL,183 Sizing Me Up,185 Sizing Them Up215 and the Youth Quality of Life Instrument-Weight
module (YQOL-W).185 Only one study241 was assigned a minimum score of ‘1’ for their assessment of
construct validity of the European Quality of Life-5 Dimensions (EQ-5D).
Degree of certainty Of the 12 included measures, four were considered to be of high quality and were
assigned a certainty value of ‘1’ (fit for purpose), including the IWQoL,181,182 the Paediatric Quality of Life
Inventory V4.0,190,191,196 Sizing Them Up184 and the YQOL-W.185 Only two were assigned a certainty score
of ‘2’ (unfit for purpose): the EQ-5D-Y (EQ-5D youth version)241–244 and the Paediatric Quality of Life
Inventory V1.0.189
Psychological well-being (4 certainty = ‘1’; 1 certainty = ‘2’; 12 certainty = ‘3’)
Scores Similar to HRQoL, studies evaluating psychological well-being measures received high scores
overall (see Appendix 25). In particular, one study evaluating the Social Anxiety Scale for Children203 was
assigned a maximum of four for all tests conducted, which included IC, TRT reliability, internal validity and
convergent validity. Of the 20 included studies, none was allocated the minimum quality score of ‘1’ and
only three were assigned a low score of ‘2’.197,204,211 Each of these, however, also conducted other forms
of evaluation, in which higher scores of ‘3’ and ‘4’ were allocated.
Degree of certainty Four measures were deemed to be of high quality and were assigned a certainty score
of ‘1’ (i.e. fit for purpose) by the internal appraisal. These were the Self-Perception Profile for Children
(SPPC);199,209 the Children’s Physical Self-Perception Profile (C-PSPP);210,245 the Children’s Self-Perceptions of
Adequacy in and Predilection for Physical Activity (CSAPPA);211 and the CPSS.207 Only one measure was
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allocated a certainty score of ‘2’ (unfit for purpose): the Self-Report Depression Symptom Scale (CES-D).246
The remaining 12 measures required further consideration and were therefore assigned an uncertainty
score of ‘3’.
Environment (5 certainty = ‘1’; 1 certainty = ‘2’; 4 certainty = ‘3’)
Scores Internal appraisal scores were generally high for the evaluations of environmental measures, with
19 out of 33 evaluations receiving the maximum of ‘4’ (see Appendix 26). Studies that were assigned
maximum scores for all included evaluations were the evaluation of the NAPSACC,247 the EPAO
(although reported only inter-rater reliability),213 the electronic equipment scale219 and the home PA
equipment scale.219 No studies were assigned a minimum score of ‘1’ and only two were assigned low
scores of ‘2’.216,217
Degree of certainty Of the 10 included measures, five were deemed to be fit for purpose, and assigned
a certainty score of ‘1’. These were NAPSACC,247 the environment and safety barriers to youth PA
measure,222 the Home Environment Survey (HES),220 the electronic equipment scale219 and the home
PA equipment scale.219 Only one was deemed unfit for purpose – the HHS214 – as this was an earlier
version of a tool for which a newer version is currently under development.
Results of expert appraisal
Of the 180 measures that were appraised, a total of 52 outcome measures were recommended for
inclusion to the CoOR outcome measures framework shown in Table 4 (see Final included studies: results
from appraisal). Information pertaining to the discussion, and key findings, of each measure is presented
below according to outcome domain. Additional information, including reasons why some measures were
excluded (i.e. internal team and expert’s comments), can be found in Appendix 17 (anthropometry
measures) and Appendix 28 (secondary outcome measures).
Anthropometry
Recommended anthropometric measures from the expert appraisal were (1) BMI and (2) DXA. Although
BMI is limited by its inability to assess body composition or fat distribution, it provides an adequate overall
proxy for health risks. Importantly, it is widely used and relatively easy to measure, compute and analyse.
The ability of BMI to provide consistency between studies that would enable comparisons to be made
between interventions is also highly valued. Experts agreed that research to consider thresholds for
clinically significant changes would be useful, to encourage greater consideration of ESs and not just
statistical significance. It was also clear, both from the evidence, and from agreement with experts, that,
although self-reported height and weight may be adequate for some population based research designs,
BMI for use in evaluation of interventions ought to be objectively measured.
Despite varied findings for the absolute accuracy of DXA, experts agreed that DXA was sufficiently precise
to recommend its use for measuring changes in body composition [although experts admitted that they
were basing decisions, in part, on wider evidence (e.g. in adults and/or other study designs that were not
included in the CoOR review)]. Furthermore, DXA was considered to be a well-used methodology, with
relatively good availability of the required equipment, at least in research and secondary care settings.
Costs of DXA measurement, however, may well preclude its use, especially in public health evaluations.
Use of WC was not advocated by the experts, primarily because they felt it offered no benefit over BMI to
measure treatment effects and was more subject to measurement error. There is considerable interobserver
variability and bias may be related to body size. In addition, evidence gathered by CoOR did not include
any validation using gold standard criterion methodologies. Skinfold measures have been extensively used
and have been validated against more direct measures of body fatness. However the observer error is
high and given the availability of superior methodologies, the CoOR expert group did not advocate using
these measurements.
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Remaining anthropometric measurements were not recommended primarily owing to a lack of existing
validity evidence, with many measurements evaluated in only one study of obese children. Experts agreed
that some of these (e.g. predicted thoracic gas volume251) may hold potential but that there were
insufficient data at present to recommend their use.
Experts emphasised the need to ensure that any anthropometric measurement is performed by trained
staff using predefined techniques and standard operating procedures, and that equipment is calibrated on
a regular basis. Additionally, it was recognised that there may be significant differences between different
manufacturers and models of equipment. Such differences need to be examined and considered in future
research. Experts also noted that the search did not identify any evaluations of the gold standard measures
of the 4C model or TBW measurement in children.
Diet
Recommended dietary assessment tools are shown in Table 4 (see Final included studies: results from
appraisal, below). Of the 22 methodologies appraised, seven were recommended. All of these were FFQs.
A total of 16 FFQs were appraised. Those that were deemed to be of a high standard (and were
subsequently recommended) included measures with strong evidence in development and evaluation.
However, at the time of writing this report (after appraisal), authors of one of these FFQs (the HSFFQ;
Blum et al.38) sent notification that it had been discontinued owing to maintenance costs. Thus, only
six diet measures have now been included in the CoOR outcome measures framework.
Caveats for almost all recommended measures are noted, primarily related to the need to conduct further
evaluation for validity and reliability evidence. Akin with all other secondary outcome domains, the specific
characteristics of each measure need to be considered prior to deciding which one to use. For example,
many have been developed and tested within predefined samples (ages, ethnicities) and are therefore only
appropriate for use in similar populations. In the case of diet, the validity and reliability findings usually
differ between different nutrients or foods. When choosing an appropriate measure, therefore, it is worth
looking more closely at the original manuscript to ensure that it is robust for nutrients or foods that will be
targets for change in an intervention.
Experts did not advocate any form of food diary or recall methodology. The decision to exclude these
methodologies was initially based on evidence presented by the CoOR review, suggesting that validity of
these measures was poor, especially in obese children. Additionally, evidence of reliability was lacking,
with no TRT reliability evaluation conducted in the identified food diary studies and in only two studies
evaluating recall methodologies. Conversely, 10 out of the 21 studies that evaluated a FFQ assessed TRT
reliability in an obese sample. In addition to concerns raised by the evidence, experts also considered diary
and recall methodologies to be less feasible, both in terms of participant burden (impacting the quality of
data) and in the processing of data from these methodologies. Whereas data FFQ measures can be
relatively easily entered, managed and analysed by people with no expertise in nutrition, this is not possible
for diaries or recall methodologies, which require trained personnel (preferably a nutritionist/dietitian)
for administration, data entry and analysis. Importantly, they are also reliant on having specific software for
entry and up-to-date databases of foods and drinks. That said, depending on the specific FFQ, these issues
may also be relevant and there is also likely to be a cost incurred for the questionnaire itself.
Overall, it was difficult to identify a measure of diet that all experts agreed they would highly recommend
for inclusion into the outcome measures framework. Decisions considered the fact that this was a
secondary outcome, specifically in trials evaluating childhood obesity treatment interventions. It was
acknowledged that many of the decisions made by experts would not apply in considering other study
designs or different populations. For example, experts are not suggesting that methods, such as food
diaries, should not be advocated in other studies (especially those with a primary outcome of diet).
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Eating behaviours
Twelve out of the 22 measures of eating behaviours that were appraised were recommended for inclusion
to the CoOR outcome measures framework. These were chosen, in part, because of strong development
and demonstration of reliability and validity, but also because experts were confident in their suitability and
feasibility, through their own knowledge of the measures (primarily via previous use in this setting).
Constructs that are assessed within these measures are varied (and described in Table 4) – see Final
included studies: results from appraisal. Thus, like diet, the choice of measure should involve consideration
of the constructs in which an intervention is expected to target (by the mechanism through which it will
influence change). For example, some measures assess parental feeding styles, yet others assess constructs
such as emotional eating, restrained eating and eating in the presence of hunger. Additionally, many of
these measures are age specific, with questionnaires such as the IFQ specifically designed to assess
parental behaviours related to infant feeding.
Although a similar (if not greater) level of evaluation was conducted for eating disorder diagnosis
measures. Seven of these measures met eligibility criteria and were subsequently appraised. However, they
were not recommended for inclusion to the CoOR outcome measures framework as they were deemed
inappropriate for use as an outcome measure in an obesity treatment evaluation (even although many
have been used in such designs) primarily because they result in a dichotomous outcome (i.e. presence or
absence of a clinically defined eating disorder). In instances when researchers are concerned about the
potential of an intervention to induce an eating disorder, these measures may have some potential.
Physical activity
Of the 24 PA outcome measures identified across 35 manuscripts, four were recommended for inclusion
to the CoOR framework. These were (1) accelerometers, (2) pedometers, (3) SOCARP102 and (4) the
Observational System for Recording Physical Activity in Children-Preschool version (OSRAC-P).103 Although
experts agreed that some of the self-reported measures were well developed, they did not advocate any
owing to issues with reporting error in samples of obese children. It was recognised that the use of
accelerometers may not always be feasible owing to costs and expertise in analysis but this method was
viewed as the best measure for assessment of PA. It was acknowledged that data from accelerometers are
often dependent on the model of accelerometer, which will improve and change with time. However,
given that evidence in this area was outside of the scope of the CoOR review, readers were encouraged to
refer to a review by de Vries et al.252
The CoOR evidence for pedometers was less strong but experts agreed it should be included as a
less-expensive option, given that it offers objective measurement. Use of pedometers that show the user
the number of steps and rely on participant reporting can be overcome by using sealed equipment in
which the number of steps is not shown and data are automatically stored for download. However,
pedometers should not be used as an outcome measure if they are an integral part of an intervention.
Experts recommended that two observation methodologies for measurement of PA be included in the
outcomes framework.102,103 These measures did not fully meet CoOR eligibility criteria but were considered
to have potential for inclusion. Expert felt that these measures offer an alternative to activity monitors,
which are also not reliant on self-report.
One objective measure that was not recommended by experts was HR monitoring.237 CoOR evidence for
this measurement was reliant on a small study of children (n= 13), which demonstrated low validity
(with large variation in agreement with a gold standard of DLW). However, based on wider evidence from
other populations, experts agreed that it may provide useful data when used in conjunction with
an accelerometer.
Experts agreed that objective measurement of PA will continue to improve and, dependent on what the
new data suggest, newer measures such as Actiheart® (CamNtech Ltd, Cambridge, UK) and SenseWear
bands could be recommended.
DOI: 10.3310/hta18510 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 51
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Bryant et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
39
Sedentary time
Measures identified by the CoOR review included those that assess sedentary behaviour, which would
capture specific sedentary activities (e.g. time/frequency of watching television), and sedentary time,
which measures the total time spent being inactive. Accelerometry was the only outcome measure – of
six reviewed – that was recommended by experts. Accelerometers are not able to measure sedentary
behaviours – only sedentary time. Thus, experts have only recommended a measure of sedentary time.
In line with other recommendations, data from self-reported measures were deemed to be too affected
by reporting bias in samples of obese children.
Similar to measures of PA, experts felt that there are many new and innovative methodologies currently
being investigated that permit the objective measurement of sedentary behaviour but that a lack of
evidence to date preclude their consideration at the time of writing (e.g. use of webcams and other
recording devices/cameras), including those identified by the CoOR review.134
Fitness
Only 1 out of the 13 outcome measures appraised in the fitness outcome domain was recommended by
experts: measured VO2peak.141 This measure is considered as the gold standard measure for fitness in
children as measurement of VO2max is often unacceptable and/or not achievable (based on compliance),
especially in obese children. Evidence presented by CoOR was based on one study,141 which conducted
evaluations in a small sample of overweight and obese children. However, given the wider evidence of its
use in children, experts agreed that it should be included. There was debate, however, about whether the
test should be conducted with a treadmill or bike. Lofkin et al.141 compared both methods and found
the bike to be more acceptable to obese children.
Experts agreed that findings for many of the other outcome measures identified by CoOR were dependent
on body weight (e.g. shuttle run, step test, etc.). These tools may be useful for within person comparisons
but were not advocated as trial outcomes for the CoOR outcome measures framework. Similar to other
domains in which objective measures are available, experts did not recommend self-reported
fitness measures.
Physiology
Of the 12 physiological outcomes (described in 26 manuscripts) only one – ‘indices of insulin sensitivity’ – was
recommended for inclusion into the framework. Experts stated that physiological outcomes have potential to
act as a primary outcome, given that they are indicators of cardiovascular health which is associated with
obesity. Furthermore, evidence presented by CoOR and wider evidence outside obesity research indicates that
many physiological outcomes can be measured with a high degree of precision (and are often feasible to
obtain based on routine clinical measurement). However, based on evidence specific to research in children
with obesity, only ‘indices of insulin sensitivity’ offered a sufficient degree of validity evidence (with many
studies demonstrating criterion validity comparing against a gold standard of the EHC test). It is important to
note that there was considerable debate around use of this outcome measure, as at present there is no
evidence related to what constitutes clinical meaningfulness within childhood obesity treatment evaluations.
A further scoping search was conducted by the CoOR team, with inclusion of terms specific to all
physiological measures and criteria/cut-offs to determine whether wider evidence of what is clinically
meaningful existed outside the knowledge of the experts (see Appendix 16). However, this did not identify
any further data within an obesity paediatric population. Given that other outcome domains also lack
information on what is clinically meaningful (e.g. anthropometric outcomes), the team decided to continue
to advocate ‘indices of insulin sensitivity’ to the framework. Experts agreed that these offer good surrogates
for insulin sensitivity, but pubertal status may affect results, which should therefore be taken into account.
There was some concern about the sensitivity of these indices in small samples, and other methods to
assess insulin sensitivity may be more appropriate for individuals or small groups (e.g. hyperglycaemic
clamp). However, there are clear practical limitations to their use in children.
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Eight manuscripts151,166–172 within the physiological domain described an evaluation of estimated energy
expenditure. These may have been more appropriately added to the fitness outcome domain (as they do
not necessarily imply ‘metabolic risk’). However, given that none of the energy expenditure measures were
advocated, it was agreed to continue to consider energy expenditure within the physiological domain.
Results for validation were variable, and one paper that was specifically focused on obese children171
showed a range of correct predictions (comparing predictions to a ventilated hood method) of between
12% and 74%. Overall, study validation results were poor to moderate and this outcome measure was
therefore not recommended at present.
Health-related quality of life
Of the 12 HRQoL measures that were appraised by CoOR, 10 were recommended for the CoOR outcome
measures framework by experts shown in Table 4) (see Final included studies: results from appraisal,
below). These measures were generally well developed and provided evidence of high reliability and
validity, with some specific to childhood obesity. The only two measures that were not recommended were
earlier versions of the Paediatric Quality of Life Inventory.188,189,195 Many of the HRQoL tools had been well
used by previous studies within and outside obesity research, and experts noted that any of the included
tools could be used subject to context. Similar to other secondary outcome domains, deciding which of the
HRQoL measures to use should be based on choosing one is that is mostly clearly aligned to the constructs
that are expected to change as part of a specific intervention. With this in mind, it would be acceptable to
choose a generic HRQoL measure over an obesity-specific measure if appropriate.
Psychological well-being
Of the 17 psychological well-being outcome measures that were appraised by CoOR, experts agreed to
include 10 (see Final included studies: results from appraisal and Table 4). These measures were generally
well developed (often involving participants) and demonstrated high-quality evaluation (although results
were variable). As they capture a range of different concepts (e.g. self-efficacy, perception of body image,
social acceptance, enjoyment, etc.), the decision of which to choose has to be based on the specific
requirements of each study. Like other domains, it is important to choose outcomes and corresponding
measures that capture what it is that is being targeted by the intervention. There was some debate
about the age of some of the measures and whether their language and concepts are remain relevant.
This was especially important for the SPPC209 (previously Perceived Competence Scale199), which had been
originally developed in 1982. However, in looking specifically at the scales, experts agreed that they were
still current and captured the fundamental domains in a child’s life, such as school and appearance,
encompassed in global self-worth. This particular measure is well used, and, although some argue that it is
a challenge for adults to administer, experts agreed that the majority of children found the style to be
highly acceptable. Other ‘older’ measures were judged on a case-by-case basis to determine whether the
scales and/or items remained relevant today.
Excluded measures were not recommended because they were based on poor validity results,197,200,210
focused on eating disorders198 or developed for a completely different population.208
Environment
Of the 10 included environmental measures (described in nine manuscripts213–220,236,247), five were
recommended for inclusion into the CoOR framework. The most likely environment targeted for change in
childhood treatment interventions is the home environment. The CoOR framework recommended three
different measures of the home environment218,219 (two studies). The first measure – the ‘HES’218 – assesses
the physical (e.g. food availability) and social environment (e.g. parental role modelling). Two other
measures described in a study by Rosenburg et al.219 are more like checklists of equipment that are available
in the home (electronic equipment scale and the home PA equipment scale). Two additional measures that
were recommended included one that measures a child-care environment (‘NAPSACC’212) and another
that is an assessment of parental and child perception of environments related to barriers to PA.220
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The decision to include NAPSACC was debated, as this is a measure, of a child-care environment, which
may be more suited as an outcome measure in prevention evaluations. However, experts were aware of
existing obesity ‘treatment’ interventions that target infants at high risk of obesity within child-care
environments, which led to its inclusion.
Exclusion of other measures was primarily based on inadequate validity and reliability findings. Experts felt
that some demonstrated ‘potential’ but that more evaluation with larger sample sizes would be required
before advocating their use. Although this outcome domain as relatively few recommended measures,
interest in this area of research is extremely popular and the experts agreed that there are potentially many
more measures that may be appropriate for use that did not meet the inclusion criteria for CoOR. It is
likely, for example, that many newly developed measures will be used as trial outcome measures in the
future. Although experts are aware that this area of methodology has gained popularity over recent years,
this was not demonstrated by the literature probably due, in part, to the CoOR eligibility criteria. Although
many environmental measures have been developed for use in obesity research, a majority of these are
appropriate for use in the evaluation of obesity prevention interventions (measures of the built
environment, community food environments, etc.).
Summary of key findings
l Body mass index and DXA were advocated as primary outcomes. Recommendation of BMI was primarily
based on ensuring comparability across studies (plus, ease of use and relatively low measurement error).
DXA was advocated as an additional measure to BMI if feasible as a means to estimate adiposity.
l In the diet domain, only FFQs were recommended, which had greater evidence of reliability and
validity, and were less dependent on weight status than other methods.
l Although often used (and generally well developed), eating disorder screening questionnaires were not
advocated as outcome measures in childhood obesity treatment evaluations.
l Objective measures were recommended by experts where available. Although generally well developed,
self-reported measures were deemed to be too much subject to reporting bias in this population.
l Measurement of sedentary behaviour (e.g. television watching) and sedentary time (e.g. time spent
inactive) need to be viewed as separate domains.
l Validity findings for many fitness outcomes were poor and/or highly variable. Importantly, many were
highly dependent on body weight. Such measures may be of use in within-person comparisons but
were not recommended as trial outcomes. VO2peak was the only fitness outcome to be recommended
by experts.
l Physiological outcomes are indicators of cardiovascular health and therefore have the potential to act
as a primary outcome. However, experts felt that further evidence is regarding establishing minimally
important difference (MID) in obese children. In this domain, only ‘indices of insulin’ was recommended
by experts, which were considered to offer a more practical approach to assess insulin compared with
gold standard methods (i.e. EHC). This recommendation was based on strong evidence of validity.
l The CoOR team are aware of the development of preference-based utility measures that permit
assessment of QALYs in obese children. However, manuscripts were not available for review at the time
of writing.
l New technologies and innovative ideas are currently being developed that will enable further
development and refinement of measures. Data on these measures are insufficient to use in
current recommendations.
l Recommendations are specific to evaluation of obesity treatment evaluations in children. These
considerations may not be applicable to other types of studies or setting (e.g. surveys, cohorts,
intensive experimental interventions and some public health evaluations).
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Final included studies: results from appraisal
The CoOR outcome measures framework is shown in Table 4. Efforts were made to obtain further
information regarding accessing and feasibility for each of these measures and are provided if available
(from authors, websites and information from manuscripts). Incomplete information within the table
indicates that no further information was obtained from these sources.
TABLE 4 The CoOR outcome measures framework
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Anthropometry
BMI/BMI-SDS Multiple papers
(see Appendix 6)
Trained researcher/clinical
staff
All age groups
BMI [weight (kg)/height (m)2]
BMI-SDS (age-adjusted BMI)
Requires scales (regularly
calibrated) and a stadiometer
to measure height
Existing staff/administrators can
be trained to measure with
good accuracy
DXA Multiple papers
(see Appendix 6)
Trained researcher/clinical
staff
All age groups
DXA bone density
measurement technology,
which can estimate
body composition
(including adiposity)
Requires specialised machinery
and staff
Cost of each measurement
estimate £50–200
Dietb
Short Youth
Adolescent
Questionnaire
(Short YAQ),
26 item
Rockett 200734
Self-complete
Suitable for children
and adolescents
Fruit, vegetables (carrots only),
cereals, white meat, red meat,
milk and milk products,
snacks, sugar sweetened
beverages, non-sugar
sweetened beverages.
Note: Most items are
presented as ‘meals’
rather than individual
components (e.g. chicken
or turkey sandwich’)
Access: https://regepi.bwh.
harvard.edu/health/KIDS/files
Copyright: EliteView(TM)
Cost: Costs incurred for
questionnaires and analysis
(although can opt to do
analysis independently).
See website for details
Feasibility: No information for
Short YAQ. Duration for
completion of full
YAQ= 20–30 minutes
Youth Adolescent
Questionnaire
(YAQ), 131 item
Rockett 1995,43
Rockett 1997,37
Perks 200030
Self-complete
Suitable for children
and adolescents
Fruit, vegetables, cereals,
white meat, red meat, fish,
milk and milk products,
snacks, sugar sweetened
beverages
Access: Through website
https://regepi.bwh.harvard.edu/
health/KIDS/files
Copyright: EliteView(TM)
Cost: Costs incurred for
questionnaires and analysis
(although can opt to do
analysis independently).
See website for details
Feasibility: Duration for
completion of full
YAQ= 20–30 minutes
continued
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Children’s Eating
Habits Questionnaire
(CEHQ-FFQ), 43 item
Lanfer 2011,36
Huybrechts 201131
Parent completed
Suitable for children
Fruit, vegetables, cereals,
white meat, red meat, fish,
milk and milk products,
snacks, oils/condiments, nuts,
sugars, sugar sweetened
beverages, non-sugar
sweetened beverages,
ready-made meals,
baked foods
Access: Via author at
ahrens@bips.uni-bremen.de
Copyright: Intellectual
property of study consortium.
The paper by Lanfer36 may
serve as a reference
Cost: Freely available, but
asked to cite paper/book. Costs
will be sought if requesting
SAS code for managing the
data and/or for defining
(derived) variables
Feasibility: Not evaluated
Australian Child
and Adolescent
Eating Survey
(ACAES), 137 item
Watson 2009,246
Burrows 200832
Self-complete
Suitable for children
and adolescents
Fruit, vegetables, red meat,
milk and milk products,
snacks, oils/condiments, sugar
sweetened beverages,
non-sugar sweetened
beverages, ready-made meals,
baked foods
Access: Via Newcastle
Innovation at
innovation@newcastle.
edu.au or www.
newcastleinnovationhealth.
com.au/research-partners/
food-frequency-questionnaires#
Copyright: Prior to use,
researchers are required to
complete a signed agreement.
The agreement outlines the
terms and conditions of using
the ACAES FFQ to ensure it is
utilised appropriately and the
nutrient data are processed
accurately. The agreement
can be obtained online at
addresses above
Cost: Yes – includes scanning,
data processing and preparation
of a dataset (not analysis). Cost
per survey is A$17, with
discounts for >100 surveys
Feasibility: Duration of
completion= 20–30minutes
Diet fat-screening
measure, 21 item
Prochaska 200150
Self-complete
Suitable for adolescents
High-fat foods/meals
including burgers, pizza, ice
cream, whole milk, oils/
dressings, etc.
Access: Listed onwebsite (within
PACES): http://sallis.ucsd.edu/
measure_paceadol.html
Copyright: No information
Cost: Website indicates that
measures are free for
research purposes. Links to
gnorman@paceproject.org for
further information
Feasibility: Duration of
completion= 5–10 minutes;
duration of scoring=
2–3 minutes
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
New Zealand FFQ,
117 item
Metcalf 2003247
Parent completed
Suitable for children
(up to 14 years)
Fruit, vegetables, cereals,
white meat, red meat, fish,
milk and milk products,
snacks, oils/condiments, sugar
sweetened beverages,
baked foods
Feasibility: (from manuscript):
Duration of completion=
20 minutes
Eating behaviours
Infant Feeding
Questionnaire (IFQ),
20 item
Baughcum 200174
Parent completed
Suitable for infants
Concern about infants weight
Concern about infant hunger
Concern about how much
infant eats
Control over how much infant
eats
Using food to calm infant
Attention/nurturance by
mother during feeding
Established feeding schedule
Awareness of infants hunger
and satiety cues
Access: The instrument is not
available online. Scale items are
shown (verbatim) in table 1 of
the paper
Copyright: None
Cost: Freely available
Feasibility: Not measured
Preschool Feeding
Questionnaire
(PFQ), 32 item
Baughcum 200174
Parent completed
Suitable for preschoolers
(infants and children)
Maternal concern about child
weight
Structure during feeding
interaction
Difficulty in child feeding
Pushing child to eat more
Using food to calm child
Child control of feeding
interaction
Age-inappropriate feeding
Access: The instrument is not
available online. Scale items are
shown (verbatim) in table 5 of
the paper
Copyright: None
Cost: Freely available
Feasibility: Not measured
Dutch Eating
Behaviour
Questionnaire for
Children (DEBQ-C),
20 item
Van Strien 2008,79
Banos 2011,83 Braet 200792
Self-complete
Suitable for children
and adolescents
Emotional eating
Restrained eating
External eating
Access: Via author:
Lien Goossens,
Lien.Goossens@UGent.be. If
using for commercial purposes,
contact Tatjana Van Strien:
t.vanstrien@psych.ru.nl
Copyright: None for child
version
Cost: Freely available for
non-commercial purposes
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Feasibility: Statistical analysis
code available on request
to author. Duration of
administration ∼10–20 minutes
Dutch Eating
Behaviour
Questionnaire for
Children (DEBQ-P),
33 item
Caccialanza 2004,98
Braet 199778
Parent completed
Suitable for children
and adolescents
Emotional eating
Restrained eating
External eating
Access: Via author:
Lien Goossens,
Lien.Goossens@
UGent.be. If using for
commercial purposes, contact
Tatjana Van Strien:
t.vanstrien@psych.ru.nl
Copyright: None for child
version
Cost: Freely available for
non-commercial purposes
Feasibility: Statistical analysis
code available on request
to author. Duration of
administration ∼10–20 minutes
Emotional Eating
Scale for Children
and Adolescents
(EES-C), 26 item
Tanofsky-Kraff 200777
Self-complete
Suitable for children
and adolescents
Eating in response to anger,
anxiety and frustration
Eating in response to
depressive symptoms
Eating in response to
feeling unsettled
Access: Via author
Marian Tanofsky-Kraff,
marian.tanofsky-kraff@usuhs.edu
Copyright: None, but
requested to cite published
papers
Cost: None
Feasibility: None
reported/evaluated
Child Feeding
Questionnaire
(CFQ), 31 item
[16-item version
also available
(Anderson 200575)]
Birch 2001,75
Haycraft 2008,93
Anderson 2005,96
Corsini 2008,97
Polat 2010,94
Boles 2010232
Parent completed
Suitable for infants
and children
Perceived responsibility
Parent-perceived weight,
perceived child weight
Parents concern about child
weight
Monitoring
Pressure to eat
Restriction
Access: Via author
Sheryl Hughes,
shughes@bcm.edu
Copyright: None
Cost: None
Feasibility: See
Anderson 200596
Infant Feeding Style
Questionnaire
(IFSQ), 83 item
(64-item version
available for infants
of < 6 months)
Thompson 200976
Parent completed
Suitable for infants
Styles:
l Laissez-faire
l Pressuring/controlling
l Restrictive/controlling
l Responsive
l Indulgent
Access: E-mail to
althomps@email.unc.edu
Copyright: None
Cost: None
Feasibility: Deemed
acceptable based on low levels
of missing data. No information
on duration
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Children’s Eating
Behaviour
Questionnaire
(CEBQ), 35 item
Sleddens 2008,72
Wardle 200173
Parent completed
Suitable for children
Food fussiness
Enjoyment of food
Food responsiveness
Emotional overeating
Satiety responsiveness
Emotional undereating
Desire to drink
Slowness in eating
Access: From website:
www.ucl.ac.uk/hbrc/
Copyright: None
Cost: None
Feasibility: Was perceived as
quick and easy by parents.
A further version for infants
(the Baby Eating Behaviour
Questionnaire) is also available
on the website. Authors are
also currently developing a
self-completion version
for adolescents
Toddler Snack Food
Feeding
Questionnaire
(TSFFQ), 42 item
Corsini 201082
Parent completed
Suitable for children
and infants
Rules
Child’s attraction
Self-efficacy
Flexibility
Allow access
Access: Email
(from manuscript)
nadia.corsini@csiro.au
Kids’ Child Feeding
Questionnaire
(KCFQ), 28 item
(16-item version
also available)
Monnery-Patris 2011,85
Carper 2000250
Self-completed
Suitable for children
Restriction and pressure to eat Access: Via author
Sandrine Monnery-Patris,
Sandrine.Monnery-Patris@
dijon.inra.fr or within
manuscript:
www.ncbi.nlm.nih.gov/
pubmed/21565236
www.sciencedirect.com/
science/article/pii/
S0195666311001358
Copyright: None, but the
author would like to be
notified of its use
Cost: None
Feasibility: Completion in
5–10 minutes
Un-named (control
in parental feeding
practices), 29 item
Murashima 201184
Parent completed
Suitable for children
Non-directive, food
environmental control, high
control, high contingency,
child-centred feeding,
encouraging nutrient-dense
foods, discouraging
energy-dense foods,
meal-time behaviours,
timing of meals
Access: (from manuscript)
murashi1@msu.edu
Feasibility: Items and details
of scoring provided as an
appendix within the paper
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Eating in the
Absence of Hunger
questionnaire
(EAH-C), 14 item
Tanofsky-Kraff 200880
Self-completed
Suitable for children
and adolescents
Negative effect, external
eating, fatigue/boredom
Access: Via author
Marian Tanofsky-Kraff,
marian.tanofsky-kraff@
usuhs.edu
Copyright: None, but
requested to cite published
papers
Cost: None
Feasibility: None
reported/evaluated
Physical activity
Accelerometer Guinhouya 2009,234
Coleman 1997,108
Noland 1990,106
Pate 2006,107
Kelly 2004105
Suitable for infants,
children and adolescents
Measurement devices for
assessment of acceleration
forces/movement intensity.
Calculates frequency and
duration of PA
Monitor (excluding software)
costs ∼£150–300 each
Pedometer Duncan 2007,248
Kilanowski 1999,114
Treuth 2003,113
Jago 2006,112
Mitre 2009110
Suitable for infants,
children and adolescents
Measures number of steps
taken (usually daily)
Sealed equipment
costs ∼ £10–100 each
Observational
System for
Recording Physical
Activity-Preschool
Version (OSRAC-P),
eight categories
Brown 2006103
Researcher conducted
Suitable for infants
and children
Activity level, type of activity,
social (e.g. initiator of activity,
group composition) and
non-social (e.g. child location)
environment circumstances
Access: Author provides
email in the manuscript:
bbrown@gwm.sc.edu
Manual available at: www.sph.
sc.edu/USC_CPARG/pdf/
OSRAC_Manual.pdf
Tool download available at:
www.sph.sc.edu/usc_cparg/
osrac.html
Copyright: Authors report no
official copyrighted though
state it has sufficient
documented history of its
development and use by the
Children’s Physical Activity
Group to give some intellectual
property rights
Feasibility: requires systematic
training of several weeks to
move trained observers to
interobserver agreement
System for
Observing
Children’s Activity
and Relationships
Ridgers 2010102
Researcher conducted
Suitable for children
Activity level, group size,
activity type, interactions
Access: Protocols manual and
observation tool available via
email to Nicky Ridgers:
nicky.ridgers@deakin.edu.au
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
During Play
(SOCARP)
Copyright: Use of the tool
should reference Ridgers et al.
(2010)83
Cost: None associated with use
or analysis, except for staff
time taken to establish the
interobserver reliability for
those who will be collecting
the data
Feasibility: Training for
interobserver reliability=
10–20 hours; Each observation
period is 10 minutes in length
(one observer during a
60-minute lunchtime would be
expected to record data from
five to six children)
Accelerometer Puyau 2002,132
Reilly 2003131
Measurement devices for
assessment of acceleration
forces/movement intensity.
Calculates frequency and
duration of PA
Monitor (excluding software)
costs ∼£150–300 each
Measured VO2peak Loftin 2004141 Measures the amount of
oxygen consumed/minute
while conducting a graded
fitness test on a treadmill,
bike or other piece of cardio
exercise equipment.
VO2peak= peak amount of
oxygen used for energy
during the test
Specialist equipment to
conduct and analyse the
data needed, in addition to
trained staff. VO2peak is more
acceptable to participants than
VO2max but still requires full
cooperation and a degree
of burden
Physiology
Indices of
insulin sensitivity
Rossner 2008,161
Keskin 2005,160
Atabek 2007,159
Gungor 2004,158
George 2011,154
Conwell 2004,153
Yeckel 2004,152
Uwaifo 2002,156
Schwartz 2008,162
Gunczler 2006155
Includes indices:
HOMA-IR
QUICKI
FGIR
FIRI
ISI COMP
HOMA-B%
WBISI
Derived from blood insulin and
glucose concentrations under
fasting conditions (steady state)
or after an oral glucose load
(dynamic). Relatively inexpensive
surrogates usually taken in
(but not restricted to) a
clinical setting
Child Health
Questionnaire
(CHQ), 50 item
Waters 2000,192,193
Landgraf 1998186
Physical functioning
Role social emotional
Role social physical
Bodily pain, mental pain,
behaviour
Access: Via website:
www.healthactchq.com/
Copyright: Registration and
licensing required
Costs: Yes, fees depend on
needs of study
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Self-esteem
General health, parent
impact – emotional, parent
impact – time, family
activities, family cohesion
Change in health
Feasibility: Completion in
10–15 minutes
DISABKIDS, 37 item Ravens-Sieberer 2007196
Self-report and
parent-report versions
Suitable for children
and adolescents
Physical well-being
Psychological well-being
Moods and emotion,
self-perception
Autonomy
Parent relation and home life
Peers and social support
School environment
Bullying
Financial resources
Access: Website:
www.child-public-health.org/
english/research/
Copyright: See website
Feasibility: 12-item version
also available, in addition to
‘smiley face’ version for aged
4–6 years. Computer-assisted
versions also available
KIDSCREEN (short),
27 item
Ravens-Sieberer 2007194
Self-report
Suitable for children
and adolescents
Physical well-being
Psychological well-being
Moods/emotions
Self-perception
Autonomy
Parent relation and home life
Peers and social support
School environment
Bullying
Financial resources
Access: Website: www.
child-public-health.org/
english/research/
Email: Ravens-Sieberer@uke.
uni-hamburg.de
Copyright: To the KIDSCREEN
Group. User agreement
required
Cost: Free for non-industry
research
Feasibility: 52-item (long) and
10-item (short) versions also
available. Duration for
completion ∼10–15 minutes
EQ-5D-Y, 5 item,
plus VAS for
overall health
Burstrom 2011,241,242
Wille 2010,243
Ravens-Sieberer 2010244
Self-report
Suitable for children
or adolescents
Mobility
Self-care
Usual activities
Pain and discomfort
Anxiety and depression
Access: English versions via
oemar@euroqol.org (EuroQol
Business Office)
Copyright: Copyrighted and
cannot be altered/modified
Cost: Free to use for
non-industry research
Feasibility: 91–100%
complete data obtained in a
multinational study (indicating
comprehension/acceptability)
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Impact of Weight
on Quality of Life
(IWQoL), 27 item
Kolotkin 2006,181
Modi 2011182
Self-complete or
parent-complete versions
Suitable for adolescents
Physical comfort, body esteem
Social life
Family relations
Access: E-mail to
Ronette L. Kolotkin:
rkolotkin@qualityoflife
consulting.com or www.
qualityoflifeconsulting.com
Copyright: Copyright ©
Ronette L. Kolotkin and
Cincinnati Children’s Hospital
Medical Centre. All commercial
rights are owned by Quality of
Life Consulting, PLLC, Durham,
NC, USA. The questionnaires
may not be used without
permission and a licence
agreement
Cost: The licence fee is
US$10/participant for
commercially funded studies,
US$5/participant for
government-funded,
foundation-funded or internally
supported studies, or US$3 per
administration for clinical
practices
Feasibility: Duration for
completion=∼8 minutes
KINDL-R
questionnaire,
24 item
Erhart 2009187
Self-report
Suitable for adolescents
Physical well-being
Emotional well-being
Self-worth
Well-being in the family
Well-being related to friends/
peers
School-related well-being
Access: Via website
http://kindl.org/cms/
fragebogen/langswitch_lang/en
Copyright: Any duplication or
distribution is permitted only
with the prior consent of the
author, and requests that
citations and date are quoted.
User agreement required
Cost: Free to non-industry
research
Feasibility: Duration for
completion ∼10 minutes.
Translated in many languages
and different versions available
for differing age groups
Paediatric Quality of
Life Inventory V4.0,
23 item
Varni 2001,190
,
Varni
2003,191 Hughes 2007196
Self-report/parent report
Suitable for infants,
children and adolescents
Physical
Emotional
Social
School
Functioning
Access: Need to complete a
user agreement form: details
on-line at www.pedsql.org.
Can also send informal
queries to PROinformation@
mapi-trust.org
Copyright: Reserved to
Dr James W Varni
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Cost: See website for details.
Funded academic research=
US$990 per study (including
delivery of one module+
US$330 per additional
module+US$25 for bank
expenses). Non-funded= free
Feasibility: Duration for
completion≤ 4 minutes
Sizing Me Up
(self-report)/Sizing
Them Up (parent
report), 22 item
Modi 2008,184
Zeller 2009183
Self-report/parent report
Suitable for children
and adolescents
Two measures of:
Emotional functioning
Physical functioning
Teasing
Positive social attributes
Social avoidance (self-report)
Mealtime challenges (parent
report)
School functioning
(parent report)
Access: Website: www.
cincinnatichildrens.org/research/
divisions/c/adherence/labs/
modi/hrqol/sizing/default/
Email: meg.zeller@cchmc.org
Copyright: Copyright
agreement (obtained from
website)
Cost: None (provided
agreement is signed)
Feasibility: Sizing Them Up
and Sizing Me Up can be used
together in clinical and research
settings. Duration for
completion= 15 minutes each
Youth
Quality-of-Life
Instrument-Weight
Module (YQOL-W),
21 item
Morales 2011185
Self-completed
Suitable for children
and adolescents
Self, social and
environment scales
Access: Via website: http://
depts.washington.edu/seaqol/
Copyright: Yes, a user’s
agreement is required
Costs: US$500 industry,
US$200 public/university,
students free (not including
analysis)
Feasibility: Duration for
completion= 5–10 minutes
Psychological well-being
Children’s Body
Image Scale (CBIS)
Pictorial
(photograph) scale
Truby 2002198
Self-completed
Suitable for children
Gender-specific
self-perception of body
image (child identifies image
most like their own out of
seven images)
[No response: experts that felt
this was now out of copyright
and is now freely available]
Body figure
perception
(pictorial), 5 item
Collins 1991205
Self-completed
Suitable for children
Self
Ideal self
Ideal other child
Ideal adult
Ideal other adult
Access: Manuscript provides
pictures
Feasibility: Pictorial scale not
dependent on literacy level
(and can be used in
different languages)
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
52
TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Self-Perception
Profile for Children
(SPPC), 36 item
Van Dongen-Melman
1993209
Self-completed
Suitable for children
Scholastic competence
Social acceptance
Athletic performance
Behavioural conduct
Global self-worth
Physical appearance
Access: Website: www.nlsinfo.
org/childya/nlsdocs/guide/
assessments/SPPC.htm
Copyright: Experts stated
that this is freely available
(information not provided by
authors)
Feasibility: Perceived
Importance Profile (PIP) is
recommended to use in
conjunction with the SPPC
(Whitehead 1995,210 below)
Perceived
Competence Scale
(aka SPPC/Harter),
28 item
Harter 1982199
Self-completed
Suitable for children
Cognitive competence
Social competence
Physical competence
General self-worth
Access: Website: www.nlsinfo.
org/childya/nlsdocs/guide/
assessments/SPPC.htm
Copyright: Experts stated
that this is freely available
(information not provided
by authors)
Physical Activity
Enjoyment Scale
(PACES), 12 item
Motl 2001249
Self-completed
Suitable for adolescents
Enjoyment
Factors influencing enjoyment
in PA
Access: Lead author,
robmotl@illinois.ed;
corresponding author for
manuscript, rdishman@
coe.uga.edu
Children’s Physical
Self-Perception
Profile (C-PSPP),
24 item
Whitehead 1995,210
Eklund 1997245
Self-completed
Suitable for children
and adolescents
Attractive body adequacy
Strength competence
Condition/stamina
Sport competence
Physical condition
Competence
Physical self-worth
General self-worth
Access: Via author
James Whitehead,
james.whitehead@email.
und.edu
Copyright: None
Cost: None
Feasibility: Note from authors:
with the structured alternate
response format, it is important
to use the sample item to
explain it to participants
Children’s Self
Perception of
Adequacy in and
Predilection for
Physical Activity
(CSAPPA), 20 item
Hay 1992211
Self-completed
Suitable for children
and adolescents
Adequacy
Predilection
Enjoyment of physical
education
Access: Questionnaire available
as an appendix within the
manuscript (Hay 1992213)
Children’s Physical
Self-Concept Scale
(CPSS), 27 item
Stein 1998207
Self-completed
Suitable for children
Physical performance
Physical appearance
Weight control
Access: Items available within
manuscript (Stein 1998207)
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Social Anxiety Scale
for children,
22 item
La Greca 1993,202 1988201
Self-report
Suitable for children
Fear of negative evaluation
from peers
Social avoidance and distress
around new peers or in new
situations
Generalised social avoidance
and distress
Access: Enquires to Liz Reyes
at ereyes@miami.edu. Website:
www.psy.miami.edu/faculty/
alagreca/#social_anxiety
Copyright: By Annette M. La
Greca and may be used only
with her written permission
Cost: For manual, US$15.00
Feasibility: The manual for the
Social Anxiety Scales contains
detailed psychometric and
normative information,
information on translations,
and copies of the scales and
their scoring. Adolescent
version also available
Body Esteem Scale
(BES), 24 item
Mendelson 1982204
Self-report
Suitable for children
and adolescents
Appearance, weight
and attribution
Access: Via e-mail to:
stephen.franzoi@
marquette.edu or
sashields@psu.edu
Copyright: Researchers must
forward details of any
research conducted with the
measure to the author:
bev@ego.psych.mcgill.ca
Environment
Nutrition and
Physical Activity
Self-Assessment to
Child Care
(NAPSACC),
56 item
Benjamin 2007247
Child-care centre staff
completed
Suitable for infants
Child-care setting:
F&V, fried food and high-fat
meat, beverages, menu and
variety, meals and snacks
Foods outside of regular
meals and snacks
Supporting HE
Nutrition education for
children, parents and staff
Nutrition policy
Active play and inactive time
Television use and television
viewing
Play environment
PA education for children,
parents and staff
Supporting PA
PA policy
Access: E-mail to
dsward@email.unc.edu. Link
to associated intervention
webpage (with details of
researcher conducted version)
at www.napsacc.org/
Copyright: None
Cost: None
Feasibility: Requires
completion by child-centre staff
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TABLE 4 The CoOR outcome measures framework (continued )
Measurement
name
First author;
administration; suitable
child age rangea Description Access/feasibility
Environment and
Safety barriers to
Youth Physical
Activity
Questionnaire,
21 item
Durant 2009220
Parent and child completed
Suitable for adolescents
Child and parent perception
of built environment:
Street environment
Street safety
Park environment
Park safety
Access: Measure used as part
of the Active Wear Study.
Details of all measures, including
this, at http://sallis.ucsd.edu/
measure_activewhere.html
Home Environment
Survey (HES),
105 item
Gattshall 2008218
Parent completed
Suitable for children
Home environment:
PA availability
PA accessibility
PA parental role modelling
PA parental policies
F&V availability
F&V accessibility
Fat/sweets availability
HE parental role modelling
HE parental policies
Access: Via email to
Michelle.Gattshall@kp.org
Copyright: None
Cost: None
Feasibility: Not reported
Home electronic
equipment scale,
21 item
Rosenberg 2010219
Parent and self-completed
Suitable for children
and adolescents
Home environment:
Electronics available in the
home
Electronics available in the
child’s or adolescent’s
bedroom
Portable electronics
Access: Measure used as part
of the Active Wear? Study.
Details of all measures,
including this at
http://sallis.ucsd.edu/measure_
activewhere.html
Home PA
equipment scale,
14 item
Rosenberg 2010219
Parent and self-completed
Suitable for children
and adolescents
Home environment: Checklist
of availability of 14 types of
PA equipment
Access: Measure used as part
of the Active Wear? Study.
Details of all measures,
including this, at
http://sallis.ucsd.edu/
measure_activewhere.html
CBIS, Children’s Body Image Scale; F&V, fruit and vegetable; FGIR, fasting glucose insulin ratio; FIRI, fasting insulin
resistance index; HE, healthy eating; HOMA-B%, homeostatic model assessment – pancreatic beta-cell function;
HOMA-IR, homeostatic model assessment – insulin resistance; ISI COMP, insulin sensitivity index composite; PACES, Physical
Activity Enjoyment Scale; QUICKI, quantitative insulin sensitivity check index; VAS, Visual Analogue Scale; WBISI, whole-body
insulin sensitivity index.
a Age presented are based on CoOR categories of infancy (< 36 months), children (36 months – 12 years) and adolescents
(> 12 years). As it is unlikely that the participant characteristics will be comparable, this was set to guide researchers
whether the tool is appropriate in terms of the comparability between the age in which the tool was developed/tested
and the age of the intended participants.
b Food frequency questionnaire food categories are CoOR defined, based on availability of items (for consistency). They
are not listed as defined by authors.
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Chapter 5 Discussion
Summary of evidence
After screening 25,486 manuscripts, the CoOR study identified 379 eligible manuscripts that described the
development and/or evaluation of 180 outcome measures for use in the evaluation of childhood obesity
treatment interventions. Appraisal of each of these measures resulted in a framework that recommended
52 measures across 10 outcome domains, for use in the future evaluation of childhood weight
management programmes. This framework provides clear guidance to researchers about appropriate
outcome domains and recommended measures in each of these domains to encourage greater adoption
of well-validated tools. This will make it easier to judge clinical effectiveness and enhance the comparability
between different studies or treatment interventions.
Outcome measures were identified via a specific methodology search for manuscripts that described the
development and/or evaluation of measures, and via citations within manuscripts of childhood obesity
treatment trials that describe the outcome measures used. For the latter, a total of 147 citations were
identified within 200 trial manuscripts. However, only 56 (13%) of citations were linked to methodology
papers that reported the development or evaluation of measures. A majority of citations were incorrect,
often referring to a previous study that had used the same measure and not a method development
report. This level of inaccuracy in citations is unacceptable and impedes the ability of readers to understand
a trial’s conduct, analysis and interpretation, and to assess the validity of its results.253 Authors are advised
to adhere to guidance set by the CONSORT statement, specifically related to the statement of
measurement of outcomes in trials: ‘All outcome measures, whether primary or secondary, should be
identified and completely defined. The principle here is that the information provided should be sufficient
to allow others to use the same outcomes’.254
Primary outcome measures that were recommended are BMI and DXA. The decision to include BMI was,
in part, based on the feasibility of its use and the ability to ensure comparability between evaluations.
Fifty-seven per cent of the eligible trials identified by the CoOR review reported using BMI (or a derivative
of BMI) as a primary outcome. Although the evidence of validity offered by the methodology studies
within the CoOR review was inconsistent for BMI, experts agreed that it can be reliably measured,
provided that administrators are well trained and equipment is regularly calibrated. However, the
limitations of BMI were also acknowledged. Primarily, BMI does not provide any information about body
composition (including adiposity) or fat distribution. This caveat needs to be considered particularly in
studies that evaluate interventions focused on PA (especially those with a lot of strength training).
However, the majority of childhood obesity programmes are multifaceted, comprising a variety of lifestyle
interventions. A further caveat of BMI (which is common to a number of outcome measures) is the lack of
evidence regarding the magnitude of change that is clinically meaningful, also referred to as a MID.
Evaluations are focused on detecting a statistical difference in change in BMI between treatment arms, but
determination of sample sizes to ensure that it is possible to detect differences requires an estimation of an
ES that is ideally based on detecting a clinically meaningful change. Limitations in the available evidence
lead to arbitrary decisions being made regarding what amount of change is meaningful. Pooled results of a
meta-analysis by Luttikhuis et al.1 report a range in change of between −0.06 and −0.014 for BMI-SDS,
and of between −3.04 and −3.27 kg/m2 for absolute change in BMI for behavioural interventions.
Medium- to high-intensity behavioural interventions in a further review by Whitlock et al. for the Agency
of Health Care Research and Quality255 report mean reductions in BMI of between 1.9 and 3.3 kg/m2. Such
data are considered by researchers in deciding what would be considered a desirable level of change.
However, there remains insufficient evidence to determine the impact of these changes on cardiovascular
risk in children (or later in life).
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In addition to measurement of BMI, the CoOR framework advocates the use of DXA measurement if
feasible. DXA is also a proxy measure of adiposity but is able to provide an estimation that differentiates
between fat and lean tissue. The equipment needed to conduct DXA measurements is expensive and,
although widely available in hospital settings, may not always be available for research purposes, especially
in community settings; thus, the CoOR framework suggests that DXA is supported with measurement of
BMI to allow comparisons between intervention evaluations. Similar to BMI, there is limited evidence
regarding the magnitude of change in adiposity that is clinically meaningful. Research in adults has
suggested a change of at least 5–10% body fat,256–257 but this is also somewhat arbitrary and there are no
standards in children. Use of DXA may also be limited to measurement of children who are not severely
obese, as some of the feasibility evidence found by CoOR suggests that some children were excluded from
the analysis owing to issues with obtaining accurate measurements in those children who were too large
to measure on the equipment.16
Secondary outcomes have been recommended for each of the outcome domains. However, researchers
are advised to include only measures that will assess what they expect to change following an intervention,
or what they believe will mediate such changes. Thus, it is not necessary to include a measure from all
outcome domains in every programme evaluation. Similarly, where multiple measures are advocated within
an outcome domain, researchers are advised to consider which measures are most closely aligned to the
intervention targets and, where available, choose a measure that has been developed in a population most
similar to the intended sample.
Experts agreed that objective measurements must be used where available (i.e. use of activity monitors
instead of self-reported PA) and where objective measures are available, no self-reported measures have
been recommended for inclusion to the framework. Although findings from the CoOR systematic review
indicated that some self-reported measures have been well developed,121,126,129 the validity evidence was
generally less strong than evaluations of objective measurements. The dependence of weight or weight
status on reporting was also apparent in CoOR findings from self-reported measures 53,55,130 and was an
issue discussed by experts incorporating wider evidence.258,259 For some outcome domains, it is not possible
(e.g. psychological well-being) or feasible (e.g. dietary assessment) to use an objective measure.
In the case of assessment of PA, use of pedometers and direct observation methods were recommended in
addition to accelerometers. Although the accuracy of pedometers and direct observation is likely to be
lower than for accelerometers, they were recommended as alternative measures, which may be more
feasible for some researchers. When using pedometers, researchers should opt for sealed equipment that
does not display the number of steps and which are not dependent on self-reporting (i.e. should have the
capacity to automatically download). Further, the use of pedometers is not recommended in evaluations of
programmes that use pedometers as part of the intervention. For all measurements relying on equipment,
it is noted that there will be some variability in data produced between different types and models of
equipment. This will have an impact on comparability between studies. Thus, researchers should report the
name, version and manufacturer of equipment used. Importantly, the same equipment should be used
throughout a single study.
Physiological outcomes, such as insulin, blood lipids and blood pressure have the potential to be primary
outcomes, as they are measured with high precision and are indicators of cardiovascular health.260 Thus,
improvements to such indicators are likely to be more clinically meaningful than reductions in weight
alone. However, at present, there is insufficient evidence on what constitutes a clinically meaningful
change or which measures are most sensitive to changes in weight. Without further clarification, experts
believed it would be premature to advocate their use as primary outcome measures. Based on the validity
evidence collated by CooR, multiple indices of insulin sensitivity were recommended for inclusion into the
outcome measures framework. However, limited evaluations (or poor validity) in other physiological
measures meant that no other measures were advocated.
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In order to determine what constitutes a MID, it is necessary to ascertain whether or not a measure is able
to measure change.261 The ability of a measure to detect a clinically meaningful change is defined as
responsiveness,262,263 whereas the interpretation of whether the change is clinically important relates to a
MID (the smallest change that would be deemed clinically beneficial). Both factors vary by population and
application. For childhood obesity treatment evaluations, responsiveness considers the relationship
between changes in demonstrated effectiveness (e.g. weight loss) and changes in scores or values from
other outcome measures. Evidence of responsiveness in eligible measures was poor or lacking in CoOR. In
order to maximise data, information regarding sensitivity to measure change was also collected, with the
key difference being that sensitivity measures change independently of clinical meaningfulness.262
However, this did not lead to substantial improvements to the data.
As previously stated, a concern for the proposed primary outcomes relates to a lack of clarity on MID,
although evidence suggests that BMI and DXA can be measured with a good degree of precision. For BMI,
wider evidence has indicated that absolute change, rather than standardised change in BMI (i.e. BMI-SDS)
may be better, as it is less dependent on baseline BMI (which may have reduced sensitivity in very obese
children).264 However, this may be overcome by adjustment for baseline BMI if using standardised
BMI-SDS, which will also provide independence from age and gender.
Only six included manuscripts in CoOR reported formally assessing responsiveness.66,170,174,181,184,186,215
Importantly, responsiveness was not ascertained for any measures of psychological well-being or eating
behaviours, and was assessed in only two HRQoL measures. These measures are most closely related to
PRO measures (although, generally, participants in obesity treatment trials are not considered as ‘patients’).
Guidance in the use of PROs suggest that if there is clear evidence that a patient’s (participant’s)
experience (relative to the intervention) has changed but the PRO scores do not change then either the
ability to detect change is inadequate or the measurements’ validity should be questioned.9 Additionally, if
there is evidence that PRO scores are affected by changes that are not specific to the intervention, the
validity of the measure may be questioned. Thus, in order to advocate their use, it would be preferable to
know if they demonstrate meaningful improvements when used in the evaluation of treatments that have
some evidence of effectiveness in childhood obesity. However, following this guidance would mean that
the CoOR outcome measures framework would not be able to advocate the majority of the measures that
have been included. Instead, it is recommended that responsiveness assessment is considered in future
research with an understanding of the caveats of using a measure with no (or little) evidence of
responsiveness. It is important to note, however, that a lack of evidence of responsiveness does not
necessary imply that each measure is not able to detect change. Additionally, the eligibility criteria set by
CoOR may have excluded wider evidence of the included tools for responsiveness (e.g. assessed in adults).
The CoOR systematic review did not identify any preference-based (utility) measures of quality of life that
would permit an estimation of QALYs. These instruments obtain the participants’ own values of varying
dimensions of their health, which combines the impact of both the quantity and quality of life, and permits
a cost–utility analysis.265 In order to generate QALYs, health utilities (or HRQoL weights) are needed. In this
model, utilities for health states are based on participants’ preferences for varying health states, with more
desirable health states receiving greater weights.266 Utilities are measured on an interval scale of 0–1,
where ‘0’ equates to death and ‘1’ indicates full health (although negative scores are also possible).
Current guidance by NICE states that the QALY should be used to estimate outcomes in economic
evaluation of competing health interventions in order to allow consistent decision making (NICE 2008267).
All identified quality-of-life measures in the CoOR review lacked preference weights and are therefore not
able to calculate QALYs. Instead, these measures derive scores for varying dimensions of health statuses.
They have been defined as HRQoL measures that are recommended to be considered for inclusion in
future evaluations in line with other secondary outcomes with the CoOR framework. But they should not
be considered as outcome measures specifically for economic evaluation unless used in cost-effectiveness
evaluations of interventions with a primary target on quality of life. However, for evaluations of childhood
obesity interventions, a more likely measure to establish cost-effectiveness is that of the primary outcome
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(i.e. cost per unit of reduction in BMI). The CoOR team are aware of research in which utility measures are
being developed for use in obese paediatric populations. Unfortunately, these were not available at the
time of the review.
How to use the Childhood obesity Outcomes Review outcome
measures framework
Figure 7 provides guidance as to how the CoOR outcome measures framework should be used by
researchers. Importantly, researchers need to first consider which (if any) secondary outcome domains are
most closely aligned to the targets of the intervention under investigation, including those that are
expected to change, those that are expected to mediate this change (if appropriate), and any that may
indicate an adverse event (if appropriate). Researchers are then advised to view the recommended
outcome measures within each of the chosen outcome domains in the framework. Any selected measure
needs to be aligned to the intervention targets, developed for use in a similar population and feasible to
implement. In deciding the similarity between populations, validation of a measure is relevant to only really
the population in which it was evaluated. However, given that is unlikely that there will be a tool that has
been developed for use, and evaluated within all populations, researchers should make informed decisions
regarding whether the characteristics of their populations are sufficiently close to the population in which
the tool was developed. For example, it would not be advisable to use a tool that was developed within a
white middle-class population of America in a South Asian lower-class population of the UK. Similarly,
tools that were developed to be self-completed by adolescents are unlikely to be relevant for completion
by parents.
Further details on each measure within the framework can be accessed from the CoOR summary tables
(see Appendices 6–15). If a measure that fulfils these criteria does not exist then the researcher may also
choose to locate an alternative measure from the summary tables, with the caveat that these were not
recommended for inclusion to the framework.
Identify study outcomes
Review recommended measures from the
outcomes framework within identified study
outcome domain(s)
Does measure address
intervention targets?
Is the population similar?
Is it feasible?
NO
YES
Review CoOR summary
tables of all outcome
measures
Use CoOR
recommended
measure
FIGURE 7 Using the CoOR outcome measures framework.
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Limitations of the research
The recommendations within the CoOR outcome measures framework are specifically intended for use as
outcome measures within studies that evaluate childhood obesity treatment evaluations. These may
or may not be suitable for other study designs. It could be argued that some measures that were not
recommended are equally, if not more, valid than those that were advocated for other populations or
treatment evaluations. However, all decisions were focused on the intended population and study design,
which means that some popular, commonly used measures were not deemed appropriate. For example,
within the diet domain only FFQs were recommended. This is perhaps of some surprise, given that
collection of diet data using diet diaries allows the detailed capture of information about food intake, as
well as contextual factors, such as when and where the food was consumed and with whom. It is possible
that they are appropriate for use in trials in which diet is a primary outcome (i.e. not obesity trials). It is
possible that they are appropriate for use in trials in which change in diet or eating behaviours is the
primary outcome. However, the validity evidence presented by CoOR demonstrated a significant impact of
body weight on reporting in food diaries, making it unsuitable for studies in this population. As a
secondary outcome, it was therefore decided that food diaries should not be advocated.
It is important to note that data that have been presented in tables in Appendices 6–15 are based on
mean values for validity and reliability. A questionnaire with multiple scales should report validity results for
each scale in addition to an overall mean. The CoOR review extracted all data for each scale, but it was
not feasible to report this volume of data. Where available, means (and ranges) were extracted as
presented by authors. If not available, the CoOR team generated mean values from the available data.
A limitation of this approach is that it does not permit readers to understand whether some scales
performed better than others. This may have a particular impact on measures of dietary assessment, for
which there will be variability in the validity and reliability data across different foods or nutrients.
Researchers wishing to assess a particular food or nutrient are advised to read the original article of the
proposed outcome measure to ensure that there is sufficient evidence of validity/reliability in relation to
specific foods or nutrient. Additionally, a copy of the database (which presents findings for individual
scales/categories) is available on request.
A further limitation of the data presented by the CoOR review is that validity and reliability findings are
often presented as correlation coefficients (with variability in inter- and intraclass correlations used). This
type of analysis produces an average correlation across all possible orderings of pairs into X and Y. The
reliance on correlations may be sufficient in the case of repeatability (i.e. evaluation of reliability), as it
infers a ratio of the variability between participants (or times) over the total variability.268 This method
assumes that the measurement error is the same for each repeated assessment, which is likely if
assessments are chosen at random with a sufficient sample size. However, this is not the case when
comparing two methods in which there is likely to be variability between participant responses. The greater
this variability, the greater the correlation coefficient. Conversely, lower between-participant variability
would lead to a lower correlation coefficient, which does not necessarily imply that the methods do not
agree. Ideally, analysis of validity should consider the differences and the standard deviations of the
difference between measurements. Provided differences within the observed LOA are not clinically
important we could use the two measurement methods interchangeably268 (although this is difficult to
judge with insufficient evidence of a MID). Outcome domains of anthropometry and diet were most likely
to use this form of analysis but this was not common to other domains. Further, there was little
consideration of whether it would be more appropriate to conduct alternative non-parametric assessments
of agreement for differences that are not evenly distributed.269 Lastly, although the CoOR study set
standards for what should be considered as a ‘gold standard’ method within each outcome domain, it is
acknowledged that this does not imply that these measures are without error.
The CoOR team recognises that there are likely to be other manuscripts describing the evaluation of
eligible measures (i.e. wider evidence of existing measures). These may provide additional evidence
regarding the robustness of the measure. However, only those that were evaluated in an obese paediatric
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sample (or with results stratified by weight status) were included unless the underlying theoretical
framework of the measure was for childhood obesity research. Given the size of the CoOR study, it was
not deemed feasible to search for all studies that had conducted evaluation on the included measures
outside the predefined eligibility criteria.
Ultimate decisions for the inclusion of each measure were based on agreement by the CoOR experts.
Discussions surrounding each measure were made, partly on the data presenting by the CoOR review
(including the internal scores for the conduct, reporting and findings of studies). However, final decisions
for inclusion were based on the expertise and experience of the CoOR experts, which incorporated wider
evidence and feasibility issues. Thus, although some measures were deemed to be of high quality by the
internal appraisal (e.g. the IFIS136) they were not necessarily advocated by the experts (i.e. no self-reported
measures of fitness were recommended).
Future recommendations
It is acknowledged that the output of the CoOR study is somewhat transient, given that new measures are
being continually developed. Recommendations from the study, however, suggest that (for the majority of
domains) existing measures are appropriate for use, negating the need to develop new measures. Instead,
future work should focus on further evaluation and refinement of these measures in different populations.
For some outcome domains, new measures are imminent, including utility-based quality-of-life measures
and measures of PA and sedentary behaviour that use new technologies. These were not available at the
time of writing. It is therefore recommended that the CoOR study is updated every 5–10 years, although
the ability of this is dependent on availability of funding.
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Chapter 6 Conclusions
The CoOR outcome measures framework provides clear guidance to researchers regardingrecommended measures for use in their evaluations of childhood obesity treatment interventions. This
should encourage a greater adoption of well-validated tools and ensure comparability between different
studies or treatment interventions. Details of the validity of each of the recommended outcome tools
provide an evidence base on which to base more accurate reporting of these measures in future studies.
In addition, further details of other measures that may be appropriate for other settings are provided to
inform decision-making.
It is recommended that further research should be conducted in the development and evaluation of
preference-based measures for cost–utility analysis in line with NICE guidance. The CoOR team are aware
of some measures currently being developed. Further research is also recommended to ascertain
responsiveness of the recommended measures. This would be possible to conduct as part of future trials of
childhood obesity treatments. Ascertainment of a MID is also recommended and should be based on
consensus by clinical and academic experts and by children and their parents. Finally, there is also a lack of
consistency within measures used in the evaluation of treatment of obesity in adults, and it is suggested
that similar work to CoOR is conducted to fill this gap in evidence.
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Appendix 1 Search 1 search strategy
Database: Ovid MEDLINE(R) 1948 to August Week 2 2011
(modified and repeated in 10 other databases; available
on request)
# Searches Results
clinical trial/ or clinical trial, phase i/ or clinical trial, phase ii/ or clinical trial, phase iii/ or clinical trial, phase
iv/ or controlled clinical trial/ or multicenter study/ or randomized controlled trial/
653,759
exp Clinical Trials as Topic/ 247,291
Evaluation studies/ 155,147
Meta-analysis/ 30,113
Validation studies/ 51,814
research design/ or cross-over studies/ or double-blind method/ or matched-pair analysis/ or random
allocation/ or “reproducibility of results”/ or sample size/ or exp “sensitivity and specificity”/ or
single-blind method/ or Early Termination of Clinical Trials/ or control groups/
743,384
(pre post or pre test or post test or non-randomi?ed or quasi experiment).tw. 11,816
Feasibility studies/ 33,415
Intervention studies/ 4941
Pilot projects/ 67,278
placebo*.tw. 131,751
(random* adj3 (study or studies or trial or trials)).tw. 190,936
(random* adj3 (allocation or assign* or allocate*)).tw. 72,994
(study adj (pilot or feasibility or evaluation or validation)).tw. 571
(studies adj (pilot or feasibility or evaluation or validation)).tw. 177
((blind* or mask*) adj2 (singl* or doubl* or trebl* or tripl*)).tw. 109,924
(matched adj (communities or schools or populations)).tw. 141
(control adj group*).tw. 219,781
((trial or trials) adj2 (clinical or controlled)).tw. 236,788
(“outcome study” or “outcome studies” or quasiexperimental or “quasi experimental” or
quasi-experimental or “pseudo experimental”).tw.
8374
(meta-analysis or crossover* or “cross over*” or cross-over*).tw. 77,609
((cluster or factorial) adj2 trial*).tw. 1240
or/1-22 1,851,224
((child* or adolescen* or teen or teens or teenager* or youth or youths or girl or girls or boy or boys or
p?ediatric* or juvenil*) adj4 (obesity or obese or adiposity)).tw.
11,629
((child* or adolescen* or teen or teens or teenager* or youth or youths or girl or girls or boy or boys or
p?ediatric* or juvenil*) adj4 (overweight or overeat* or “over weight” or “over eat*”)).tw.
4580
((child* or adolescen* or teen or teens or teenager* or youth or youths or girl or girls or boy or boys or
p?ediatric* or juvenil*) adj4 ((weight or bmi or “body mass index”) adj2 (gain* or change* or increas*
or loss))).tw.
1865
((infant or infants or “young people” or “young person” or “young adult” or “ young men” or “young
women” or “schoolchild*”) adj4 (obesity or obese or adiposity)).tw.
716
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# Searches Results
((infant or infants or “young people” or “young person” or “young adult” or “ young men” or “young
women” or “schoolchild*”) adj4 (overweight or overeat* or “over weight” or “over eat*”)).tw.
275
((infant or infants or “young people” or “young person” or “young adult” or “ young men” or “young
women” or “schoolchild*”) adj4 ((weight or bmi or “body mass index”) adj2 (gain* or change* or
increas* or loss))).tw.
935
or/24-29 16,320
Weight Gain/ 18,875
weight loss/ 19,028
Body Weight Changes/ 4
Ideal Body Weight/ 41
Adiposity/ 2784
Overweight/ 6841
obesity/ or obesity hypoventilation syndrome/ or obesity, abdominal/ or obesity, morbid/ or
prader-willi syndrome/
112,599
Adolescent behavior/ 16,695
exp Child behavior/ 12,609
adolescent/ 1,436,947
child/ 1,235,275
child, preschool/ 682,135
infant/ 578,637
38 or 39 or 40 or 41 or 42 or 43 2,333,340
31 or 32 or 33 or 34 or 35 or 36 or 37 141,780
44 and 45 32,263
30 or 46 36,196
23 and 47 6705
addresses/ or lectures/ or anecdotes/ or biography/ or interview/ or comment/ or directory/ or editorial/ or
legal cases/ or case reports/ or legislation/ or letter/ or news/ or newspaper article/ or patient
education handout/
2,804,108
48 not 49 6519
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Appendix 2 Search 2 search strategy
Database(s): Ovid MEDLINE(R) 1948 to August Week 2 2011
(modified and repeated in 10 other databases; available
on request)
# Searches Results
((child* or adolescen* or teen or teens or teenager* or youth or youths or girl or girls or boy or boys or
p?ediatric* or juvenil*) adj4 (obesity or obese or adiposity)).tw.
11,629
((child* or adolescen* or teen or teens or teenager* or youth or youths or girl or girls or boy or boys or
p?ediatric* or juvenil*) adj4 (overweight or overeat* or “over weight” or “over eat*”)).tw.
4580
((child* or adolescen* or teen or teens or teenager* or youth or youths or girl or girls or boy or boys or
p?ediatric* or juvenil*) adj4 ((weight or bmi or “body mass index”) adj2 (gain* or change* or increas*
or loss))).tw.
1865
((infant or infants or “young people” or “young person” or “young adult” or “ young men” or “young
women” or “schoolchild*”) adj4 (obesity or obese or adiposity)).tw.
716
((infant or infants or “young people” or “young person” or “young adult” or “ young men” or “young
women” or “schoolchild*”) adj4 (overweight or overeat* or “over weight” or “over eat*”)).tw.
275
((infant or infants or “young people” or “young person” or “young adult” or “ young men” or “young
women” or “schoolchild*”) adj4 ((weight or bmi or “body mass index”) adj2 (gain* or change* or
increas* or loss))).tw.
935
or/1-6 16,320
obesity/ 102,151
obesity hypoventilation syndrome/ 565
obesity, abdominal/ 545
obesity, morbid/ 8517
prader-willi syndrome/ 2048
Weight Gain/ 18,875
weight loss/ 19,028
body weight changes/ 4
Ideal Body Weight/ 41
adiposity/ 2784
Overweight/ 6841
or/8-18 141,780
Adolescent behavior/ 16,695
exp Child behavior/ 12,609
adolescent/ 1,436,947
child/ 1,235,275
child, preschool/ 682,135
infant/ 578,637
or/20-25 2,333,340
19 and 26 32,263
7 or 27 36,196
exp validation studies/ 51,814
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# Searches Results
exp reproducibility of results/ 219,955
reproducib*.tw. 88,002
exp psychometrics/ 45,677
psychometr*.tw. 19,152
clin#metr*.tw. 372
observer variation/ 26,493
“observer variation”.tw. 740
discriminant analysis/ 6053
reliab*.tw. 235,792
valid*.tw. 274,556
coefficient.tw. 92,800
“internal consistency”.tw. 11,083
((cronbach* or cronback*) adj5 (alpha or alphas)).tw. 6847
“item correlation?”.tw. 253
“item selection?”.tw. 239
“item reduction?”.tw. 253
agreement.tw. 123,618
precision.tw. 50,812
imprecision.tw. 3056
“precise values”.tw. 112
(test adj2 retest).tw. 11,223
(reliab* adj2 (test or retest)).tw. 11,612
stability.tw. 172,904
(intrarater or “intra rater”).tw. 1438
(interrater or “inter rater” or interator).tw. 7185
(intertester or “inter tester”).tw. 275
(intratester or “intra tester”).tw. 217
(interobserver or “inter observer”).tw. 11,243
(intraobserver or “intraobserver”).tw. 3641
(intertechnician or “inter technician”).tw. 16
(intratechnician or “intra technician”).tw. 5
(interexaminer or “inter examiner”).tw. 889
(intraexaminer or “intra examiner”).tw. 549
(interassay or “inter assay”).tw. 5086
(intraassay or “intra assay”).tw. 3259
(interindividual or “inter individual”).tw. 14,867
(intraindividual or “intra individual”).tw. 6112
(interparticipant or “inter participant”).tw. 27
(intraparticipant or “intra participant”).tw. 21
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# Searches Results
kappa?.tw. 75,369
“coefficient of variation”.tw. 13,427
repeatab*.tw. 13,573
(replicab* adj2 (measure? or findings or result? or test?)).tw. 128
(repeated adj2 (measure? or findings or result? or test?)).tw. 20,667
generali#a*.tw. 18,375
concordance.tw. 19,838
(intraclass adj5 correlation*).tw. 8176
discriminative.tw. 8148
“known group”.tw. 314
“factor analys#s”.tw. 19,413
“factor structure?”.tw. 4819
dimensionality.tw. 3020
subscale*.tw. 17,508
“multitrait scaling analys#s”.tw. 63
“item discriminant”.tw. 63
“interscale correlation?”.tw. 64
(error? adj3 (measure* or correlat* or evaluat* or accuracy or accurate or precision or mean)).tw. 22,281
(variability adj (individual or interval or rate analysis)).tw. 23
(uncertainty adj3 (measurement or measuring)).tw. 657
“standard error of measurement”.tw. 492
sensitiv*.tw. 780,838
responsiv*.tw. 141,921
(limit adj3 detection).tw. 30,895
“minimal detectable concentration”.tw. 68
interpretab*.tw. 3824
(small* adj5 ((real or detectable) adj3 (change* or difference))).tw. 247
“meaningful change”.tw. 320
“minimal* important change”.tw. 38
“minimal* important difference”.tw. 202
“minimal* detectable change”.tw. 152
“minimal* detectable difference”.tw. 19
“minimal* real change”.tw. 0
“minimal* real difference”.tw. 0
“ceiling effect”.tw. 700
“floor effect”.tw. 187
“item response model”.tw. 48
“item response theory”.tw. 803
(irt adj3 model*).tw. 146
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# Searches Results
rasch.tw. 1387
“differen* item function*”.tw. 460
“computer* adaptive test*”.tw. 236
“item bank”.tw. 132
“cross cultural equivalence”.tw. 65
or/29-112 1,969,251
“conceptual framework”.tw. 5202
Concept Formation/ 8423
conceptuali#ation.tw. 4355
operationali#ation.tw. 658
“construct development”.tw. 38
“pre testing”.tw. 237
“cognitive interview*”.tw. 231
“patient interview*”.tw. 1529
Consensus/ 3480
“item pooling”.tw. 2
“content development”.tw. 62
“cognitive theory”.tw. 883
“cognitive debrief*”.tw. 87
tourangeau.tw. 6
“survey development?”.tw. 74
interviews as topic / 32,428
or/114-129 56,595
113 or 130 2,015,462
(measure* or test or tests or scale or scales or rate or rates or rating*).tw. 3,753,606
(inventory or inventories or score* or index or indexes or instrument or instruments or tool or tools or
questionnaire* or survey*).tw.
1,366,656
“Outcome Assessment (Health Care)”/ 39,977
exp Health Status Indicators/ 158,577
Questionnaires/ 241,283
or/132-136 4,559,127
28 and 131 and 137 3741
addresses/ or lectures/ or anecdotes/ or biography/ or comment/ or directory/ or editorial/ or legal cases/
or case reports/ or legislation/ or letter/ or news/ or newspaper article/ or patient education handout/
2,784,229
138 not 139 3707
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Appendix 3 Search 1 references
(included childhood obesity treatment trials)
The following list of references includes eligible search 1 trials, from which citations of outcomemeasures used were obtained.
1. Adamo KB, Rutherford JA, Goldfield GS. Effects of interactive video game cycling on overweight and
obese adolescent health. Appl Physiol Nutr Metab 2010;35:805–15.
2. Albala C, Ebbeling CB, Cifuentes M, Lera L, Bustos N, Ludwig DS. Effects of replacing the habitual
consumption of sugar-sweetened beverages with milk in Chilean children. Am J Clin Nutr
2008;88:605–11.
3. Andelman MB, Jones C, Nathan S. Treatment of obesity in underprivileged adolescents. Comparison
of diethylpropion hydrochloride with placebo in a double-blind study. Clin Pediatr (Phila)
1967;6:327–30.
4. Aragona J, Cassady J, Drabman RS. Treating overweight children through parental training and
contingency contracting. J Appl Behav Anal 1975;8:269–78.
5. Atabek ME, Pirgon O. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month,
randomized, double-blind, placebo-controlled clinical trial. J Pediatr Endocrinol 2008;21:339–48.
6. Bacon GE, Lowrey GH. A clinical trial of fenfluramine in obese children. Curr Ther Res Clin Exp
1967;9:626–30.
7. Barkin SL, Gesell SB, Poe EK, Ip EH. Changing overweight Latino preadolescent body mass index:
the effect of the parent–child dyad. Clin Pediatr (Phila) 2011;50:29–36.
8. Bathrellou E, Yannakoulia M, Papanikolaou K, Pehlivanidis A, Pervanidou P, Kanaka-Gantenbein C,
et al. Parental involvement does not augment the effectiveness of an intense behavioral program for
the treatment of childhood obesity. Hormones 2010;9:171–5.
9. Bauer S, de Niet J, Timman R, Kordy H. Enhancement of care through self-monitoring and tailored
feedback via text messaging and their use in the treatment of childhood overweight. Patient Educ
Couns 2010;79:315–19.
10. Bean MK, Mazzeo SE, Stern M, Bowen D, Ingersoll K. A values-based Motivational Interviewing (MI)
intervention for pediatric obesity: study design and methods for MI values. Contemp Clin Trials
2011;32:667–74.
11. Berkowitz RI, Fujioka K, Daniels SR, Hoppin AG, Owen S, Perry AC, et al. Effects of sibutramine
treatment in obese adolescents: a randomized trial. Ann Intern Med 2006;145:81–90.
12. Berkowitz RI, Wadden TA, Gehrman CA, Bishop-Gilyard CT, Moore RH, Womble LG, et al. Meal
replacements in the treatment of adolescent obesity: a randomized controlled trial. Obesity
(Silver Spring) 2011;19:1193–9.
13. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the
treatment of adolescent obesity: a randomized controlled trial. JAMA 2003;289:1805–12.
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14. Berry D, Savoye M, Melkus G, Grey M. An intervention for multiethnic obese parents and overweight
children. Appl Nurs Res 2007;20:63–71.
15. Boutelle KN, Cafri G, Crow SJ. Parent-only treatment for childhood obesity: A randomized controlled
trial. Obesity (Silver Spring) 2011;19:574–80.
16. Bravender T, Russell A, Chung RJ, Armstrong SC. A ‘novel’ intervention: a pilot study of children’s
literature and healthy lifestyles. Pediatrics 2010;125:e513–17.
17. Brownell KD, Kelman JH, Stunkard AJ. Treatment of obese children with and without their mothers:
changes in weight and blood pressure. Pediatrics 1983;71:515–23.
18. Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, et al. Short-term metabolic and
cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
Pediatr Diabetes 2008;9:567–76.
19. Carrel AL, Clark RR, Peterson SE, Nemeth BA, Sullivan J, Allen DB. Improvement of fitness, body
composition, and insulin sensitivity in overweight children in a school-based exercise program:
a randomized, controlled study. Arch Pediatr Adolesc Med 2005;159:963–8.
20. Chandra RK. Obesity in childhood: a clinical trial of low-calorie ‘limical’. Indian J Pediatr
1968;35:23–6.
21. Chang C, Liu W, Zhao X, Li S, Yu C. Effect of supervised exercise intervention on metabolic
risk factors and physical fitness in Chinese obese children in early puberty. Obes Rev
2008;9(Suppl. 1):135–41.
22. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body
composition in obese adolescents: a randomized controlled trial. JAMA 2005;293:2873–83.
23. Clarson CL, Mahmud FH, Baker JE, Clark HE, McKay WM, Schauteet VD, et al. Metformin in
combination with structured lifestyle intervention improved body mass index in obese adolescents,
but did not improve insulin resistance. Endocrine 2009;36:141–6.
24. Coates TJ, Jeffery RW, Slinkard LA, Killen J, Danaher BG. Frequency of contact and monetary
reward in weight loss, lipid change, and blood pressure reduction with adolescents. Behav Ther
1982;13:175–85. URL: www.mrw.interscience.wiley.com/cochrane/clcentral/articles/912/
CN-00183912/frame.html.
25. Coppins DF, Margetts BM, Fa JL, Brown M, Garrett F, Huelin S. Effectiveness of a multi-disciplinary
family-based programme for treating childhood obesity (The Family Project). Eur J Clin Nutr
2011;65:903–9.
26. Daniels SR, Long B, Crow S, Styne D, Sothern M, Vargas-Rodriguez I, et al. Cardiovascular effects
of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind,
placebo-controlled study. Pediatrics 2007;120:e147–57.
27. Danielsson P, Janson A, Norgren S, Marcus C. Impact sibutramine therapy in children with
hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab
2007;92:4101–6.
28. Davis AM, James RL, Boles RE, Goetz JR, Belmont J, Malone B. The use of TeleMedicine in the
treatment of paediatric obesity: feasibility and acceptability. Matern Child Nutr 2011;7:71–9.
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29. Davis JN, Tung A, Chak SS, Ventura EE, Byrd-Williams CE, Alexander KE, et al. Aerobic and strength
training reduces adiposity in overweight Latina adolescents. Med Sci Sports Exerc 2009;41:1494–503.
30. Demol S, Yackobovitch-Gavan M, Shalitin S, Nagelberg N, Gillon-Keren M, Phillip M.
Low-carbohydrate (low and high-fat) versus high-carbohydrate low-fat diets in the treatment of
obesity in adolescents. Acta Paediatr 2009;98:346–51.
31. Diaz RG, Esparza-Romero J, Moya-Camarena SY, Robles-Sardin AE, Valencia ME. Lifestyle
intervention in primary care settings improves obesity parameters among Mexican youth. J Am
Diet Assoc 2010;110:285–90.
32. Doyle AC, Goldschmidt A, Huang C, Winzelberg AJ, Taylor CB, Wilfley DE. Reduction of overweight
and eating disorder symptoms via the Internet in adolescents: a randomized controlled trial. J Adolesc
Health 2008;43:172–9.
33. Duckworth LC, Gately PJ, Radley D, Cooke CB, King RF, Hill AJ. RCT of a high-protein diet on hunger
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2009;17:1808–10. URL: www.mrw.interscience.wiley.com/cochrane/clcentral/articles/987/
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34. Duffy G, Spence SH. The effectiveness of cognitive self-management as an adjunct to a behavioural
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35. Duggins M, Cherven P, Carrithers J, Messamore J, Harvey A. Impact of family YMCA membership on
childhood obesity: a randomized controlled effectiveness trial. J Am Board Fam Med
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36. Dunshea-Mooij C, Wall C, King C. ‘Games Galore’; a feasibility study to investigate the effect of a
physical activity and a nutrition education programme for 10–14 year old New Zealand overweight
and obese children. Proc Nutr Soc New Zeal 2003;28:71–4.
37. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A reduced-glycemic load diet in the
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Appendix 4 Data extraction form for search 1
1. Ref Man ID: ……………
2. Reviewer initials: ……………
3. Authors: …………… [put * next to contact author]
4. Year: ……………
[Unless otherwise stated, tick relevant box(s)]
5. Study design:
5.1 Pilot study
5.2 Feasibility study
5.3 Phase III RCT
5.4 Pre-post
5.5 Other (please write in)
6. Type of intervention:
6.1 Lifestyle
6.2 Diet
6.3 Physical activity
6.4 Sedentary behaviour
6.5 Drug/surgical
6.6 Other (please write in)
7. Intervention delivered to:
7.1 Child only
7.2 Parent/caregiver only
7.3 Child and parent(s)/caregiver
7.4 Other (please write in)
8. Sample size (final):
8.1 Individual
8.2 Family
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9. E thnicity (continents and subcategories):
9.1 Europe
9.2 UK
9.3 Ireland
9.4 Eastern Europe
9.5 Scandinavian
9.6 Spain
9.7 France
9.8 Germany
9.9 Italy
9.10 Antarctica
9.11 Asia
9.12 South Asia (Indian, Pakistani, Bangladeshi)
9.13 Middle East
9.14 China
9.15 Japan
9.16 Other Asian background
9.17 North America
9.18 USA
9.19 Canada
9.20 Mexico
9.21 Central America and Caribbean islands
9.22 South America
9.23 Brazil
9.24 Argentina
9.25 Australia
9.26 Australia
9.27 New Zealand
9.28 Africa
9.29 North Africa
9.30 South Africa
9.31 Other (please state)
9.32 Not stated
Note: Turkey is part of Asia (Middle East) and Europe; Russia is part of Europe and Asia.
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10. Ethnicity:
10.1 White
10.2 Black
10.3 Caribbean
10.4 African
10.5 African American
10.6 Any other black background (please write in)
10.7 South Asian
10.8 Indian
10.9 Pakistani
10.10 Bangladeshi
10.11 Any other Asian background (please write in)
10.12 Northeast Asian
10.13 China
10.14 Korean
10.15 Japan
10.16 Southeast Asian or South Mongoloid
10.17 Thailand
10.18 Malaysia
10.19 Indonesia
10.20 Philippines
10.21 Turanid (Kazakhstan, Hungary, Turkey)
10.22 Bambutid race (African Pygmies)
10.23 Hispanic or Latino
10.24 Native Hawaiian or Other Pacific Islander
10.25 Alaska Native or American Indian
10.26 Australian Aborigines
10.27 Melanesian (New Guinea, Papua, Solomon islands)
10.28 Mixed ethnic groups
10.29 Ethnicity not defined
10.30 Other (please write in)
10.31 Other (but not stated what other is)
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11. Sample age:
11.1 Infant (< 36 months)
11.2 Child (36 months to 12 years)
11.3 Adolescent (> 12 years)
11.4 Infant and children
11.5 Children and adolescents
11.6 All ages
12. Primary outcome measure:
Name of tool Author Year
12.1 BMI/BMI-SDS/%BMI (self-report)
12.2 BMI/BMI-SDS/%BMI (measured)
12.3 Weight (self-report)
12.4 Weight (measured)
12.5 SFT
12.6 Waist circumference
12.7 Waist–hip ratio
12.8 Mid-arm circumference
12.9 DXA
12.10 BIA
12.11 Hydrodensitometry weighing
12.12 Near infrared interactance (NIR)
12.13 BOD POD (air displacement)
12.14 Total body electrical conductivity (TOBEC)
12.15 Magnetic resonance imaging (MRI)
12.16 Computed tomography (CT)
12.17 Other measure of obesity (please specify)
12.18 Not reported
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13. Secondary outcome measures (if more than one type of measure within each outcome, report name
of tool and first author for each measure)
Outcome Type of measure Name of tool First author Year
13.1 Anthropometry BMI (self-report)
BMI (measured)
Weight (self-report)
Weight (measured)
Waist circumference
Waist-to-hip ratio (WHR)
Skinfold thickness (multiple sites or one
site – measured with calipers)
Mid-arm circumference
Dual energy X-ray absorptiometry (DXA)
Bioelectrical impedance (BIA)
Hydrodensitometry weighing
Near infrared interactance (NIR)
BOD POD (air displacement)
Total body electrical conductivity (TOBEC)
Magnetic resonance imaging (MRI)
Computed tomography (CT)
Other (please write in)
13.2 Other measure/
proxy of adiposity
13.3 Diet Weighed food diary/record
Estimated food diary/record
FFQ
Semiquantitative FFQ
Multiple-pass dietary recall
24-hour dietary recall
Food intake checklist [i.e. specific food/
groups (e.g. fruit and vegetable intake
checklist)]
Diet history
Diet observation (DVD or direct observation)
Doubly labelled water
Dietary nitrogen
Other (please write in)
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Outcome Type of measure Name of tool First author Year
13.4 Eating behaviour Eating behaviour checklists
Eating disorders questionnaires/observations
Other (please write in)
13.5 PA Activity monitor/movement sensors
Activity diaries
Retrospective questionnaires
Activity recalls
Direct observation (recorded or researcher
conducted)
Other (please write in)
13.6 Sedentary
behaviour
TV questionnaire
Screen time questionnaires
Activity monitor/movement sensors
Direct observation (recorded or
researcher conducted)
13.7 Psychological
well-being
Self-esteem
Self-perception
Depression
Anxiety
Behaviour
Psychiatric dysfunction
Perceived competence
Body image
General well-being
Other (please write in)
13.8 Economics Direct costs
Quality-of-life scales
Other (please write in)
13.9 Environment Geospatial (food/retail outlets)
Built environment (e.g. neighbourhood
layout)
Home environment [physical
(e.g. food availability) and social
(e.g. rules and policies)]
School/nursery environment [physical
(e.g. food availability) and social
(e.g. rules and policies)]
Other (please write in)
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
120
Outcome Type of measure Name of tool First author Year
13.10 Fitness Heart rate (resting and/or recovery)
Aerobic capacity/agility (step test,
shuttle runs, sprints, timed/endurance
runs/walk/bike)
Room calorimetry (CO2/VO2, energy
expenditure)
Indirect calorimetry (CO2/VO2, energy
expenditure)
Doubly labelled water
Respiratory exchange ratio
Packed cell volume
Muscular strength
Muscular endurance
Flexibility, other (please write in)
13.11 Physiological Blood pressure
Metabolic markers (e.g. lipids, glucose,
insulin, leptin, adipocytokines)
Other (please write in)
13.11 Other (please
write in)
13.12 Not reported
14. Comments: ……………
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Appendix 5 Data extraction form for search 2:
dietary assessment
1a . Ref Man ID: ……………
1b. Manuscript type:
Primary development paper □ Original used and evaluated □ Modified and evaluated □
1c. Category of measurement tool.
l Questionnaires/surveys with scales or categories with pre-defined terms □
l Diaries, recalls, direct observations or monitors with open responses/recall/observation □
l Biochemical or anthropometric measures or assays □
2. Reviewer initials: ……………
3. First author: …………… [put * next to contact author]
4. Year: ……………
Outcome measure details
5a. Full name of measure: ……………
5b. Acronym of measure: …………… [mark N/A where appropriate]
6. Type of measurement:
6.1 Weighed food diary/record
6.2 Estimated food diary/record
6.3 FFQ
6.4 Semi-quantitative FFQ
6.5 24-hour dietary recall
6.6 Food intake checklist [i.e. specific food/groups (e.g. fruit and vegetable intake checklist)]
6.7 Diet history
6.8 Diet observation (DVD or researcher)
6.9 Dietary patterns
6.10 Other
Provide details:
DOI: 10.3310/hta18510 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 51
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Bryant et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
123
7. Mode of administration:
7.1 Self-completed
7.2 Parent completed
7.3 Interview administered in person – parent
7.4. Interview administered over telephone – parent
7.5 Interview administered in person – child
7.6 Interview administered over telephone – child
7.7 Interview administered in person – parent and child
7.8 Interview administered over telephone – parent and child
7.9 Researcher conducted/observed (direct measures)
8.0 Other
Provide details:
7b. Method of data collection:
7b.1 Pen and paper
7b.2 Personal digital assistants
7b.3 Smart phones
7b.4. Web-based tools
7b.5 Download data
7b.6 Biochemical (e.g. blood, urine, etc.)
7b.6 Other
Provide details:
8a. Sample age:
8a.1 Infant (< 36 months)
8a.2 Child (36 months to 12 years)
8a.3 Adolescent (> 12 years)
8a.4 Infant and children
8a.5 Children and adolescents
8a.6 All ages
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8b Sample weight status:
8b.1 All obese
8b.2 Obese and overweight
8b.3 Overweight
8b.4 Mixed (stratified)
8b.5 Mixed (non-stratified)
9. Ethnicity (continents and subcategories):
9.1 Europe
9.2 UK
9.3 Ireland
9.4 Eastern Europe
9.5 Scandinavian
9.6 Spain
9.7 France
9.8 Germany
9.9 Italy
9.10 Antarctica
9.11 Asia
9.12 South Asia (Indian, Pakistani, Bangladeshi)
9.13 Middle East
9.14 China
9.15 Japan
9.16 Other Asian background
9.17 North America
9.18 USA
9.19 Canada
9.20 Mexico
9.21 Central America and Caribbean islands
9.22 South America
9.23 Brazil
9.24 Argentina
9.25 Australia
9.26 New Zealand
9.27 Africa
9.28 North Africa
9.29 South Africa
9.30 Other (please state)
9.31 Not stated
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9b. Race
9b.1 White
9b.2 Black
9b.3 Caribbean
9b.4 African
9b.5 African American
9b.6 Any other black background (please write in)
9b.7 South Asian
9b.8 Indian
9b.9 Pakistani
9b.10 Bangladeshi
9b.11 Any other Asian background (please write in)
9b.12 Northeast Asian
9b.13 China
9b.14 Korean
9b.15 Japan
9b.16 Southeast Asian or South Mongoloid
9b.17 Thailand
9b.18 Malaysia
9b.19 Indonesia
9b.20 Philippines
9b.21 Turanid (Kazakhstan, Hungary, Turkey)
9b.22 Bambutid race (African Pygmies)
9b.23 Hispanic or Latino
9b.24 Native Hawaiian or Other Pacific Islander
9b.25 Alaska Native or American Indian
9b.26 Australian Aborigines
9b.27 Melanesian (New Guinea, Papua, Solomon islands)
9b.28 Mixed ethnic groups
9b.29 Race not defined
9b.30 Other (please write in)
9b.31 Other (but not stated what other is)
10. Number of items: …………… [mark N/A where appropriate]
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11. Categories/domains:
11.1 No categories/domains
11.2 Fruits
11.3 Vegetables
11.4 Cereals and cereal products
11.5 Meat: white meat
11.6 Meat: red and processed meat
11.7 Meat: fish and other proteins
11.6 Milk and milk products
11.8 Beans and pulses
11.9 Snack foods
11.10 Oils, spreads and condiments
11.11 Nuts and seeds
11.12 Sugars and preserves
11.13 Baby foods
11.14 Sugar-sweetened beverages
11.15 Non-sugar sweetened beverages
11.16 Ready-made foods (including takeaway and frozen)
11.17 Baked goods
11.18 Macronutrients
11.19. Protein
11.20 Carbohydrate
11.21 Fat
11.22 Micronutrients
11.23 Energy intake
Other
Provide details:
12A. Tool development/theoretical framework
Question Response options Score
12A1. The concept to be measured was clearly
stated (rationale and description)
4= strongly agree (concepts are named and clearly defined)
3= agree (concepts are named and general described)
2= disagree (concepts only named but not defined)
1= strongly disagree (concepts are not clearly named
or defined)
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Question Response options Score
12A2. Was a theoretical or conceptual framework
used or referenced?
4= strongly agree (theory/framework used as a basis for
development)
3= agree (theory/framework named and incorporated)
2= disagree (theory/framework named but not used)
1= strongly disagree (no theory/framework described)
0=N/A= (biochemical/anthropometry, direct
measures/observations)
12A3. Populations that the measure was intended
for were adequately described
4= strongly agree (describes at least four characteristics
including: age, gender, race/ethnicity and SES)
3= agree (three characteristics reported)
2= disagree (two characteristics reported)
1= strongly disagree (no characteristics reported)
12A4. Were the populations that the measure was
intended for involved in measurement
development?
4= strongly agree (at least three methods of involvement
including: part of study team, steering committee, pilot
testing, cognitive interviews/focus groups)
3= agree (involved using at least two methods)
2= disagree (populations minimally involved in one method)
1= strongly disagree (populations not involved)
0=N/A (biochemical/anthropometry)
If response to 12A4 is 1 or 0, skip to A5
12A4a.1. Please specify how they were involved l Steering/advisory committee □
l Pilot test □
l Focus group □
Other:
12A5. Determination of items? Subject specific (e.g. from literature) □
Data driven (e.g. analysis of existing dietary database) □
Combination of subject specific and data driven □
Item from existing tool □
N/A (e.g. diary/recall methods) □
Other:
12A6a. Did they start with a larger pool and then
narrow down items included?
Yes □
No □
Not reported □
12A6b. Was a systematic process used to generate
a pool of items
4= strongly agree (expert and/or clinical input/review, data driven
approach and user input)
3= agree (two of the three approach for strongly agree)
2= disagree (one of the three approaches for strongly agree)
1= strongly disagree (no clear methodology reported)
0=N/A (all non-itemised questionnaires/surveys)
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Tool evaluation
12B. Reliability testing: internal consistency
Question Response options Score
12B1. Was internal consistency measured? Y/N
If answer to B1 is no, skip to section C
12B2. Results for internal consistency
Scale domain/name Cronbach’s alpha KR-20 Split half R
12B3. Results for full tool Yes □
No □
12B4. Scale results provided at a range?
(if ‘no’ please work out range)
Yes □
No □
12B5. Other statistics? Yes □
No □
Statistical name(s) and result(s)
12B6. Sample size N=
12B7. Robustness 4= Strongly agree (adequate sample size, reported by scale
category, appropriate stats, adequate results, for example:
l sample size> 50
l alpha> 0.7
l KR-20> 0.7)
l Split half:
3=Agree (3 of 4)
2= disagree (2 of 4)
1= strongly disagree (< 2 of 4)
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12C. Reliability: reproducibility
Question Response options Score
12C1. Was reproducibility measured? Y/N
If answer to C1 is no, skip to section D
12C2. How was reproducibility measured? Tick all that apply:
TRT □
Inter-rater □
If answer to 12C3 is test–retest fill out section
12C3a, if answered inter-rater go to C3b
12C3a. Results for TRT
12C3. Interval between tests . . . years
. . . weeks
. . . days
. . . hours
12C4. Scale domain/name t-test
(or non-para
equivalent)
Correlation Pearson’s/
ICC/rho
Kappa
12C5. Results for full tool Yes □
No □
12C6. Scale results provided at a range
(if ‘no’ please work out range)
Yes □
No □
12C7. Other statistics? Yes □
No □
Statistical name(s) and result(s):
12C8. Sample size? N=
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Question Response options Score
12C9. Robustness 4= Strongly agree (adequate sample size, reported by scale category,
appropriate stats, adequate results e.g.
l sample size ≥ 50
l κ≥ 0.4
l Spearman/Pearson ≥ 0.4
3=Agree (3 of 4)
2=Disagree (2 of 4)
1= Strongly disagree (< 2 of 4)
12C3b. Results for inter-rater
12C1b. Scale domain/name % agreement Correlation
Pearson’s/
ICC/rho
Kappa Kripendorff’s alpha
12C2b. Results for full tool Yes □
No □
12C3b. Scale results provided at a range
(if no, please work out range)
Yes □
No □
12C4b. Other statistics? Yes □
No □
12C5b. Sample size? N=
12C5b. Robustness 4= Strongly agree (adequate sample
size, reported by scale category,
appropriate stats, adequate
results, e.g.
l Sample size – study specific
l Pearson’s/ICC/rho≥ 0.40
l κ≥ 0.40
l Kripendorff’s alpha≥ 0.80
3=Agree (3 of 4)
2=Disagree (2 of 4)
1= Strongly disagree (< 2 of 4)
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12D. Internal validity testing
D. Internal validity
Question Response
12D1. Was internal validity testing performed? Y/N
If answer to 12D1 is ‘no’ go to section 12E
12D2. Type of analysis Principle components analysis □
Principle factor analysis □
Confirmatory factor analysis
(structural equation modelling) □
Cluster analysis □
Indexed-based analysis □
Varimax rotation □
Other:
12D3. Identified factors Factor
loading
Range of
factor
loadings
No.
of
items
Eigenvalue Coefficient % total
variance
12D4. Results for full tool?
12D5. Scale results provided as a range?
12D6. Other stats? Sensitivity,
specificity, discriminate validity testing?
Yes □
No □
Statistical name and results
12D7. Sample size? N=
12D8. Robustness 4= Strongly agree (adequate sample
size, reported by scale category,
appropriate stats, adequate results,
e.g. sample size of five participants
per item:
l Eigenvalue ≥ 1
l Factor
loading=High> 0.6, Low< 0.4
l Range of factor loading
l No. of items
l Coefficient ≥ 0.5
l % total variance
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12E. External validity testing
Question Response options
12E1. Was validity testing performed? Y/N
If answer to E1 is ‘no’ skip to F1
12E2. What statistical tests were used? Tick all that apply
Criterion validity □
Convergent validity □
Construct validity □
Content validity □
Face validity □
Depending on what validity test was done please fill out results in appropriate section
12E3 Criterion validity
12E3i. Gold standard reference method DLW with PABA (para-aminobenzoic acid) □
DLW without PABA □
Goldberg cut-off= energy intake: BMR (lab measured) □
Goldberg cut-off= energy intake: BMR (estimated) □
Goldberg cut-off (measured) with physical activity (objective) □
Goldberg cut-off (measured) with physical activity (self-report) □
Goldberg cut-off (estimated) with physical activity (objective) □
Goldberg cut-off (estimated) with physical activity (self-report) □
Dietary nitrogen–urinary nitrogen (multiple measures with PABA) □
Dietary nitrogen–urinary nitrogen (single measure with PABA) □
Dietary nitrogen–urinary nitrogen (multiple measures no PABA) □
Dietary nitrogen–urinary nitrogen (single measure no PABA) □
Direct observation □
Other:
12E3ii. Results for scales/domain Pearson’s/
Spearman’s
Regression
coefficient
t-test Agreement
(%)
Agreement
(kappa)
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Question Response options
12E3 iii. Results for full tool
12E3iv. Scale provided as a range
(if ‘no’ please work out range)
Yes □
No □
12E3v. Other stats? Sensitivity,
specificity, discriminate
validity testing?
Yes □
No □
Statistical name and results
12E3vi. Sample size? N=
12E3vii. Robustness 4= Strongly agree (adequate sample size, reported by scale category, appropriate
stats, adequate results, e.g.:
l Sample size: adequate: > 100
l Pearson’s/Spearman’s ≥ 0.4
l Regression coefficient= p> 0.5 or r≥ 0.50
l Agreement
l κ≥ 0.4
l t-test p> 0.05, t-value> 1
l AUC> 0.7
3=Agree (3 of 4)
2=Disagree (2 of 4)
1= Strongly disagree (< 2 of 4)
12E4 Convergent validity
12E4i. Comparison method Weighed food diary/record □
Estimated food diary/record □
FFQ □
Semi-quantitative FFQ □
24-hour diet recall □
Multiple-pass dietary recall □
Food intake checklist (e.g. fruit and vegetable intake checklist) □
Diet history □
Food purchase record □
Electronic observations (e.g. mobile phone photographs) □
Other:
12E4ii. Results for scales/domain Pearson’s/
Spearman’s
Regression
coefficient
t-test Agreement
(%)
Agreement
(kappa)
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Question Response options
12E4iii. Results for full tool
12E4iv. Scale provided as a range
(if ‘no’ please work out range)
Yes □
No □
12E4v. Other stats? Sensitivity,
specificity, discriminate
validity testing?
Yes □
No □
Statistical name and results
12E4vi. Sample size? N=
12E4vii. Robustness 4= Strongly agree (adequate sample size, reported by scale category, appropriate
stats, adequate results, for example:
l Sample size: > 100
l Pearson’s/Spearman’s ≥ 0.4
l Regression coefficient= p> 0.5 or r≥ 0.50
l Agreement
l κ≥ 0.4
l t-test p> 0.05, t-value> 1.
l AUC> 0.7
3=Agree (3 of 4)
2=Disagree (2 of 4)
1= Strongly disagree (< 2 of 4)
12E5 Construct validity
12E5i. Construct Obesity □
Eating behaviour □
Screen time □
Physical activity □
Disease outcome □
Other:
12E5ii. Results for scales/domain Pearson’s/
Spearman’s
Regression
coefficient
t-test Agreement
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Question Response options
12E5iii. Results for full tool Yes □
No □
12E5iv. Scale provided as a range
(if ‘no’ please work out range)
Yes □
No □
12E5v. Other stats? Sensitivity,
specificity, discriminate
validity testing?
Yes □
No □
Statistical name and results
12E5vi. Sample size? N=
12E5vii. Robustness 4= Strongly agree (adequate sample size, reported by scale category, appropriate
stats, adequate results, for example:
l Sample size: > 100
l Pearson’s/Spearman’s ≥ 0.4
l κ ≥ 0.4
l Regression coefficient= p> 0.5 or r≥ 0.50
l Agreement
l t-test p> 0.05, t-value> 1
l AUC> 0.7
3=Agree (3 of 4)
2=Disagree (2 of 4)
1= Strongly disagree (< 2 of 4)
12E6 Content validity
12E6i. Stakeholders Experts – general review/consensus □
Experts – content validity ratio □
Other:
12E6ii. Method Consensus methodology □
Focus groups □
Interviews □
Other:
12E6iii. Results for scales/domain Content
validity
ratio
Content
validity index
Other
12E6iiib. Open response for results
12E6iv. Sample size? N=
12E6v. Robustness Not applicable
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Question Response options
12E7 Face validity
12E7i. Stakeholders Experts – general review/consensus □
Experts – content validity ratio □
Other:
12E7ii. Method Consensus methodology □
Focus groups □
Interviews □
Other:
12E7iii. Results for scales/domain
12E7iiib. Open response for results
12E7iv. Sample size N=
12E7v. Robustness N/A
12F. Responsiveness
12F1a. Was responsiveness testing performed? Y/N
If answer to F1 is ‘no’ skip to G1
F2a. Results for responsiveness test(s)
12F1b. Time interval . . . years
. . . weeks
. . . days
. . . hours
12F2. Method Change over time (non-intervention dependent) □
Change following an intervention □
12F3. Results for scales/domains Standardised
response means
Effect
size
Other
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Question Response options
12F4. Results for full tool? Yes □
No □
12F5. Scale results provided as a range (if ‘no’ please work
out range)
Yes □
No □
12F6. Other stats? Sensitivity, specificity, discriminate
validity testing?
Yes □
No □
Statistical name and results
12F7. Sample size? N=
12F8. Robustness 4= Strongly agree (adequate sample size, clear report of
with or without intervention, appropriate stats by scale
(if applicable), adequate results (e.g.?)
3=Agree (3 of 4 for strongly agree)
2=Disagree (2 of 4 for strongly agree)
1= Strongly disagree (< 2 of 4 for strongly agree)
13A. Cultural Language adaptations or translations
Question Response options
13A1. Has the measure been adapted and/or translated
for use in different cultures/languages?
Yes □
No □
If answer to G1 is ‘no’ skip to H1
13A2. What language is it in?
13A3. If ‘yes’ specify languages or cultures.
13A4. Methods used for translation and/or adaptation
14A. Scoring/cut-offs
Question Response option Score
14A1. Does the paper provide sufficient detail on
how data should be reported?
4= Strongly agree (must include information on response
options and scoring/cut-offs AND interpretation of scoring)
3=Agree (includes information on response options and
scoring/cut-offs)
2=Disagree (includes information on response options or
scoring/cut-offs)
1= Strongly disagree (scoring/cut-offs or interpretation
not reported)
If answer to H1 is 1, skip to I1
14A2. Is there a published manuscript? Yes □ [citation if differs from current
paper]
No □
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
138
Question Response option Score
14A3. Is there a website? Yes □
[URL]
No □
14A4. Is there an author contact Yes □
[author contact]
No □
15. Burden
Question Response options Reviewer response
15a1. Is the administrative burden discussed? Y/N
If answer to 15a1 is ‘no’ skip to 15b
15a2. What sources of burden are addressed? Time required to administer □
Training requirements for those administering □
Other
(report all that apply)
15a3. For each source provide range (or
summary) of results
15a4. Was burden considered acceptable? 4= Strongly agree □
3=Agree □
2=Disagree □
1= Strongly disagree □
15b1. Do they report on the level of
cognitive ability on behalf of participant
(e.g. reading level)?
Y/N
If answer to 15b1 is ‘no’ skip to 16
15b2. If yes, what level of ability
was required?
16a. Is information on cost available? Y/N (If applicable please provide cost per participant)
16b. Is information on copyright available? Y/N (If possible please provide link/details)
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Appendix 6 Anthropometry studies:
summary table
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Appendix 16 Additional scoping searches for
quality-adjusted life-years and clinical cut-offs
in physiological measures
Preference-based utility measures (enabling calculation of
quality-adjusted life-years)
Run: 9 October 2012.
Ovid MEDLINE(R) <1946 to September Week 4 2012>.
Search strategy:
1. child/ (1,290,311)
2. *obesity/ (76,973)
3. “economic evaluation*”.tw. (5200)
4. program evaluation/ec 323
5. *Cost-Benefit Analysis/ (3917)
6. 3 or 4 or 5 (8933)
7. 1 and 2 and 6 (12)
8. quality-adjusted life years/ (5950)
9. quality adjusted life.tw. (4795)
10. (qaly or qalys or qald or qale or qtime).tw. (3954)
11. 8 or 9 or 10 (8286)
12. obesity/ (112,373)
13. 1 and 11 and 12 (14)
14. 7 or 13 (22)
Clinical meaningfulness of physiological outcome measures in
childhood obesity
Run: 30 October 2012.
Ovid MEDLINE(R) <1946 to October Week 3 2012>.
Search strategy:
1. Insulin/ (151,351)
2. Ghrelin/ (4430)
3. Glucose Tolerance Test/ (27,736)
4. Basal Metabolism/ (6360)
5. Blood Pressure/ (228,480)
6. Heart Rate/ (134,007)
7. ((insulin or Ghrelin or HOMA or “Hyperglycemic clamp*” or “Oral Glucose Tolerance Test*” or OGTT
or “Haemoglobin A1c” or “Estimated Resting Metabolic Rate*” or “Predicted Resting Energy
Expenditure*” or “Basal metabolic rate*” or BMR or “Blood pressure*” or Systolic or Diastolic or
“Blood cholesterol*” or “Heart rate*”) adj5 “clinical relevanc*”).tw. (119)
8. Hemoglobin A, Glycosylated/ (20,012)
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9. Cholesterol/bl [Blood] (55,968)
10. 1 or 2 or 3 or 4 or 5 or 6 or 8 or 9 (525,688)
11. (insulin or Ghrelin or HOMA or “Hyperglycemic clamp*” or “Oral Glucose Tolerance Test*” or OGTT
or “Haemoglobin A1c” or “Estimated Resting Metabolic Rate*” or “Predicted Resting Energy
Expenditure*” or “Basal metabolic rate*” or BMR or “Blood pressure*” or Systolic or Diastolic or
“Blood cholesterol*” or “Heart rate*”).tw. (568,813)
12. 10 or 11 (803,029)
13. adolescent/ or child/ or child, preschool/ or infant/ (2,444,484)
14. weight gain/ or weight loss/ or overweight/ or exp obesity/ (155,575)
15. 13 and 14 (36,168)
16. (clinical* adj3 (relevan* or meaningful* or useful* or appropriate*)).tw. (105,700)
17. 12 and 16 (7237)
18. 15 and 16 and 17 (49)
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Appendix 17 Appraisal decision forms:
anthropometry
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Appendix 18 Diet methodology studies:
development and evaluation scores
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Appendix 21 Sedentary time/behaviour
methodology studies: development and
evaluation scores
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Appendix 22 Fitness methodology studies:
development and evaluation scores
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development and evaluation scores
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Appendix 27 Non-English manuscripts of
search 1 trials (data not extracted)
Childhood obesity treatment trials
1. Alves JG, Galé CR, Souza E, Batty GD. Effect of physical exercise on bodyweight in overweight
children: a randomized controlled trial in a Brazilian slum. Cad Saúde Pública 2008;24:s353–9.
URL: www.mrw.interscience.wiley.com/cochrane/clcentral/articles/132/CN-00666132/frame.html
2. Barnow S, Stopsack M, Bernheim D, Schroder C, Fusch C, Lauffer H, et al. Results of an outpatient
intervention for obese children and adolescents. Psychother Psychosom Med Psychol 2007;57:353–8.
3. Blaik A, Westphal S, Dierkes J, Aronica S, Luley C. Comparison of two nutritional interventions in
obese families. Ernahrungs-Umschau 2011;58:122–7.
4. Bustos Lozano G, Moreno Martin F, Calderin Marrero MA, Martinez Quesada JJ, Diaz Martinez E,
Arana Canedo C. Comparative study of medical advice and cognitive-behavioral group therapy in the
treatment of child-adolescent obesity. An Esp Pediatr 1997;47:135–43.
5. Canlorbe P, Borniche P, Toublanc JE. Controled trial of an anorectic (An 448) in the treatment, of
childhood obesity. Nouv Presse Med 1976;5:1061–2.
6. Dai J, Jiang Z, Zhang B. Exercise and nutrition therapy for simple obesity in children. Chin J Clin Rehabil
2006;10:20–2.
7. de Mello ED, Luft VC, Meyer F. Individual outpatient care versus group education programs. Which
leads to greater change in dietary and physical activity habits for obese children? J Pediatr (Rio J)
2004;80:468–74.
8. Ebert-Joisten M, Hahnemann B. ‘A cheerful magician munch moderately’. The psychomotoric answer
to overweight in childhood. Ernahrungs-Umschau 2004;51:B9–12.
9. Flodmark CE. A family-therapeutic method for the national disease of obesity. Start the treatment
already when the children are about 10 years old! Lakartidningen 1996;93:2347–50.
10. Foger M, Bart G, Rathner G, Jager B, Fischer H, Zollner-Neussl D. Exercise, dietary counselling and
psychological support in the treatment of obese children. A controlled study over 6 months.
Monatsschr Kinderh 1993;141:491–7.
11. Golebiowska M, Chlebna-Sokol D, Kobierska I, Konopinska A, Malek M, Mastalska A, et al. Clinical
evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties
and side effects. Przegl Lek 1981;38:355–8.
12. Golebiowska M, Chlebna-Sokol D, Mastalska A, Zwaigzne-Raczynska J. The clinical evaluation of
teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic
patterns and exercise capacity. Przegl Lek 1981;38:311–14.
13. Graf C, Kupfer A, Kurth A, Stutzer H, Koch B, Jaeschke S, et al. Effects of an interdisciplinary
intervention on the BMI-SDS and the endurance performance capacity of adipose children:
the CHILT III project. Dtsch Z Sportmed 2005;56:353–7.
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14. Guzzaloni G, Calo G, Grugni G, Mazzilli G, Tonelli E, Ardizzi A, et al. Short term use of
dexfenfluramine in a group of obese adolescents. Clin Dietol 1993;20:363–72.
15. Huang SH, Weng KP, Hsieh KS, Ou SF, Lin CC, Chien KJ, et al. Effects of a classroom-based
weight-control intervention on cardiovascular disease in elementary-school obese children. Acta
Paediatr Taiwan 2007;48:201–6. URL: www.mrw.interscience.wiley.com/cochrane/clcentral/articles/
986/CN-00629986/frame.html
16. Jiang J, Xia X, Hui J, Cheng X. Comprehensive family based behavior modification for obese children.
Chin Ment Health J 1997;11:242–4, 37.
17. Kang S, Kwoun S, Choi Y, Lim Y, Park D. The effects of Monacolin-inoculated rice embryo on the
body fat and serum lipid profiles of obese elementary school students. Korean J Community Nutr
2005;10:565–73.
18. Kim HD, Park JS. The effect of an exercise program on body composition and physical fitness in obese
female college students. Taehan Kanho Hakhoe Chi 2006;36:5–14.
19. Kim H-S. Effects of behavior modification on obesity index, skinfold thickness, body fat, serum lipids,
serum leptin in obese elementary school children. Taehan Kanho Hakhoe Chi 2003;33:405–13.
20. Kwon MS, Hwang KS. Effects of an exercise program on body composition, cardiopulmonary function,
and physical fitness for obese children. Taehan Kanho Hakhoe Chi 2007;37:568–75.
21. Le Q, Wang DX, Xia XH. Clinical observation on effect of heze oral liquid in treating children simple
obesity. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi= Chinese J Integr Trad
Western Med/Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
2002;22:384–5.
22. Lehrke S, Becker S, Laessle RG. Structured behavioral therapy with obese children: therapeutic effects
in nutrition. Verhaltenstherapie 2002;12:9–16.
23. Lehrke S, Laessle R. Multimodal treatment for obese children: outcome with respect to psychosocial
criteria. Verhaltenstherapie 2002;12:256–66.
24. Leopold K, Wechsler JG. Obesity: gradual-schedule therapy and long-term results. MMW Fortschr Med
2001;143:I–VIII.
25. Letonturier P. Reducing obesity. Presse Med 2006;35:77–8.
26. Li L, Wang Z-Y. Clinical therapeutic effects of body acupuncture and ear acupuncture on juvenile
simple obesity and effects on metabolism of blood lipids. Zhongguo zhenjiu 2006;26:173–6.
27. Li WH, Wang JD, Gu LM, Wang YZ. Treatment of simple obesity with electro-acupuncture and
auricular acupoint pressing: a report of 177 cases. Zhong xi yi jie he xue bao 2004;2:449, 58.
28. Liebermeister H, Jahnke K, Voss HJ, Englhardt A, Probst G. Initial and late results of diet therapy in
obesity. Dtsch Med Wochenschr 1968;93:2149–55.
29. Liebermeister H, Probst G, Jahnke K. Experience with the appetite depressant, fenfluramine
hydrochloride, in adiposity. Med Klin 1969;64:1201–7.
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30. Lin RD, Lai SP, Cheng PL, Tang FC. Effect of nutrition education intervention on the physical fitness of
exercise-induced weight loss children. Nutr Sci J 2005;30:183–95.
31. Livieri C, Novazi F, Lorini R. The use of highly purified glucomannan-based fibers in childhood obesity.
Pediatr Med Chir 1992;14:195–8.
32. Malecka-Tendera E, Koehler B, Muchacka M, Wazowski R, Trzciakowska A. Efficacy and safety of
dexfenfluramine treatment in obese adolescents. Pediatr Pol 1996;71:431–6.
33. Mulkens S, Fleuren D, Nederkoorn C, Meijers J. RealFit: a multidisciplinary (CBT) group treatment for
obese youngsters. Gedragstherapie 2007; 40:27–48.
34. Nagai N, Takekawa A. Assessment of the weight change in the improvement class for obese children.
Japan J Nutr 1999;57:211–20.
35. Rascher W. Hypertension and the metabolic syndrome. Even children and adolescents require
treatment. MMW Fortschr Med 2003;145:43.
36. Sabet-Sarvestani R, Kargar M, Kave MH, Tabatabaee H. The effect of dietary behavior modification on
anthropometric indices in obese adolescent female students. Iran J Pediatr 2008;18(Suppl. 1):71–6.
37. Seo NS, Kim YH, Kang HY. Effects of an obesity control program based on behavior modification and
self-efficacy in obese elementary school children. Taehan Kanho Hakhoe Chi 2005;35:611–20.
38. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar H, et al. Randomized
placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients.
Ter Arkh 2000;72:50–4.
39. Spranger J. Appetite depressants in the management of obesity in children. An expanded double-blind
study with chlorphentermin (Avicol). Munch Med Wochenschr 1963;105:1338–41.
40. Spranger J. Phentermine resinate in obesity. Clinical trial of Mirapront in adipose children. Munch Med
Wochenschr 1965;107:1833–4.
41. Stauber T, Petermann F, Korb U, Bauer A, Hampel P. Cognitive behavioral stress management for
training obese children and adolescents. Monatsschr Kinderheilkd 2004;152:1084–94.
42. Strata A, Cucurachi L, Cucurachi P, Dell’anna A, Zuliani U. Model for clinico-pharmacological
experimentation with an appetite depressant. Clinical trial with a delayed-action preparation.
Clin Ter 1968;44:495–516.
43. Tak YR, An JY, Kim YA, Woo HY. The effects of a physical activity-behavior modification combined
intervention (PABM-intervention) on metabolic risk factors in overweight and obese elementary school
children. Taehan Kanho Hakhoe Chi 2007;37:902–13.
44. Wang L, Sun MX, Wang MF, Yan Y, Li BW, Zhong WJ, et al. Effects of different interventions on body
mass index and body fat content in overweight and obese adolescents. Chin J Clin Nutr
2011;19:16–18.
45. Wu X, Wang J, Dong H. Childhood obesity intervention study in Xuzhou. Mod Prev Med
2010;37:2225–6.
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46. Yang EJ. The effect of dumbbell exercise program training on body composition, blood lipids and
cognitive perception in obese high school girls. Korean Nurse 1998;37:51–67.
47. Yu C, Zhao S, Zhao X. Treatment of simple obesity in children with photo-acupuncture. Zhongguo
Zhong Xi Yi Jie He Za Zhi 1998;18:348–50.
48. Dobe M, Geisler A, Hoffmann D, Kleber M, von Koding P, Lass N, et al. The Obeldicks concept. An
example for a successful outpatient lifestyle intervention for overweight or obese children and
adolescents. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011;54:628–35.
49. Ferrer Lorente B, Fenollosa Entrena B, Ortega Serrano S, Gonzalez Diaz P, Dalmau Serra J.
Multidisciplinary treatment of pediatric obesity. Results in 213 patients. An Esp Pediatr 1997;46:8–12.
50. He YF, Wang WY, Fu P, Sun Y, Yu SY, Chen R, et al. Effects of a comprehensive intervention program
on simple obesity of children in kindergarten. Chin J Pediatr 2004;42:333–6.
51. Korsten-Reck U. Obesity in childhood and adolescence: experiences and results of the intervention
programme FITOC (Freiburg Intervention Trial for Obese Children) after 1.5 years. ZFA
2006;82:111–17.
52. Korsten-Reck U, Bauer S, Keul J. Sports and nutrition: an ambulatory care program for obese children
(long-term experiences). Padiatr Padol 1993;28:145–52.
53. Salas A MI, Gattas Z V, Ceballos S X, Burrows A R. Effects of psychological support as an adjunct to a
weight reducing program among obese children. Rev Med Chil 2010;138:1217–25.
Note: Full eligibility checking of the following citations has not been conducted.
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Appendix 28 Childhood obesity Outcomes
Review appraisal decision form: secondary outcomes
No. Diet First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
1 Korea FFQ Lee 200748 2 2 Very specific to Korean diet
and only TRT with
poor development
2 QFQ Yaroch 200041 2 2 Poor development with
inadequate evaluation
robustness scores
(TRT and validity= 2)
owing to sample size
and poor results
3 Short YAQ Rockett
200734
1 1 Although development was
not strong (although was
created from long version –
with good development),
evaluation is good for this
short, much-used tool
4 YAQ Rockett
199543
3 1 Well developed, but
evaluation not great
(validation was comparing
with other similar national
survey data and TRT had
poor results
(Note: later testing was in
slightly different version
and evaluation was better)
This is a long tool, and
may not always be
feasible in all evaluations
5 Rockett
199737
6 Perks 200030
(identified
from a review
post meeting)
7 Picture
sort FFQ
Yaroch 200042 3 2 Developed specifically for
obese/overweight, but has
poor TRT. Validation is
strong, but this is a long
tool and participants
were not involved
in development
Might be useful for those
with poor English/literacy,
learning difficulties or the
very young
8 CEHQ-FFQ Lanfer 201136 3 1 Very strong development
with good evaluation for
the tests that were
conducted (but are limited
by criterion of milk
consumption only)
9 Huybrechts
201131
10 ACAES Watson
200946
1 1 Very strong development
and good overall validation
(analysis needs to be
adjusted for BMI for
stronger validity)
11 Burrows
200832
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No. Diet First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
12 Brief diet
screener
Nelson 200944 3 2 Very strong development
(including participants) but
results for robustness were
poor based on low sample
size and correlations
13 Brief diet
screener
Davis 200945
14 Intake of
fried food
away from
home
Taveras
200551
2 2 Single item, poor findings
with poor development
15 FIQ Epstein 200049 2 2 Development not great,
with convergent validity in
only a small sample size
16 Diet fat
screening
measure
Prochaska
200150
3 1 Used in trial, although
developed as a screening
tool. Development and
results are strong but not
stratified by obese (and is
not focused on obesity)
Useful tool – but should
be used only if the
intervention focuses on
reduction of dietary fat.
Also specifically measured
in 14 years only
17 New
Zealand
FFQ
Metcalf
200347
1 1 Very strong development
and reliability testing, but
needs further validity
testing
18 HSFFQ Blum 199938 3 1 Good development, but
only tested for convergent
validity so far (which was
strong)
Note: at the point of
submission of this report,
authors contact CoOR to
notify that this FFQ has
been discontinued due to
costs of maintenance
Note: needs TRT
19 FFQ Crawford
199433
2 2 Development not strong/
clear and poor results
for the only testing
(criterion validity)
No TRT and limited to
preschool. More
testing required
20 DGI-CA Golley 201145 3 2 Development not strong/
clear but strong results
for construct validity
No TRT
21 FIFI-FFQ Vereecken
201039
(identified
after meeting)
2 No external decision, as this arrived (from the library)
after involvement from experts. Decision based on those
of similar tools
Early testing (convergent validity only) of this new tool
that has potential in the future
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No. Diet First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
22 Diet
history
Sjoberg
200353
2 2 Decision based on all diet
history papers. Although
strong correlations in
Sjoberg, others (Waling,54
Maffeis55), which were
stratified by obese, were
not strong and even worse
in obese samples
23 Waling 200954
24 Maffeis
199454
25 3-day
food
record
Maffeis
199455
3 2 All 3-day diaries considered
together in decision-making.
This has poor validity in
obese. Singh57 also shows
poor validity and Crawford33
has strong – but compares
with lunch-time
observations only
(others=DLW/Lusk’s)
26 O’Connor
200164
27 Crawford
199433
28 9-day
food diary
Singh 200957 2 2 Little development
information, with
poor validity
Diaries deemed to be
explanatory tools, but not
valuable as outcome
measures
29 2-week
food diary
Bandini
199058
2 2 Little development
information, with
poor validity
30 2-week
food diary
Bandini
199959
(identified
from a review,
post meeting)
31 Tape-
recorded
food
record
(3 day)
Lindquist
200060
3 2 Although reasonable
development and criterion
validity robustness, the
correlation with DLW was
very poor
32 Tape-
recorded
food
record
Van Horn
199056
(same paper
as above)
(identified
after meeting)
3 2
33 Tape-
recorded
240-hour
recall
Van Horn
199056
(identified
after meeting)
3 2
34 7-day
diet record
Bratteby
1998410
2 2 Little development
information, with
poor validity
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No. Diet First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
35 8-day
food
record
Champagne
199663
(identified
from a review,
post meeting)
3 2
36 Champagne
199862
(identified
from a review,
post meeting)
37 24-hour Baxter 200665 3 2 Decision for 24-hour recall
has been based on all
papers, which have varying
results Baxter results are
strong (compared with
observation) but there was
a significant effect of
obesity on accuracy.
Johnson showed poor
correlation with DLW. Lytle
and Crawford used direct
observation and both were
well correlated
TRT conducted but
showed odd correlations
with BMI. Validity studies
all have poor findings
38 Johnson
199668
39 Lytle 199867
40 Crawford
199433
41 DILQ Edmunds
200266
3 2 Developed for completion
in school. Development
strong, but statistical tests
are not great. Tested
responsiveness, but this
was not strong
42 DOCC Ball 200770 3 2 Well developed with strong
evaluation, but at child
centre level with no
description of sample
(even though diet is
measured on an
individual level)
Maybe suitable for
prevention/population
based research but is
high burden (researcher
administered)
43 FBQ Vance 200871 3 2 Strong development and
reliability, but criterion
validity results are not
clear/strong
44 Biomarkers Martinez de
Icaya 200069
(identified
after meeting)
3 2 Added after experts
provided feedback.
May be appropriate for
inclusion but needs to be
further considered in
future research
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No.
Eating
behaviours First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR
internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
1 ChEDE-
interview
Decaluwé
200481
3 2 Evaluation results/
robustness= variable
All screening tools for
ED (ED diagnosis) and
therefore not included on
this basis2 Bryant-
Waugh
1996411
Development and face
validity paper only
3 Tanofsky-
Kraff 2005413
4 ChEDE-Q Goossens
2010412
3 2 ED diagnosis
5 Jansen
2007229
6 Tanofsky-
Kraff 2003230
7 IFQ Baughcum
200174
3 1 Moderate development
and evaluation
Note: needs TRT
8 PFQ Baughcum
200174
3 1 Evaluation for
questionnaire structure
only (IC, FA). Stratified by
obesity for scores
(greater in obese)
Note: needs TRT
9 KEDS Childress
199389
3 2 Moderate development
and evaluation
ED diagnosis
10 QEWP-A Johnson
199990
2 2 Used by trial in past
(cited as Steinburg) but
not obesity outcome (ED)
ED diagnosis
11 Steinberg
200491
As above
12 DEBQ-C Van
Strien 200879
3 1 Reasonably strong tool.
No convergent validity
or responsiveness
Note: needs TRT
13 Banos
201183
14 Braet 200792
15 DEBQ-P Caccialanza
200498
3 1 Good structural validity,
little other
16 Braet 199778
17 ChEAT Maloney
198886
2 2 Variable results and
not designed (although
has been used in obesity
trial): ED
ED diagnosis
18 ChEAT Smolak
1994100
19 ChEAT Ranzenhofer
2008101
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No.
Eating
behaviours First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR
internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
20 EAT Wells
1985414
(identified
from a
review post
meeting)
2 2 Primary Development is in
adults (Garner and
Garfinkel 1979a). Little has
been done to make it
compatible for children
and adolescents. ChEAT is
later developed from this
and is more specific
to children
21 YEDE-Q Goldschmidt
200799
3 2 ED but used in trials.
Poor development but
strong evaluation
ED diagnosis
22 EES-C Turnofsky-
Kraff 200777
1 1 Strong tool, although
development did not
include participants
23 C-BEDS Shapiro
2007231
2 2 ED diagnosis
24 CFQ Birch 200175 1 1 Although studies should
ensure that it is
appropriate for their
specific population
characteristics, this is a
well-used tool with good
development and
reasonably strong
evaluation. Needs
responsiveness testing
Haycroft paper needs
double checking. Also
need to expand search to
include other validation
papers outside CoOR
remit
Needs responsiveness
testing
25 Haycraft
200893
26 Anderson
200596
27 Corsini
200897
28 Polat 201094
29 Boles
2010232
30 MRFS-III Shisslak
199987
2 2 Well developed and
robust, but ED – not
obesity (even although
previously used in a trial)
ED diagnosis
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No.
Eating
behaviours First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
CoOR
internal comments
Expert collaborator
comments
CoOR
internal
decision
Expert
consensus
decision
31 IFSQ Thompson
200976
3 1 Well developed but needs
more evaluation
Needs TRT
32 CEBQ Sleddens
200872
1 1 Reasonably well
developed, with good
robustness scores for
evaluation conducted.
Would benefit from
further criterion/
convergent validity
and responsiveness
Also available in other
languages [Portuguese
version picked up by
CoOR search
(Viana 200814)]
33 Wardle
200173
34 TSFFQ Corsini
201082
1 1 Well developed,
robust tool. Needs
responsiveness testing
35 KCFQ Monnery-
Patris 201185
3 1 Development not great,
but reasonable evaluation
May be more appropriate
in environmental domain
36 Carper
2000250
37 Un-named
(control in
parental
feeding
practices)
Murashima
201184
3 1 Good evaluation, although
construct validity findings
were very weak
Need to check relevance
to construct
38 EAH-C Tanofsky-
Kraff 200880
1 1 Development good,
except does not include
participants. All evaluation
very strong
39 Un-named
(parental
feeding
strategies)
Kroller
200888
2 2 Strong development, but
little evaluation and with
German population
Poor evaluation
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No. Physical activity Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments Expert comments
CoOR
internal
decision
Expert
consensus
decision
40 Accelerometer Kelly 2004105 1 1 Well-used tool with
reasonable validation.
Would benefit with
responsiveness testing
Fit for purpose but
often dependent
on the model.
Accelerometers will
improve and change
with time. The best
recommended
actigraph instrument
is GT31M. For
information on the
best types of
accelerometers please
refer to de Vries
review paper
41 Accelerometer –
Actigraph
Pate 2006107
42 Accelerometer –
Caltrac monitor
Noland
1990106
43 Accelerometer –
TriTrac Triaxial
Coleman
1997108
44 Accelerometer
(Actigraph)
Guinhouya
2009234
45 HR monitoring Maffeis
1995237
2 2 (May be more suitable
to Fitness domain)
Tested against DLW, but
found very large
variation in agreement
in obese (overall poor)
Poor in the individual
level and depends on
the calibration.
More superior when
used in combination
with accelerometer
46 Pedometer Kilanowski
1999114
3 1 Criterion validity testing
reasonably strong, but
little else tested
Objective tool so less
prone to bias. Again,
often depends on
type of pedometer47 Duncan
2007248
48 Jago 2006112
49 Mitre 2009110
50 Treuth 2003113
51 SenseWear
Pro2 Armband
Backlund
2010111
3 2 Validity testing strong,
but done with small
sample. Two models
tested, with stronger
results for model 5.1
52 3D-PAR Pate 2003417 3 2 Criterion validity testing
strong, but done with
small sample
All self-reports
deemed
inappropriate
53 AQuAA Slootmaker
2009117
2 2 Criterion validity testing
showed questionnaire
always overestimated
activity in obese
All self-reports
deemed
inappropriate
54 Activity rating
scale
Sallis 1993121 2 2 Poor validation results All self-reports
deemed
inappropriate
55 Godin–Shephard
Physical Activity
Survey
Sallis 1993121 3 2 TRT good, but validity
results poor
All self-reports
deemed
inappropriate
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No. Physical activity Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments Expert comments
CoOR
internal
decision
Expert
consensus
decision
56 7-day recall
interview
Sallis 1993121 1 2 Existing evaluation is
strong (better in
older children)
All self-reports
deemed
inappropriate
57 APARQ Booth 2002123 3 2 Good development
and strong TRT but
poor validation
All self-reports
deemed
inappropriate
58 CLASS Telford
2004115
3 2 Involved participants
in development.
Reasonable robustness
for evaluation, although
criterion validity results
were poor. Parent report
better than self-report
All self-reports
deemed
inappropriate
59 GEMS Activity
Questionnaire
Treuth 2003113 3 2 Only African American
girls. Reasonable
development, with good
TRT, but poor validation
All self-reports
deemed
inappropriate
60 Activitygram Treuth 2003113 2 2 Results of reliability and
validity testing were
poor (although
conducted well)
All self-reports
deemed
inappropriate61 Welk 2004
116
(identified
post meeting)
62 Moderate to
vigorous physical
activity screening
Prochaska
2001235
(study 3)
1 2 Good development,
with involvement of
participants and strong
criterion evaluation
(also did pilot study 1).
Needs responsiveness
testing
All self-reports
deemed
inappropriate
63 Prochaska
2001235
(study 2)
64 National
Longitudinal
Survey of
Children
and Youth
Sithole 2008130 2 2 Items within a National
Survey. Only inter-rater
reliability testing and
poor development
All self-reports
deemed
inappropriate
65 Outdoor Playtime
Checklist –
checklist
Burdette
2004122
(study 1)
2 2 Poor validation results,
and convergent validity
is (both tools) only
marginally better even
although were
compared with
each other
All self-reports
deemed
inappropriate
66 Outdoor Playtime
Checklist – recall
Burdette
2004122
(study 2)
2 2
67 Physical
Activity Diary
Epstein
1996119
2 2 Not great development
or evaluation
All self-reports
deemed
inappropriate
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No. Physical activity Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments Expert comments
CoOR
internal
decision
Expert
consensus
decision
68 PAQ Janz 2008129 3 2 Strong development,
but variable findings in
evaluation for all studies
(even though a lot of
evaluation has been
conducted). Criterion
validity is poor.
[Note: adolescent
version is similar in
terms of structure (with
odd words changed)
and finding – which is
why they have been
grouped together]
All self-reports
deemed
inappropriate69 PAQ-C Kowalski
1997118
70 PAQ-A Kowalski
1997125
71 PAQ-C Crocker
1997128
(study 1)
72 PAQ-C Crocker
1997128
(study 2)
73 PAQ-C Crocker
1997128
(study 3)
74 PAQ-C Moore 2007126
(study 1)
75 PAQ-C Moore 2007126
(study 2)
76 PAQ for
Pima Indians
Kriska 1990241 1 2 Reasonable
development, but very
poor evaluation
findings
All self-reports
deemed
inappropriate
77 PAQ for
Pima Indians
Goran 1997127
78 PDPAR Trost 1999418 3 2 Development and
validity not great, but
reliability is good and
this is a well-used tool
(there are likely to be
other papers that have
not yet been identified)
All self-reports
deemed
inappropriate79 PDPAR Weston
1997120
80 PDPAR Welk 2004116
81 PDPAR McMurray
2008419
82 YRBS Troped
2007238
2 2 Items within surveillance
tool with reasonable
TRT and criterion validity
– but only just. Not
designed as an outcome
measure, even although
it was previously used
as one
All self-reports
deemed
inappropriate
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No. Physical activity Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments Expert comments
CoOR
internal
decision
Expert
consensus
decision
83 SOCARP Ridgers
2010102
[previous
Category 4
(not eligible)
but
recommended
by experts]
1
84 OSRAC Brown 2006103
[previous
Category 4
(not eligible)
but
recommended
by experts]
1
ED, eating disorder.
Note that ‘study 1’ and ‘study 2’ are used to indicate manuscripts that report two studies in one paper. This is distinct from
manuscripts published in the same year by the same lead author, which are distinguished by their individual reference
citation numbers.
a Not linked to bibliography: Garner DM, Garfinkel PE. The eating attitudes test: an index of the symptoms of anorexia
nervosa. Psychol Med 1979;9:273–9.
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No.
Sedentary
behaviour First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments
Expert
comments
CoOR
internal
decision
Expert
consensus
decision
1 Accelerometer –
WAM-7154
Reilly 2003131 3 1 Only assessed criterion
validity, but results
were strong
Objective but can
often depend
on device
2 Accelerometer –
Actigraph
Puyau 2002132 Strong criterion and
convergent validity, but
small sample size for both
3 Mini-Mitter
Actiwatch
monitors
Puyau 2002132 3 1 Strong criterion and
convergent validity, but
small sample size for both
Objective but can
often depend
on device
4 MARCA Ridley 2006133 3 2 Well developed,
using participants
5 EMA: self-report
survey on
mobile phones
Dunton 2011134 3 2 Well developed,
using participants
Has potential but
needs to be
explored further
6 Habit books
with index cards
Epstein 2004135
(identified
post meeting)
3 2
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No. Fitness Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments Expert comments
CoOR
internal
decision
Expert
consensus
decision
1 6-minute walk
test (6MWD)
Morinder
2009138
3 2 Reasonable evaluation Body weight
dependent
2 Height-
adjustable
step test
Francis
1991148
3 2 Reasonable evaluation Body weight
dependent
3 20-m shuttle
run
Suminski
2004140
3 2 Reasonable evaluation Body weight
dependent
Further
evaluation required
4 Leger
1988139
5 International
Fitness Scale
(IFIS)
Ortega
2011136
1 2 Although development is
not great, evaluation
is robust
Self-report should not
be used to report CVF.
Also not valid for
change from baseline
to follow-up
6 Bioelectrical
impedance
Roberts
2009147
2 2 Large variation in findings
(especially by gender) and
magnitude of bias
7 Fitnessgram Morrow
2010140
2 2 Although developed for
obesity research, this is
school based (and likely to
be for prevention).
Good reliability, but no
validation conducted
8 Submaximal
Treadmill Test
Nemeth
2009149
3 2 [Stats need checking – not
confident that extracted
value relates to model
building and not validation]
Body weight
dependent
9 BMR with
fat-free mass
Drinkard
2007143
2 2 Although significant
correlations – limits of
agree are outside
acceptable range and there
was sign magnitude of bias
in obese
10 Estimated
maximal
oxygen
consumption
and maximal
aerobic power
Aucouturier
2009144
2 2 Although significant
correlations= poor
agreement and authors
suggest the estimated
measures are not valid
11 Physical
working
capacity on
cycle ergometer
Rowland
1993145
(identified
post
meeting)
3 2
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No. Fitness Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments Expert comments
CoOR
internal
decision
Expert
consensus
decision
12 Aerobic
cycling power
Carrel
2007146
2 2 Poor results for validation
tested in a small sample size
Based on this single
study no but for
wider evidence it is
considered a good
tool
13 Measured
VO2 peak
Loftin
2004141
3 1 Good validity for both bike
and treadmill, but bike was
more acceptable to
participants
Measured VO2 peak
(bike) is often referred
to as a criterion
measure
14 Harvard
Step Test
Meyers
1969142
(identified
post
meeting)
Body weight dependent
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No. Physiology First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments (note: not
judged on
development, as these
measures were not
developed specifically
for obesity) Expert comments
CoOR
internal
decision
Expert
consensus
decision
1 Indices of
insulin
sensitivity
Yeckel
2004152
1 1 All comparing fasting
indices with gold
standard (clamp or
OGTT). Strong results
throughout, indicating
the fasting measures are
a reasonably good
surrogate
Good in epidemiology
with large samples as
opposed to an
individual level
A clamp should be used
in smaller studies. They
are good surrogates for
insulin sensitivity but
puberty status may
affect results
2 Fasting indices
of insulin
sensitivity
Conwell
2004153
3 Indices of
insulin
sensitivity
George
2011154
4 Gunczler
2006155
5 Uwaifo
2002156
6 Insulin
sensitivity and
pancreatic beta
cell function
Gungor
2004158
7 Fasting indices
of insulin
sensitivity
Atabek
2007159
8 Homeostasis
model
assessment of
insulin
resistance
Keskin
2005160
9 Rossner
2008161
10 Indices of
insulin
sensitivity
Schwartz
2008162
11 Impaired
fasting glucose
Cambuli
2009163
3 2 Low sensitivity, but
high specificity
12 Hyperglycaemic
clamp
Uwaifo
2002157
3 2 Comparison of two gold
standards, basing
euglycaemic clamp as
the primary. Found
hyper to overestimates
Good measure but not
appropriate for obese
sample
13 Oral Glucose
Tolerance
Test (OGTT)
Libman
2008164
3 2 Results for TRT are
reasonable, but unclear
for validity
14 13C-glucose
breath test –
insulin
resistance
Jetha 2009165 3 2 Although results are
good, they are variable
Diagnostic
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No. Physiology First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments (note: not
judged on
development, as these
measures were not
developed specifically
for obesity) Expert comments
CoOR
internal
decision
Expert
consensus
decision
15 Ultrasound
analysis of
liver
echogenicity
Soder
2009177
3 2 Good correlation
between radiologists
using three ultrasound
units, but no
further testing
16 HbA1c Nowicka
2011174
3 2 Overall= poor sensitivity
17 Ghrelin Kelishadi
2008175
3 2 Poor construct validity
but has tested
responsiveness, which
was good
18 PPG Russoniello
2010420
(included
post meeting)
Feedback from experts
on the provisional
CoOR Framework,
including consideration
of this measure, did not
lead to its inclusion
19 Estimated
resting
metabolic rate
Molnar
1995166
3 2 All compared predicted
REE with measured REE.
Variable results but all
suggest that predictions
are adequate.
Hofsteenge results are
not as good and this is
specifically for
obese sample
20 Predicted REE Rodriquez
2002167
21 Lazzer
2006168
22 Firouzbakhsh
1993169
23 Derumeaux-
Burel 2004170
24 Predicted REE Hofsteenge
2010171
25 DXA-lean body
mass for REE
Schmelzle172 1 2 Strong results
26 BMR with
fat-free mass
Dietz 1991173 3 2 Derivation of fat-free
mass not clear,
therefore comparisons
not clear. Results
are poor
OGTT, oral glucose tolerance test; REE, resting energy expenditure.
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No.
Health-related
quality of life First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments
Expert
comments
CoOR
internal
decision
Expert
consensus
decision
1 Child Health
Questionnaire
(CHQ)
Waters
2000192
3 1 CoOR appraisal scores for quality are
poor. Convergent validity results
presented only for significant items
2 Landgraf
1998186
3 Waters
2000193
4 DISABKIDS Ravens-
Sieberer
2007194
(study 1)
3 1 Strong development and evaluation
but only did IC and convergent validity
5 KIDSCREEN Ravens-
Sieberer
2007194
(study 2)
3 1 Strong development and evaluation
but only did IC and convergent validity
6 EQ-5D-Y Burstrom
2011241
2 1 Well-used, historical tool with further
testing in sample stratified by obese
Convergent validity with youth
version doing better than original
adult version
7 Burstrom
2011242
8 Wille
2010243
9 Ravens-
Sieberer
2010244
Also measure TRT with strong
agreement (although kappa
less strong)
10 Impact of Weight
on Quality of
Life (IWQoL)
Kolotkin
2006181
1 1 Strong evaluation – including
responsiveness. Also tested in a
Dutch study (identified by CoOR),
although not able to translate
Wouters 201015
11 Modi
2011182
12 KINDL-R
Questionnaire
Erhart
2009187
3 1 Good evaluation of IC, FA and
convergent validity, but development
not strong
13 Paediatric Cancer
Quality of
Life Inventory
Varni
1998188
3 2 This tool was used as a basis for
construction of the PedsQL
14 Paediatric Cancer
Quality of Life
Inventory (long)
Varni
1998195
Only evaluates inter-rater and not
specific to obesity
15 Paediatric Quality
of Life
Inventory V4.0
Varni
2001191
1 1 Development acceptable and
strong evaluation
16 Paediatric Quality
of Life
Inventory V4.0
Varni
2003190
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No.
Health-related
quality of life First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Comments
Expert
comments
CoOR
internal
decision
Expert
consensus
decision
17 Hughes
2007196
18 Paediatric Quality
of Life V1.0
Varni
1999189
2 2 First version – updated since
19 Sizing Me Up Zeller
2009183
3 1 Overall very good – but no
involvement of participants and poor
construct validity
20 Sizing Them Up Modi
2008184
1 1 Very high evaluation scores but no
participant involvement
in development
21 Youth Quality of
Life Instrument –
Weight Module
(YQOL-W)
Morales
2011185
1 1 Very good development and strong
evaluation specific for obese
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No.
Psychological
well-being First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Decision of
certainty:
1. certain – good
evidence, fit for
purpose;
2. certain – poor
evidence, not fit
for purpose;
3. uncertain –
requiring
further
consideration Expert comments
CoOR
internal
decision
Expert
consensus
decision
1 Children’s Body
Image Scale (CBIS)
Truby 2002198 3 1 May be more
appropriate for ED
research, although
was stratified
by obesity
Developed specifically
for children’s body
image perception for
eating disorders.
Additional manuscript
Truby 2004; Br J
Psychol (not
identified by CoOR)
2 Body figure
perception
(pictorial)
Collins 1991205 3 1 Good development
but evaluation
less strong
Needs further
evaluation. Is
reference population
relevant to UK?
3 Self-Control Rating
Scale (SCRS)
Kendall 1979197 3 2 Development not
strong but has
been tested
thoroughly.
However,
robustness score
always fails for
poor results in
validity testing
4 Self-Perception
Profile for
Children (SPPC)
Van
Dongen–Melman
1993209
1 1 Used participants in
development and
all evaluation tests
were strong. Needs
responsiveness
testing
Experts also noted a
version that is used in
adolescents (SPPA),
which was not
identified by the
CoOR search
The ‘Perceived
Importance Profile’
(PIP) Whitehead
1995;182,210 below) is
an add-on to the
SPPC and should be
used in conjunction
to determine the
degree to which
children feel their
perceptions of their
selves is important
5 Perceived
Competence Scale
(aka SPPC/Harter)
Harter 1982199 Same tool (name
change) as SPPC
6 Physical Activity
Enjoyment
Scale (PACES)
Motl 2001252 3 1 Used participants in
development, but
only assessed CFA
(which was strong)
For use in
adolescents only
7 Self-report
Depression
Symptom Scale
(CES-D)
Radloff 1991246 2 2 Poor development,
and assessed IC
only (in which
a< 0.7). Developed
originally for adults
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No.
Psychological
well-being First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Decision of
certainty:
1. certain – good
evidence, fit for
purpose;
2. certain – poor
evidence, not fit
for purpose;
3. uncertain –
requiring
further
consideration Expert comments
CoOR
internal
decision
Expert
consensus
decision
8 Children’s Physical
Self-Perception
Profile (C-PSPP)
Whitehead
1995210
1 1 Good development,
including
participants. Strong
reliability and good
structure, but needs
further evaluation
9 Children’s Physical
Self Perception
Profile (C-PSPP)
Eklund 1997245
(identified
post meeting)
10 Children’s
Perceived
Importance Profile
(C-PIP)
Whitehead
1995210
3 1 Developed without
participants. Tested
in small sample,
with reasonable
results
More testing needed,
especially construct
validity, but is
recommended to use
in conjunction with
the SPPC
11 Children’s Self-
perceptions of
Adequacy in
Predilection for
Physical
Activity (CSAPPA)
Hay 1992211 1 1 Well developed,
with strong results
12 Body Shape
Questionnaire
(BSQ)
Conti 2009206 3 2 Poor development
with moderate
results
Developed for adults
13 Children’s Physical
Self-concept
Scale (CPSS)
Stein 1998207 1 1 Strong
development using
participants, with
strong evaluation,
although needs
more testing
(showed
discriminate validity
by obesity)
14 Pediatric Barriers to
a Healthy Diet
Scale (PBHDS)
Janicke 2007200 3 2 Well developed
with participants,
with good
robustness scores
for evaluation.
However, all lost
scores relate to
poor results
Needs much more
evaluation;
diet focused
15 Body Image
Avoidance
Questionnaire
(BIAQ)
Riva 1998421 3 2 Development not
great, but internal
testing on scale is
very good. Needs
more evaluation
16 Video distortion Probst 1995208 3 2 Poor development
with reasonable
evaluation
Technically difficult;
developed for
disordered eating
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No.
Psychological
well-being First author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Decision of
certainty:
1. certain – good
evidence, fit for
purpose;
2. certain – poor
evidence, not fit
for purpose;
3. uncertain –
requiring
further
consideration Expert comments
CoOR
internal
decision
Expert
consensus
decision
17 Social Anxiety
Scale for
Children–Revised
version (SASC-R)
La Greca 1993202
(identified
post meeting)
3 1 Both large studies
with multiple
evaluation (IC, FA,
TRT, convergent
validity) with fairly
strong results,
but – not tested
for obese. Included
as identified in
search 1 (already
being used)
Basis of development
and subsequent use
is not child obesity,
but social anxiety is
an issue in some
obese children.
Measure is fit for
purpose and social
anxiety is an issue in
some obese children
18 Social Anxiety
Scale for
Children (SASC)
La Greca 1988201
(identified
post meeting)
19 Nowicki–Strickland
Locus of Control
Scale (NS-LOCS)
Nowicki 1973203
(identified
post meeting)
3 2 Fairly robust testing
in large samples.
May be dated
Met criterion for
eligibility but the
basis of development
and subsequent use
is not child obesity
20 Body Esteem
Scale (BES)
Mendelson
1982204
(identified
post meeting)
3 1 Minimal testing in
small sample.
Identified through
a review and
presents results
by obesity
[construct validity
correlation with
weight (R= 0.55)]
Long pedigree in
child obesity
research. It has gone
through a few minor
modifications and is
still the best measure
of this construct in
the context of child
obesity. Fewer people
are using a single
measure of body
esteem, as most
measures of
dimensional
self-esteem and
quality of life include
some assessment of
satisfaction with
appearance.
However, I would
definitely recommend
the measure for
inclusion and would
specify the version in
the citation: www.
sciencedirect.com/
science/article/pii/
S0193397396900301
CFA, confirmatory factor analysis.
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No. Environment Author
Decision of certainty:
1. certain – good
evidence, fit for
purpose; 2. certain –
poor evidence,
not fit for purpose;
3. uncertain –
requiring further
consideration
Internal appraisal comments
Expert
appraisal
comments
CoOR
internal
decision
Expert
consensus
decision
1 Nutrition and
Physical Activity
Self-assessment to
Child
Care (NAPSACC)
Benjamin
2007247
1 1 Very good development and
strong criterion validation (but a
child-care centre tool)
Has good
potential, but
may be too
intervention
specific (may
not be
generalisable)
2 Environment
and Policy
Assessment and
Observation
(EPAO)
Ward
2008213
3 2 Development involved users,
but has no information on
individual level. Needs further
assessment (inter-rater
very strong)
High degree
of burden
3 Healthy Home
Survey (HHS)
Bryant
2008214
2 2 First stage of testing, (second
version has been developed –
but is in analysis phase)
4 Environment and
Safety Barriers to
Youth Physical
Activity
Questionnaire
Durant
2009220
1 1 Very strong tool but would
benefit with criterion validity
and responsiveness
5 Family Eating and
Activity Habits
Questionnaire
(FEAHQ)
Golan
1998215
3 2 Has potential (and has strong
results for responsiveness), but
needs further testing (reliability
results were poor)
Poor reliability
in small sample.
Cross-cultural
validity not clear
6 Parenting
Strategies for
Eating and Activity
Scale (PEAS)
Larios
2009216
3 2 Good internal structure but
some of the evaluation results
are poor
Poor
psychometrics
7 Family Food
Behaviour
Survey (FFBS)
McCurdy
2010217
3 2 Holds potential, but has poor
robustness because of sample
size in evaluation
Small sample
size
8 Home Environment
Survey (HES)
Gattshall
2008218
1 1 Very well developed with strong
evaluation, but is quite long
9 Electronic
equipment scale
Rosenberg
2010219
(study 1)
1 1 Well developed using
participants with strong
validation. Needs criterion and
responsiveness testing
10 Home Physical
Activity
Equipment scale
Rosenberg
2010219
(study 2)
1 1 Well developed using
participants with strong
validation. Needs criterion and
responsiveness testing
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